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ABSTRACT 
  
 
ELIZABETH RADCLIFF.  Effects of hydrocephalus on hospital use, associated costs, 
and access to care among children with spina bifida.  (Under the direction of DR. 
SARAH B. LADITKA and DR. CYNTHIA H. CASSELL) 
 
 
 Objectives: This study examined hospital resource use, including timeliness of 
surgical repair of spina bifida (SB), and geographical access to hospital care, by the 
presence of hydrocephalus, isolated or non-isolated SB, and selected sociodemographic 
characteristics among children with SB.  
 Methods: This was a retrospective, statewide, population-based study of children 
with SB, born in Florida 1998-2007, identified by the Florida Birth Defects Registry and 
linked to hospital discharge records.  Information about hospitalizations, lengths of stay, 
and costs were obtained from hospital discharge data for infants (<1 year) and children 
ages one to four years.  Time to SB surgical repair was calculated using procedural codes 
and hospital discharge data.  One-way travel time and distance to access hospital care 
were calculated using geocoded maternal residential addresses, hospital addresses, and 
Florida road networks.  Chi-square tests and logistic, Poisson, generalized linear 
regression, and ordinary least squares were used to examine the study objectives.  Models 
were adjusted for hydrocephalus; isolated (no other major birth defect) vs. non-isolated 
SB, and selected predisposing, enabling, and need characteristics 
 Results: Of 614 children, 42.4% of children had isolated SB and hydrocephalus; 
32.3% had isolated SB without hydrocephalus; 14.5% had non-isolated SB and 
hydrocephalus, and 10.9% had non-isolated SB without hydrocephalus.  In adjusted 
results, infants with isolated SB and hydrocephalus had 53% more hospitalizations and 
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2.6 times the number of hospitalized days and costs compared with infants with isolated 
SB without hydrocephalus.  Infants and children with non-isolated SB and hydrocephalus 
had twice the number of post-birth hospitalizations and hospitalized days than children 
with isolated SB without hydrocephalus, but only about 40% higher costs.  Regarding 
timeliness of surgical repair, of 299 infants with a recorded repair, 68.6% had repair by 
day two, 15.1% had repair days three through seven, and 16.4% had repair after day 
seven.  In adjusted results, hydrocephalus was the only characteristic associated with 
repair by day two (adjusted prevalence ratio=1.80, 95% confidence interval: 1.31-2.48).  
Of 612 children with a geocoded address, 56.4% of infants and 61.4% of children had a 
one-way average travel time of ≤30 minutes to hospitals.  Infants with non-isolated SB 
and hydrocephalus traveled the longest to hospitals (mean: 60.8; median: 34.2; range 5-
494 minutes).  In adjusted results, non-isolated SB, maternal minority race/ethnicity, 
lower maternal education, and rural residence were associated with lower likelihood of 
traveling ≤30 minutes to hospitals during infancy. 
 Discussion: Comorbidities substantially increase hospital resource use for 
children with SB, particularly during infancy.  Results also showed that the majority of 
infants with SB had a timely repair.  Infants with non-isolated SB and hydrocephalus 
traveled the longest to access hospital care.  Findings underscore the need to consider 
comorbidities when examining hospital resource use for children with SB and other birth 
defects.  Results also demonstrate that birth defects registry data and GIS-based methods 
are useful to evaluate geographical access to hospitals for children with birth defects. 
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CHAPTER 1: INTRODUCTION 
 
 
1.1 Background of Birth Defects and Spina Bifida 
An infant is born with a birth defect every 4.5 minutes, and major birth defects are 
diagnosed in 3% of all live births in the United States [1-3].  Birth defects are conditions 
present at birth that involve structural or functional abnormalities in one or more parts of 
the body, and may result in adverse effects on a child’s health, development, and 
functional capacities [2, 4, 5].  Birth defects are among the leading causes of pediatric 
hospitalizations and contribute substantially to the health care costs in the United States 
[2, 6-8].  Birth defects are also the leading cause of mortality during the first year of life, 
accounting for 20% of all infant deaths [9]. 
Spina bifida (SB), one type of major birth defect, is a neural tube defect (NTD) 
that results from a failure of the caudal neural tube to fuse early in embryonic 
development [10, 11].  This complex birth defect affects approximately 1,500 live-born 
U.S. infants each year [1] and typically requires life-long, multidisciplinary health care.  
Children with special health care needs (CSHCN), a broader group that includes children 
with birth defects, typically use more health services, have greater costs, and face more 
barriers when accessing health services than children without special health care needs 
[2, 7, 12-15].  We know that children with SB have greater hospital costs than children 
who do not have SB and that they incur their greatest costs during their first year of life 
[14].  Spina bifida may be accompanied by multiple comorbidities.  The presence of
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comorbidities may influence health care use and costs [16, 17].  Timely surgical repair of 
SB may reduce the effects of certain comorbidities and mortality associated with SB [16, 
18-21]. 
1.2 Statement of Problem 
 Gaps exist in our understanding of how specific comorbidities affect hospital use 
and access to care among children with SB.  In addition, little information is available 
about how the effects of comorbidities may change across payer types and through 
childhood.  Few studies have examined timeliness of services for children with SB, 
including the percentage of infants who have a timely surgical repair of SB. 
The objective of my dissertation research was to explore the effects of 
comorbidities including hydrocephalus, one of the most common comorbidities 
associated with SB, on hospital resource use (number of hospitalizations, number of 
hospitalized days, and associated inpatient costs) and access to hospital care for children 
with SB.  My study also explored predisposing, enabling, and need characteristics 
associated with hospital resource use and access to hospital care.  In addition, my study 
explored predisposing, enabling, and need characteristics associated with timely surgical 
repair of SB and the effect of hydrocephalus and isolated versus non-isolated SB on 
timely surgical repair of SB. 
1.3 Overview of Data Sources  
This dissertation research was a retrospective, statewide, population-based 
analysis of inpatient hospital use and access to care for children with SB ages birth 
through four years born in Florida between January 1, 1998, and December 31, 2007.  
Florida was chosen because it provided a robust and diverse study population.  The state 
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of Florida was the fastest growing and fourth most populous state according to the 2000 
U.S. Census [22, 23].  In addition, Florida was fourth in number of annual live births, 
second in number of live births to non-Hispanic Black women, and third in number of 
live births to Hispanic women during the study period of 1998-2008 [22-24]. 
The state of Florida also supports a statewide, population-based birth defects 
registry and a statewide agency for the collection of hospital discharge data that provided 
information for this project.  The statewide, population-based study sample used in this 
study included linked, longitudinal data from the Florida Birth Defects Registry (FBDR) 
and the Florida Bureau of Vital Statistics, both within the Florida Department of Health 
(FDOH), and from the Florida Agency for Health Care Administration (AHCA).  These 
agencies provided robust, diverse sources of information for this project. 
The Florida AHCA is a statewide organization that oversees Florida’s Medicaid 
program and the licensure of the state's 41,000 health care facilities [25].  The Florida 
AHCA provided the hospital discharge data for this research project.  The Florida AHCA 
data included information on inpatient and ambulatory hospital use and charges for 
registered Florida hospitals, birth centers, and surgical centers in the state [25]. 
The FBDR is a statewide, population-based surveillance system that uses passive, 
case-finding techniques to identify infants having at least one FBDR-eligible 
International Classification of Disease, Ninth revision; Clinical Modification (ICD-9-
CM) code diagnosed during the first year of life [26-28].  The FBDR includes live-born 
infants whose mothers are Florida residents at the time of the infant’s birth.  The FBDR 
excludes infants who were adopted or prospective adoptees or whose mothers delivered 
out-of-state [27].  The Florida Bureau of Vital Statistics provided official birth and death 
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records for the FBDR [27].  In addition to vital statistics data, the FBDR identifies 
diagnosis codes present in several other datasets to increase case ascertainment and 
provide a more complete registry of birth defects in Florida.  These data include 
information from the Centers for Medicare and Medicaid Services Minimum Data Set 
and from the Early Steps Program data set.  The FBDR merges information from these 
datasets to create a single, non-duplicated dataset of Florida infants with birth defects.   
Algorithms involving maternal, paternal, and child social security numbers were 
used by the FBDR as the primary linking variables; additional linkages were based on 
demographic and medical data.  The linking rates varied across data sets from 85% to 
95%; the overall linkage rates provided a robust study size for this research [28, 29].  An 
evaluation of the FBDR found that the program correctly identified 86.6% of infants born 
with selected birth defects between 2003 and 2006 [29].  FBDR case ascertainment for 
SB without anencephaly during 2003-2006 was 87.9% [29]. 
The FDOH, the FBDR, the Florida AHCA, and the University of South Florida 
have collaborated for over 15 years to create the state of Florida’s birth defects registry.  
As part of a collaborative project with the University of North Carolina at Charlotte 
(UNC Charlotte), the University of South Florida and the FDOH created a subset of 
infants in the FBDR with selected major birth defects that linked FDBR records to the 
Florida AHCA discharge records.  The longitudinal data for this project included 
inpatient and outpatient hospitalizations that were initiated between January 1, 1998 and 
December 31, 2008.  This allowed for at least one year of hospitalizations for each infant 
with SB.  Data linkage was conducted by the FDOH and the University of South Florida 
using a step-by-step linking strategy.  Linkage was conducted in stages that ranged from 
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high to lower levels of confidence in the linkage.  For example, stage 1 consisted of an 
exact match between infant Social Security Number (SSN), maternal SSN, infant date of 
birth, and infant sex.  Subsequent stages included linkages based on less exact matches 
between infant and maternal SSNs; crossover matching between infant, maternal, and 
paternal SSN; and “fuzzy” matching on date of birth (e.g., a one or two day variability in 
date of birth or reversed month and day digits).  When a link was established during a 
given step, the record was then removed from the pool of available records to be linked 
during subsequent, lower-confidence stages.  Linkage was conducted separately for 
infants born as singletons versus those born as part of a multiple (twin or triplet) birth 
because multiple births increase the complexity of linkages steps.  Details of this stepwise 
linking strategy have been described previously [30]. 
Following secure transmission of these linked data sets to UNC Charlotte, data 
from children with neural tube defects were merged with the two Florida AHCA data 
sets.  Neural tube defects, specifically SB without anencephaly, were identified using the 
ICD-9-CM codes 740.0, 740.1, and 741.00-741.93.  The first Florida AHCA data set was 
an infancy dataset that contained data on hospitalizations initiated during the first year of 
life.  The second Florida AHCA data set was a longitudinal dataset that contained data for 
hospitalizations initiated after the first year of life.  Hospital discharge data from January 
1, 1998 through December 31, 2008 were used to allow for at least one year of 
hospitalizations for each infant with SB.  Because of increasingly smaller numbers over 
the years, I only used data from birth through four years for the statistical analyses in my 
dissertation.  
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In the study period of 1998-2007, Florida reported 2,135,079 live births [27].  
Among the 2.1 million infants, the FBDR identified about 70,000 infants who were born 
with a major birth defect [27].  The University of South Florida and the FDOH created a 
subset of 52,759 FBDR infants with selected major birth defects, including SB, which 
linked to the Florida AHCA discharge records.  Figure 1.1 (page 9) shows the process for 
identification of infants for the final study samples. 
1.4 Data Management  
This dissertation used data from a larger research project funded by the March of 
Dimes Foundation grant #5-FY09-533, conducting research under protocols approved by 
the FDOH Institutional Review Board (IRB), the Centers for Disease Control and 
Prevention’s (CDC) National Center on Birth Defects and Developmental Disabilities 
(NCBDDD) IRB, and by the UNC Charlotte IRB) (Protocol #12-07-12).  The UNC 
Charlotte IRB Protocol #12-07-12 is valid through July 15, 2014.  For the purpose of my 
dissertation, a new protocol was submitted and approved by the UNC Charlotte IRB 
(Protocol approval #12-12-24).  
The data acquired from the FBDR and the Florida Bureau of Vital Statistics, 
within the FDOH, and from the Florida AHCA, and provided by the University of South 
Florida were de-identified except for maternal residential address at the time of the 
infant’s birth and corresponding longitudinal and latitudinal (X, Y) coordinates.  
Appropriate measures, including storage of data on a secure network, remained in place 
throughout this project to ensure confidentiality of the data.  Data use agreements were 
also in place, signed by the respective agencies necessary to carry out this dissertation 
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project.  The agencies signing the data use agreements included the FDOH, the 
University of South Florida, the CDC’s NCBDDD, and UNC Charlotte. 
1.5 Relevance to Current Health Care Priorities 
The goals of Healthy People 2020 highlight the need to increase the proportion of 
CSHCN who have access to a medical home [31].  Similarly, the Spina Bifida 
Association’s 2012 Congressional Policy Agenda called for ensured access to care for 
individuals with SB, especially through provision of adequate insurance [32].  Experts 
convened by the CDC helped establish public health research priorities, including 
timeliness of services and access to care, for selected birth defects including orofacial 
clefts, craniosynostosis, congenital heart defects, and Down syndrome [33-36].  Finally, 
the National Institute of Health has recognized pediatric hydrocephalus as an under-
researched area [37].  Findings from my dissertation addressed these identified health 
care priority areas by examining access to care and standards of care for children with 
SB.  Findings from my dissertation research contribute new information to our 
understanding of how hydrocephalus and isolated vs. non-isolated SB influence health 
resource use and access to care as comorbidities to SB. 
1.6 Objectives of my Dissertation Research 
My dissertation research focused on health resource use, timeliness of care, and 
access to care among children with SB, a type of birth defect that is included under the 
broader category of CSHCN.  My research had three specific objectives.  The first 
objective was to examine the effects of hydrocephalus, as well as other predisposing, 
enabling, and need characteristics, on hospital use and associated costs among children 
with SB (Chapter 3).  The second objective was to explore predisposing, enabling, and 
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need characteristics associated with the timeliness of primary surgical repair of SB 
(Chapter 4), including the role of hydrocephalus and isolated versus non-isolated SB.  
The third objective was to investigate the effects of hydrocephalus, as well as other 
predisposing, enabling, and need characteristics, on access to hospital care in terms of 
travel time and distance for children with SB (Chapter 5).  Aday and Anderson’s 
Framework for the Study of Access to Medical Care provided the theoretical structure for 
my research.  Chapter 2 reviews the literature that is relevant to my research topics. 
My research improved upon previous studies in several ways.  First, it addressed 
topics in health care priority areas by providing a better understanding of the influence of 
the comorbidity hydrocephalus on hospital resource use and access to care among 
children with SB.  Second, by reporting the percentage of children who had timely 
surgical repair of SB, the results of this research contributed to our knowledge of 
adherence to standards of care for children with SB.  Findings also suggested factors 
associated with timeliness of surgical repair among children with SB.  Understanding 
factors associated with timely care are important because of known associations between 
timing of the surgical repair of SB and later comorbidities.  Finally, findings of this 
research added to our understanding of geographic access to care for children with SB 
with findings based on Geographic Information Systems (GIS) methods. 
Increasing our understanding in each of these areas can help inform opportunities 
for improved health service delivery, health outcomes, and quality of life for children 
with SB and their families.  My research can also help inform research for children with 
other types of birth defects. 
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Figure 1.1 Selection of the three study samples for examination of Aim 1) hospital 
resource use, Aim 2) timely surgical repair of SB, and Aim 3) geographical access to 
hospital care among Florida-born children with spina bifida, birth through four years of 
age, 1998-2007 
 
 
1. All Florida live-births, 1998-2007:  
     2,135,079 children 
2. All Florida-born children with selected major 
birth defects, 1998-2007:  
    52,759  children, unduplicated  
3. Florida-born children with neural tube 
defects  
     914 children 
4. Florida-born children with spina bifida (SB) 
without anencephaly:   
     668 children 
5. Florida-born children with SB and linked 
hospitalizations:   
      AIM 1 STUDY SAMPLE:  614 children 
      Examined for hospital resource use and costs 
7. Florida-born children with SB & 
geocoded maternal residential address 
at birth: 
 
AIM 3 STUDY SAMPLE: 612 children 
Examined for travel time and distance 
6. Florida-born children with SB, a  
birth hospitalization, a surgical repair 
 of SB, and no neonatal death: 
 
AIM 2 STUDY SAMPLE: 299 children 
Examined for timely repair 
 
 
 
CHAPTER 2: LITERATURE REVIEW 
 
 
My review of the literature begins with an overview of the nature, prevalence, and 
significance of birth defects in the U.S. health care system, with a specific focus on the 
epidemiology of spina bifida (SB).  I continue with a description of the current 
management and treatment of SB and an explanation of isolated versus non-isolated SB 
and associated comorbidities, including hydrocephalus.  I then describe research that 
examined the influence of comorbidities on health outcomes for children with SB and 
literature related to the timeliness of the primary surgical repair of SB.  Next, I review 
current literature on hospital resource use, including measures such as charges, costs, and 
numbers and lengths of hospital admissions for children with birth defects, including SB.  
Finally, I describe findings on the role of predisposing, enabling, and need characteristics 
on hospital resource use, timeliness of care, and access to care for children with birth 
defects, including SB.  Chapter 2 concludes with a description of how this literature, 
coupled with the Aday and Anderson Framework for the Study of Access to Medical 
Care, provided a theoretical and literature-informed framework for my dissertation 
research. 
2.1 Overview of Birth Defects: Definition, Prevalence, and Significance 
Birth defects are conditions present at birth that involve structural or functional 
abnormalities in one or more parts of the body [2, 4, 5].  Birth defects can result in 
adverse effects to a child’s health, development, and functional capacities [2].  Most birth 
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defects occur early in pregnancy, typically during the first trimester [4, 5].  Some birth 
defects are due to genetic or chromosomal abnormalities (e.g., an extra chromosome 21 
results in Down syndrome).  Other birth defects may be caused by environmental 
exposures (e.g., fetal alcohol spectrum disorders may result from drinking alcohol during 
pregnancy) or by deficiencies in certain micronutrients (e.g., a folic acid deficiency is 
associated neural tube defects) [5, 38, 39].  Birth defects can also be associated maternal 
age, diabetes, obesity, or infection [4, 39].  The specific causes of most birth defects, 
however, remain unknown.  Most birth defects are thought to be the result of multiple 
factors [4, 5]. 
In the United States, an infant is born with a birth defect every 4.5 minutes [5].  
The overall prevalence estimate of major birth defects in the United States is 1 in 33 or 
approximately 3% of all live births [1, 3].  Birth defects are a leading contributor to 
disability and pediatric hospitalizations and accounted for more than $2.6 billion in 
annual hospital costs in the United States in 2004 [2, 6-8].  In addition, birth defects are 
the leading cause of death during the first year of life, accounting for more than 20% of 
all infant mortality [9].  The impact of birth defects on children, families, and health care 
systems make birth defects an important focus for public health and health services 
research. 
2.2 Overview of Spina Bifida, a Specific Major Birth Defect  
2.2.1 Description of Spina Bifida 
Neural tube defects (NTDs) are a type of birth defect that affect the central 
nervous system and that occur very early in embryonic development, usually by the 28th 
day post-conception [10, 11].  The birth defect category of NTDs includes several 
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different types of central nervous system malformations, such as omphalocele, 
encephalocele, anencephaly, and SB [10, 11, 40, 41].  Anencephaly, a defect not typically 
compatible with life, and SB without anencephaly are the most common forms of NTDs 
[11, 41, 42].  
Spina bifida is specifically a defect in which the caudal neural tube does not close 
completely at some point along the spine from the cervical to the sacral regions [10, 11].  
Spina bifida occulta (“closed”) occurs when a small gap in the spine exists, but no 
opening occurs on the back, thus the spinal cord and nerves remain essentially intact [10, 
11, 41].  This type of SB presents few health care problems and may not be diagnosed at 
birth [43].  Meningomyelocele, an “open” type of SB, involves the herniation of both the 
meninges (the membranes that surround the central nervous system) and the spinal cord 
into a sac outside the vertebral column [10, 43].  Meningomyeloceles are the most serious 
and most common presentation of SB and may result in significant disability [11, 41].  A 
2012 National Birth Defects Prevention Study used population-based birth defects 
surveillance data from a 10-state area to examine infants with various presentations of SB 
[42].  The researchers found that 85.6% of infants with SB had the subtypes of SB that 
included myelomeningocele, meningocele, and myelocele [42].  Other research reports as 
many as 90% of children with SB have the myelomeningocele type [11, 41]. 
The severity of neurologic impairment is related to the position of the defect 
along the spinal column, which then directly affects the child’s mobility and ability to 
maintain bowel and bladder control [44].  In addition, a child with SB is at risk for related 
challenges, such as hydrocephalus, scoliosis and other orthopedic issues, urinary tract 
infections and chronic renal disease, and obesity [44-46].  A child with SB may face 
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challenges with educational, social, and psychological development [47] and typically 
requires life-long, multidisciplinary health care. 
2.2.2 Epidemiological Profile of Spina Bifida 
The occurrence of NTDs has notably declined in the United States because of the 
availability of prenatal diagnosis [46, 48, 49].  The occurrence of NTDs has also declined 
substantially since the mandatory fortification of the U.S. cereal grain supply with folic 
acid [48, 50-53].  In 1998, the U.S. government passed legislation that required 
mandatory fortification of the nation’s cereal grain supply with folic acid.  In the years 
following mandatory folic acid fortification, the occurrence of NTDs decreased 
significantly [48, 50-53].  Research reported a SB prevalence estimate of 2.62 cases per 
10,000 live births prior to mandatory folic acid fortification (October 1995 through 
December 1996) compared to a SB prevalence estimate of 2.02 cases per 10,000 live 
births for October 1998 through December 1999, a decrease in prevalence of 22.9% [52].  
More recent reports on post-fortification trends found an additional decrease of 6.9% in 
SB prevalence between 1999-2000 compared to 2003-2005 data [54].  The most recent 
annual U.S. prevalence estimate for SB is approximately 1,500 infants or 1 in 2,858 live 
births per year [1].  According to Florida Birth Defects Registry (FBDR) data, an average 
of 70 infants with SB were born each year in the state of Florida between 1998-2007 
[27].  Table 2.1 (page 34) shows the distribution of births of children with SB included in 
the study by year of birth.  Figure 2.1 (page 35) shows the distribution with an overall 
trend line included. 
Differences in prevalence estimates of SB exist across racial and ethnic groups.  A 
study using 2003-2005 birth certificate data from 46 U.S states and the District of 
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Columbia (representing 90% of all live births in the U.S. during the study period) found 
2.00 cases of SB per 10,000 live births among infants of non-Hispanic White mothers, 
1.96 cases of SB per 10,000 live births among infants of Hispanic mothers, and 1.74 
cases of SB per 10,000 live births among infants of non-Hispanic Black mothers [54].  A 
multi-site, population-based study of children born between 1997-2005 with non-
syndromic SB reported that Hispanic mothers had a higher prevalence rate of each type 
and subtype of SB than either non-Hispanic White or non-Hispanic Black mothers [42].  
Another study using 1991-2002 population-based, birth defects surveillance data from 10 
U.S. regions reported that prevalence of SB among children 0 to 19 years was lowest 
among male and non-Hispanic Black children [55]. 
The mortality rate for SB without anencephaly is approximately 10%, with the 
majority of deaths occurring in the first year of life [56-58].  A study using 1979-2003 
data from 10 U.S. birth defects registries reported one-year survival probabilities across 
the study period for infants with SB [59].  Results showed improvements in survival rates 
for all racial and ethnic categories [59].  However, differences remained in overall  
adjusted, one-year survival probabilities (non-Hispanic White: 96%; non-Hispanic Black: 
88%; Hispanic: 93%) [59].  These results suggested differences in survival across 
race/ethnicity.  Slightly lower mortality rates may be associated with more aggressive and 
early treatment of SB, including early surgical repair of SB [18, 20, 21, 56].  These 
studies did not address payer type and access to care, both of which could have 
influenced the outcomes reported. 
2.2.3 Initial Management and Treatment of Infants with Spina Bifida  
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Fifty years ago, children born with SB received only palliative care because of 
lack of viable options for clinical treatment [46, 60-62].  New medical and surgical 
interventions now provide hope for both survival and improved quality of life and health 
outcomes for children born with SB [49, 63, 64]. 
The Spina Bifida Association’s publication Guidelines for Spina Bifida Health 
Care Services throughout the Lifespan comes closest to standardized guidelines for the 
care of individuals with SB [65].  Postnatal surgical closure of the defect within the first 
48 hours of life is the current recommended standard of treatment for SB, particularly for 
infants with myelomeningocele [65].  Surgical closure includes closing the opening in the 
spinal column as well as restoring skin and muscle tissues that cover the site [66].  
Prompt closure of the site is important because it prevents infection from developing in 
the exposed nerves and tissues [66].  Prompt surgical repair also protects the exposed 
nerves and structures from additional trauma [66, 67].  Surgical closure, however, does 
not restore function lost because of damage to exposed neural tissue. 
A growing body of research suggests an alternate prenatal surgical repair of the 
SB defect [68-73].  The Management of Myelomeningocele Study (MOMS) conducted a 
randomized control trial in 2003 to compare the safety and efficacy of prenatal surgical 
repair of the SB defect with that of postnatal surgical repair [68, 74].  Prenatal surgical 
repair was associated with a reduced need for shunt placement for treatment of 
hydrocephalus and improved mobility in early childhood [56, 68].  After recruiting 183 
of the projected 200 participants, researchers halted the trial because of the efficacy of the 
prenatal surgical repair [68].  Related to my dissertation research, no Florida hospitals 
participated in the MOMS clinical trial [68, 74]. 
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 Prenatal surgical repair of SB may pose risks to both mother and fetus.  Risks 
include abruption of the placenta and uterine scarring among mothers, and preterm births 
among infants [56, 68].  In addition, the numbers of facilities in the United States that can 
perform the surgery are limited [75].  Thus, the adoption of prenatal surgical repair of SB 
is not yet widespread [56, 76, 77].  The Spina Bifida Association recommends caution in 
the acceptance of a new standard of care based on a single study [75] with a sample size 
that is small and not representative of the U.S. population.  The post-natal surgical repair 
of SB therefore remains the primary method of initial treatment. 
2.2.4 Isolated versus Non-Isolated Spina Bifida  
 Birth defects may present as a single condition or may present in conjunction with 
other major or minor birth defects.  In general, children are classified as having an 
isolated birth defect if they: 1) have a single major birth defect; 2) have a major birth 
defect and a minor birth defect; 3) have multiple major defects that affect a single organ 
system; or 4) have a major defect accompanied by a documented sequence of related 
defects and no additional unrelated major defects [78]. 
Similar to other birth defects, SB can present as a single condition in a newborn or 
can occur with other conditions diagnosed at birth or later in life.  Isolated SB is SB with 
the single SB malformation or SB with sequential or associated malformations such as 
hydrocephalus, hip dislocation, or defects of the urinary system [12, 79, 80].  Isolated SB 
can also include SB with other minor anomalies, such as low set ears, skin tags, or bent 
fingers (clinodactyly) [12, 80].  Non-isolated SB is defined as SB with another major, 
unrelated malformation and without a syndromic diagnosis [12, 79, 80].  
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Approximately 15% to 25% of cases of SB are non-isolated; that is, they occur 
with another anomaly not related to the central nervous system defect [81, 82].  Children 
with non-isolated SB most commonly have orofacial clefts, cardiac defects, and 
abdominal wall anomalies [81, 82]. 
In my dissertation research, classification of each infant as having isolated or non-
isolated SB was informed by discussions with expert clinical consultants from the 
Centers for Disease Control and Prevention’s (CDC) National Center on Birth Defects 
and Developmental Disabilities (NCBDDD), as well as previous research [12, 79].  An 
expert clinical consultant from the CDC’s NCBDDD manually reviewed about 15% of 
selected individual cases that required additional consideration because of multiple 
conditions.  For example, patent ductus arteriosus (PDA) is a heart condition common 
among premature infants.  If an infant with SB had a PDA, the infant was considered to 
have isolated SB if the infant was premature, but non-isolated SB if the infant was born at 
term.  These and other similar situations required a case-by-case review.  I referenced 
surveillance guidelines from the National Birth Defects Prevention Network (NBDPN) 
for International Classification of Disease, Ninth revision; Clinical Modification (ICD-9-
CM) diagnostic codes for major birth defects [83].  Table A in the appendix shows a list 
of ICD-9-CM diagnostic codes considered as major birth defects by the NBDPN for its 
surveillance and research purposes. 
2.2.5 Comorbidities Associated with Spina Bifida  
One of the most common comorbidities associated with SB is hydrocephalus [56, 
66].  Hydrocephalus is an abnormal accumulation of cerebrospinal fluid in the ventricles 
of the brain that can cause swelling and increased intracranial pressure [37, 66].  This 
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increased pressure can cause multiple central nervous system-related symptoms and may 
result in seizures, brain damage, and if untreated, death [56, 84].  Even when treated, 
hydrocephalus is associated with chronic conditions, including cognitive and 
developmental disabilities [47, 85-87].  Hydrocephalus is diagnosed in approximately 80-
90% of children with SB whose defect type is a meningomyelocele [43, 66, 88-90] and is 
the leading cause of death among children with SB [21]. 
The National Institute of Health recognizes hydrocephalus as a serious, but under-
researched health issue [37].  Few standardized protocols exist for managing 
hydrocephalus among children with SB [91].  Treatment for hydrocephalus typically 
involves the surgical placement of a ventriculoperitoneal (VP) shunt, which is tubing that 
travels from the ventricles of the brain into the peritoneal cavity to continually drain 
excess cerebrospinal fluid [43, 66, 92].  The optimal timing for shunt placement has not 
been established [91].  Options for timing of the shunt include 1) immediate placement in 
conjunction with a high spinal level of SB; 2) placement later in the child’s life 
depending on clinical symptoms; or 3) “expectant monitoring” in the presence of 
asymptomatic but expanded ventricles [61, 91].  Among children with SB and 
hydrocephalus, approximately 15% undergo immediate VP shunt placement in 
conjunction with the surgical repair of their SB defect, and as many as 80-90% eventually 
undergo surgical placement of the VP shunt [56].   
A child with SB also faces comorbidities that develop over time as an indirect 
result of their condition.  Additional comorbidities include neuropathic bladder with 
urinary tract infections and chronic renal disease, orthopedic problems, chronic skin 
ulcerations, and obesity [46, 93-95].  A child with SB also faces challenges with 
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educational, psychological, and social development [47, 95-97].  Children with SB face 
higher risks of learning disorders and attention deficit hyperactivity disorder than 
children without SB, and academic challenges in secondary and postsecondary education 
[47, 95].  As children with SB move into adolescence and adulthood, individuals face 
challenges with social interaction, anxiety, and depression [47, 95, 98]. 
In general, individuals who have multiple comorbidities have poorer health 
outcomes and higher health care costs than those without comorbidities [17].  One study 
found that children with multiple medical conditions were eight times as likely to be high 
users of physician services as those without multiple conditions [99].  Another study 
reported that among children with special health care needs (CSHCN), those with more 
than one chronic condition were 27% more likely to be hospitalized in the course of a 
year than those with only one chronic condition [100].  Children with SB and the 
comorbidity hydrocephalus can experience lower scores of intelligence than children with 
SB only, and scores may decrease with increasing numbers of shunt revisions [47].  
Researchers using 2000-2005 administrative datasets from the Children’s Hospital of 
Alabama found that shunt revisions for hydrocephalus resulted in a median 
reimbursement by insurers of over $5000 per admission, thus contributing to higher 
health costs for these children [101]. 
In general, individuals who have multiple comorbidities have poorer health 
outcomes and higher health care costs than those without comorbidities [17].  Health 
resource use by individuals with multiple conditions may appear different when the 
conditions are examined separately as compared with examining the conditions together 
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[17].  Thus, a concurrent examination of comorbidities is important to understanding 
health resource use among individuals with more than one health condition. 
2.2.6 Timeliness of Care for Children with Spina Bifida 
Experts convened by the CDC helped establish public health research priorities, 
including timeliness of services, for selected birth defects, including orofacial clefts, 
craniosynostosis, congenital heart defects, and Down syndrome [33-36].  In addition to 
being a core component of the Institute of Medicine’s quality of care framework, timely 
care is important in the reduction of comorbidities among children with birth defects and 
can contribute to improved quality of life and lower health care use and costs [12, 16, 17, 
102-105]. 
One recent study examined timeliness of care among children with birth defects.  
The study reported the timeliness of primary surgical repair among Medicaid-eligible 
children with cleft lip and/or cleft palate who were born between 1995- 2002 in North 
Carolina [106].  In that study, between 58% and 90% of children with orofacial clefts had 
timely repair, depending on maternal demographics and other factors, such as prenatal 
care at a local health department and region of residence in the state [106].  
Among children with SB, researchers found that timely post-natal surgical repair 
of SB reduces the risk of injury to the exposed neural tissues and reduces the risk of 
central nervous system or other infections [56].  Timely surgical repair of SB has also 
been associated with a reduction in the risk of comorbidities, including infection of a VP 
shunt [18], neurogenic bladder [16], and neurodevelopmental delays [19].  In addition, 
mortality rates appear lower if SB repair occurs in the first 36-48 hours of life [18, 20, 
21]. 
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However, timely care among children with birth defects remains an understudied 
area.  To my knowledge, no peer-reviewed research exists on adherence to recommended 
standards of care of timely surgical repair of SB among infants with SB.  Further, no 
studies have examined factors associated with the timing of the initial surgical repair for 
infants with SB.  A better understanding of timely surgical repair of SB is useful because 
early surgical repair reduces mortality and decreases the likelihood of certain 
comorbidities associated with SB, such as neurogenic bladder, neurodevelopmental 
delays, and VP shunt infections [16, 18-21, 107]. 
2.3 Health Resource Use and Access to Care for Children with Spina Bifida 
2.3.1 Hospitalizations and Hospitalized Days among Children with Spina Bifida  
 Children with special heath care needs use more health care services and have 
higher health care expenditures than those without special health care needs [13, 108, 
109].  A study using the 2000 Medical Expenditure Panel Survey Data (MEPS) found 
that CSHCN had four times the number of hospital admissions and seven times the 
number of hospital days than those without special health care needs [13].  In addition, 
CSHCN accounted for over 52% of pediatric hospital days, despite accounting for only 
16% of the pediatric population [13].  
Researchers using the 2004 Agency for Healthcare Research and Quality (AHRQ) 
Healthcare Cost and Utilization Project (HCUP) Nationwide Inpatient Sample (NIS) data 
found that hospitalizations for birth defects were longer and more costly than 
hospitalizations unrelated to birth defects [8].  In the same study, SB was listed as a 
diagnosis in 28,300 separate hospital admissions nationwide, making it the sixth most 
commonly listed birth defect diagnosis among all hospitalizations [8].  Using the 2003 
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Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project 
Kids’ Inpatient Database (KID) data, researchers found that newborns with SB had an 
average length of stay for birth hospitalizations of 15.1 days, in comparison to an average 
hospital stay of 2.1 days for newborns with uncomplicated births [2].  Ouyang et al. used 
2001-2003 national private health MarketScan Commercial claims data to examine health 
care expenditures of both children and adults with SB [14].  They found that the majority 
of children with SB had at least one hospital re-admission in their first year of life 
following a birth hospitalization and that the highest percent of hospitalizations per year 
occurred in the first year of life [14].  Another study used a population-based sample of 
infants born in Florida 1998-2007 to examine hospital use during infancy [110].  These 
researchers found that infants with SB were hospitalized an average of 2.4 times during 
infancy and spent an average of 25 days in the hospital during the first year of life [110].  
In another study, researchers used data from the 2000, 2003, 2006, and 2009 Kids 
Inpatient Databases, and found that children with SB ages 1-20 years were more likely to 
receive inpatient care at children’s hospitals or in pediatric units when compared to all 
children [111].  These researchers also found that the proportion of children with SB 
covered by Medicaid rose during the course of the study period, as did the proportion for 
all children in the study [111]. 
2.3.2 Health Care Costs among Children with Spina Bifida 
The study of health care costs associated with any medical condition is complex 
because costs can be reported in multiple ways [112].  Health care charges refers to the 
fees that a health care provider requests for performance of a particular health care 
service [113, 114], whereas health care expenditures are actual dollars paid for health-
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related services by an individual or by a public or private payer [113, 114].  Health care 
cost is a general term that reports the dollar amount a health care provider incurs to 
deliver health services [114].  Hospital charges are facility fees that do not typically 
include professional fees.  Charges are usually higher than costs or expenditures.  Costs, 
charges, and expenditures cannot be directly compared. 
It is also important to recognize that hospital costs, charges, or expenditures do 
not capture the full health care economic costs associated with any medical condition.  To 
better estimate the total cost of care for a specific medical condition, information on other 
direct costs are needed; these include physician fees, outpatient costs, and prescription 
drug costs.  Including an estimate of indirect costs, such as the value of care provided by 
the family in the home or the value of lost parental work time, can also help to provide a 
more complete understanding of financial costs. 
 A number of studies have explored health care costs for children with SB 
compared with children who did not have SB [2, 8, 12-15].  Using nationally 
representative 2000 MEPS data, researchers found that children born with SB from birth 
to 18 years had medical expenditures three times those of the average for special needs 
children [13].  Using 2001-2003 national private health claims MarketScan Commercial 
data, researchers found that average medical expenditures for the first 18 years of life 
were thirteen times higher for a child with SB than for a child without SB [14].  In the 
study just described, the authors also explored changes in health care costs over the 
lifespan of individuals with SB and found that individuals had the highest average total 
expenditures during their first year of life [14].  Economic evaluations estimated lifetime 
direct costs of $279,000 and lifetime total costs of $636,000 for individuals with SB [115, 
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116].  A more recent study calculated lifetime direct costs for a child with SB of 
approximately $730,000 in 2010 dollars [117].  Another study used data from the Florida 
Birth Defects Registry and hospital discharge data to examine inpatient hospital costs 
during infancy for Florida children with SB born from 1998 through 2007.  Researchers 
found that during the first year of life, children with SB had average total hospital costs 
of $39,000 across all payer types (in 2011 dollars) [110].  The majority of these costs 
occurred during the birth hospitalization [110].  Using the North Carolina birth defects 
registry and Medicaid data, Cassell et al. (2011) compared health care expenditures 
among North Carolina Medicaid-enrolled children with SB with and without 
hydrocephalus for different age groups, including during the first year of life, for children 
who were born in North Carolina 1995-2002.  The authors found that infants born with 
SB who developed hydrocephalus had Medicaid health care expenditures 2.6 times 
higher than infants born with SB who did not develop hydrocephalus [12].  However, this 
study only examined one payer type, a public payer perspective, and only examined 
children from birth to five years. 
 Little research has explored health service use and specifically hospital resource 
use among children with SB in presence of common comorbidities.  No research has 
examined the number of hospital admissions or lengths of stay for children with SB by 
the presence or absence of hydrocephalus or by isolated (no other coded major birth 
defect) vs. non-isolated SB.  Further, no studies have examined these characteristics over 
the years of early childhood and across various health insurance payer types.  
2.3.3 Access and Barriers to Health Care 
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 The Institute of Medicine’s quality of care framework includes equity in access to 
care as a fundamental measure of quality health care [102].  Lack of access based on 
inadequate health insurance coverage, race/ethnicity, educational level, or geographic 
barriers may result in increased morbidity and increased mortality [102, 118]. 
 The Healthy People 2020 program overseen by the U.S. Department of Health 
and Human Services included access to care in their series of Maternal-Infant-Child 
Health (MICH) goals [31].  MICH Goal 30.2 states that Healthy People 2020 programs 
will “increase the proportion of children with special health care needs who have access 
to a medical home” [31].  MICH Goal 31 states that another objective of Healthy People 
2020 is to “increase the proportion of children with special health care needs who receive 
their care in family-centered, comprehensive, coordinated systems” [31].  Similarly, the 
Spina Bifida Association’s 2012 Congressional Policy Agenda calls for ensured access to 
care for individuals with SB, especially through provision of adequate insurance [32]. 
Previous studies have examined five interdependent dimensions of access to care 
[119-121].  Those dimensions include availability, accessibility, accommodation, 
affordability, and acceptability [119-121].  Availability is associated with the adequacy of 
health care personnel, facilities, and special services [120, 121].  Accommodation 
describes the relationship the health care providers’ organizational plans to accept clients, 
and clients’ perceptions of the plans’ suitability and appropriateness [120, 121].  
Affordability addresses health care costs, clients’ abilities to pay those costs, as well as 
clients’ perceptions of the value of the costs [120, 121].  Acceptability is the relationship 
between attitudes of clients and providers about personal and practical characteristics that 
influence both seeking and providing care [120, 121].  The final dimension of access to 
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care is accessibility.  Accessibility describes the relation between the location of the 
health care service or provider and the potential health care client, and examines 
measures such as transportation resources, travel time and distance, and travel costs [120, 
121].  My dissertation research focused on the dimension of accessibility. 
A number of studies have explored barriers to accessing health care for children 
[122-128].  Barriers to care can fall into the categories of personal barriers, financial 
barriers, or organizational (structural) barriers [129], generally paralleling the dimensions 
of access to care [121].  Personal barriers result from individual perceptions of health 
care need or personal health beliefs.  Personal barriers can also include cultural and social 
influences, such as language barriers and expectations of care [127, 129].  Financial 
barriers occur when an individual has insufficient monetary resources or health insurance 
coverage to access adequate health care [108, 127, 129-131].  Organizational or structural 
barriers are factors related to the health care system and include such characteristics as 
capacity, transportation, and geographic location of resources [129, 132].  Factors in each 
of these three categories (personal, financial, or organizational and structural) influence 
the ability of an individual to access health care.  The inability to access health care can 
result in missed or delayed opportunities for health services and can ultimately result in 
poorer health outcomes and higher health care costs [127]. 
Personal and financial barriers are commonly reported barriers to accessing care 
for children with or without special health care needs and include such barriers as low 
income, minority status, and lack of insurance [125, 130, 133, 134].  In a study of Latino 
children, researchers found that children of immigrant parents were less likely to have 
insurance and less likely to access routine health care than Latino children of parents born 
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in the United States [135].  Studies have found that CSHCN are particularly likely to face 
barriers to accessing health care [122, 124-127, 130].  Among CSHCN, adequate 
insurance has been reported to be the most critical determinant of access to care [127].   
 Less research exists on organizational or structural barriers to accessing health 
care, and specifically for children with birth defects, a subset of CSHCN.  In one study, 
researchers used data from the 2001 U.S. National Household Travel Survey and found 
that the average distance traveled to access medical or dental care was 10.2 road miles or 
22.0 minutes [136].  This study also found that rural residents traveled 31.4% longer time 
to access care than residents of urban areas [136].  Specifically examining access to care 
for CSHCN, researchers used 2000-2002 data from the National Survey of Children with 
Special Health Care Needs and found that CSHCN who lived in rural areas were less 
likely to be seen by a pediatrician than children living in urban areas [128].  Another 
study using data from the 2005-2006 National Survey of Children with Special Health 
Care Needs found that geographic disparities existed in access to care for CSHCN in the 
western and northeastern regions of the United States [137].   
 While a number of studies have used survey data to examine access to care for 
CSHCN and specifically for children with birth defects, a subset of CSHCN [123, 128, 
137], fewer studies have used GIS methods to examine access to care.  Using a statewide, 
population-based birth defects registry data and geographic information system (GIS) 
methods, researchers found geographic disparities in access to pediatric genetic clinics 
among children born with major structural or chromosomal anomalies in Texas between 
1999 and 2004 [138].  Using a statewide, population-based birth defects registry and 
survey data in North Carolina, a qualitative study of perceived barriers to care among 
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mothers of children with orofacial clefts born between 2001-2004 found multiple 
perceived barriers to accessing care, including location of services, and lack of 
transportation [124].  Using the same North Carolina data, researchers also found that 
children with orofacial clefts traveled an average of 80 miles and 92 minutes one-way, to 
access cleft and craniofacial care [123].  The travel distance varied by maternal 
education, child’s age, and cleft type [123].  In another study, researchers used data from 
the statewide, population-based Texas birth defects registry data and GIS methods to 
examine mortality among infants with congenital heart disease born between 1996- 2003.  
These researchers found no association between increased mortality rates and home 
distance to a cardiac center [139].  Using linked Florida birth defects registry and hospital 
discharge data from 1998-2007, researchers calculated one-way travel time and distance 
to access hospital care for infants with SB [140].  Researchers found that 56.4% of 
infants traveled less than 30 minutes to access hospital care, while 22.4% traveled more 
than 60 minutes to access hospital care [140].   
 Collectively, the studies reviewed in the preceding paragraph contribute to our 
understanding of the role that structural barriers play in accessing to health care, 
especially for CSHCN, including children with birth defects.  The findings of these 
studies suggest that geographic location is associated with the use of health care services.  
These studies also suggest that CSHCN may travel longer times and distances to access 
health care than individuals without these conditions. 
Notwithstanding previous research, the role of geography remains an important 
and under-researched component to understanding heath care access [141].  Few studies 
have examined the role of geography and access to health care among children with birth 
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defects.  Siffel et al. examined the role of GIS in birth defects surveillance, noted that 
‘place’ is the least researched of the three epidemiological components (person, place, 
and time) [142] because of the challenges inherent in geographic research methods.  
These challenges include standardizing and defining spatial features and maintaining 
individual confidentiality [143].  Siffel et al. recommended an expanded and wide-
ranging use of GIS in collaborative birth defects research to better understand the role of 
place in birth defect interventions [143].  Similarly, Kirby noted that the evaluation of the 
spatial component of disease occurrence, specifically intellectual and developmental 
disabilities, could address previously unanswered issues related to geographical 
distribution of incidence and prevalence, and of distribution of appropriate health care 
providers or health services use [144].  To date, researchers have used GIS methods to 
examine risk factors or geographic distribution of birth defects [145-150], but limited 
research has used GIS methods to examine access to care for children with birth defects 
[138, 140].  
2.4 Framework for Study of Health Resource Use and Access  
Access to care is the use of appropriate and adequate health care services and 
encompasses all the factors that may facilitate or hinder an individual’s use of those 
services [151].  Access to care involves linkages to a health care provider, and also 
includes the assurance that the services rendered are appropriate and delivered in a timely 
manner [151].   
Aday and Andersen’s Framework for the Study of Access to Medical Care is a 
conceptual model that suggests that health policy decisions, health system characteristics, 
as well as predisposing, enabling, and need characteristics can be used to describe and 
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predict health care use [152].  Aday and Andersen suggest that health policy has a direct 
influence on both the characteristics of a health delivery system and on the population at 
risk [152].  The model suggests that health policy plays an important role in use of health 
services and is often the ultimate target of health services research [152]. 
The Aday and Andersen model is a commonly used framework for research on 
health care use among CSHCN.  Researchers have examined child and family level 
variables, as well as system characteristics to explore access to care, unmet health care 
needs, and the economic burden of health care for CSHCN using the framework of the 
Andersen and Aday model [134, 137, 153, 154].  The Aday and Andersen model lends 
itself to research that uses surveys or administrative data to provide information on 
individual and system level characteristics that may influence health care use [155] and 
thus was selected as the framework for this dissertation research.   
In the Aday and Andersen model, the health delivery system is comprised of all 
the components required for providing health care to consumers [152].  These 
components broadly include two categories of components: resource and organizational.  
Resource components include the facilities, workforce, equipment, and capital required to 
deliver services.  Resources are evaluated in terms of volume and distribution.  
Organizational resources for health delivery are divided into entry and structure 
components.  Entry components correspond to the concept of access and are the means 
by which an individual gains access to the medical care system [152].  The structural 
components are system characteristics that describe a health consumer’s experience 
following entry into a health care system.  
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Aday and Andersen also describe characteristics that affect the population at risk.  
These characteristics are the predisposing, enabling, and need factors that affect an 
individual’s heath care utilization [152, 156].  Predisposing characteristics include 
individual demographic characteristics as well as health values, and explain a person’s 
propensity to use health care services.  Enabling characteristics include those 
characteristics that facilitate an individual’s use of health services and include measures 
such health insurance and geographic proximity to care.  Need characteristics are the 
perceived or evaluated measures indicating that health services are required.  
Characteristics of the population at risk are all individual characteristics.  Some of these 
individual characteristics may be mutable such as health insurance, while others such as 
ethnicity are not. 
Heath policy, system, and individual characteristics are all health inputs in the 
Aday and Andersen Framework for the Study of Access to Medical Care.  The outputs of 
this model are health care utilization and satisfaction of the health consumer.  Health care 
utilization describes the type, location, and purpose of health care services, and time 
interval between use of services [152].  The final component of the model is consumer 
satisfaction.  The satisfaction of the health consumer with the services provided 
represents the consumer’s attitudes and perceptions of the health services they actually 
received.  Convenience, time, personal interactions, and cost may each be dimensions in 
the measure of satisfaction.  
For my dissertation research, I examined three of the five components of the Aday 
and Andersen framework: 1) characteristics of the health delivery system; 2) 
characteristics of the population at risk; and 3) use of health services.  These components 
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are shown in Figure 2.2 (page 36).  I modified the Aday and Andersen model to identify 
both characteristics of the health delivery system and characteristics of the population at 
risk as predisposing, enabling, and need characteristics.  My primary outcomes were 
selected measures of the use of health services.  Figure 2.3 (page 37) shows the 
conceptual model for my dissertation. 
2.5 Summary of Background and Significance of Research 
Although the numbers of children born with SB are decreasing, the severity, 
costs, and challenges of this birth defect continue to make it a major factor in health care 
economic and societal costs in the United States and for children with SB and their 
families.  My dissertation addresses several knowledge gaps by examining hospital 
resource use for children with SB with and without hydrocephalus and by isolated (no 
other coded major birth defect) versus non-isolated SB from birth through year four.  In 
addition, my research reports the percentage of children who have timely surgical repair 
of SB, and examines predisposing, enabling, and need characteristics associated with 
timely repair.  Finally, my research uses geographic systems information to address the 
access to care research priorities recommended by Healthy People 2020 and the Spina 
Bifida Association.  I report one-way travel time and distance to access hospital care for 
children with SB from birth through age four.   
This information contributes to our understanding of the influence of 
comorbidities and of predisposing, enabling, and need characteristics on hospital resource 
use and geographical access to hospital care among children with SB.  A more complete 
understanding of hospital use and costs, of access to hospital services, and of timeliness 
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of care can contribute to improved health care service delivery and improved health 
outcomes for children with SB. 
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Table 2.1: Infants with spina bifida without anencephaly 
born in Florida by birth year, 1998-2007 
Year of birth Number (n=614) 
Percent of study 
sample 
1998 64 10.4 
1999 81 13.2 
2000 60 9.8 
2001 64 10.4 
2002 58 9.4 
2003 51 8.3 
2004 63 10.3 
2005 62 10.1 
2006 50 8.1 
2007 61 9.9 
Note: Infants in this table (n=614) had at least one 
matched hospital discharge record.  All infants with spina 
bifida without anencephaly= 668. 
 
Data sources: Florida Birth Defects Registry, 1998-2007 
and hospital discharge data from the Florida Agency for 
Health Care Administration, 1998-2008. 
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Figure 2.1 Number and trend line for Florida-born infants with spina bifida without 
anencephaly with at least one hospitalization initiated during first year of life, 1998-2007.  
(Note: Mandatory dietary folic acid fortification in U.S. began in January 1998) 
 
 Data sources: Florida Birth Defects Registry, 1998-2007 and hospital discharge   
 data from the Florida Agency for Health Care Administration, 1998-2008. 
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Figure 2.2 Aday and Andersen’s Framework for the Study of Access to Medical Care 
 
 Note: boxes in green were addressed in this dissertation 
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CHARACTERISTICS OF THE POPULATION AT RISK 
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  Figure 2.3 Conceptual framework for examination of hospital use, costs, and access to care among  
Florida-born infants with spina bifida, 1998-2007, adapted from the Aday and Andersen  
Framework for the Study of Access to Medical Care 
 
 
 
 
 
CHAPTER 3: EFFECTS OF HYDROCEPHALUS ON HOSPITAL USE AND 
ASSOCIATED COSTS AMONG CHILDREN WITH SPINA BIFIDA 
 
 
3.1 Introduction 
 Birth defects are a leading contributor to disability and pediatric hospitalizations 
in the United States and account for more than $2.6 billion in annual hospital costs [2, 6-
8].  Comorbidities influence both hospital resource use and health care costs for children 
with birth defects [17, 99, 101, 157, 158].  This research focused on one type of major 
birth defect, spina bifida (SB), and examined the effect that hydrocephalus had on 
hospital use and costs during the first four years of life.  Hydrocephalus is one of the most 
common comorbidities of SB.  This study also examined predisposing, enabling, and 
need characteristics associated with hospital use and costs.   
 Findings of this study contribute to our understanding of health care resource use 
by children with SB.  Findings identify predisposing, enabling, and need characteristics 
that may affect hospital use and costs.  Finally, by quantifying the difference in health 
resource use by the presence of hydrocephalus, results from this research can inform 
program planning and policy development, which contributes to improved health care 
delivery and improved health outcomes for children with SB 
3.2 Literature Review 
3.2.1 Epidemiology of Neural Tube Defects and Spina Bifida 
Spina bifida is a neural tube defect (NTD) that results from a failure of the caudal 
.
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neural tube to fuse early in embryonic development [10, 11].  Spina bifida is one of the 
most severe birth defects compatible with life [46, 159].  Spina bifida affects a child’s 
mobility and ability to maintain bowel and bladder control [97].  A child with SB is also 
at risk for comorbidities associated with SB such as hydrocephalus, neurogenic bladder 
and decreased renal function, orthopedic problems including scoliosis and lower limb 
issues, and obesity [46, 62].  A child with SB may also face challenges with educational, 
social, and psychological development [47] and typically requires life-long, 
multidisciplinary health care.   
The most recent annual U.S. prevalence estimate for SB is approximately 1,500 
infants or 1 in 2,858 live births per year [1].  According to the Florida Birth Defects 
Registry (FBDR) data, an average of 70 infants with SB were born each year in the state 
of Florida between 1998- 2007 [27]. 
3.2.2 Isolated or Non-isolated Spina Bifida 
 Spina bifida may present as a single condition in a newborn or it may be 
accompanied by other conditions diagnosed at birth or later in life.  Isolated SB is SB 
with the single SB malformation or SB with sequential or associated malformations, such 
as hydrocephalus, hip dislocation, or defects of the urinary system [12, 79, 80].  Isolated 
SB can also include SB with other minor anomalies, such as low set ears, skin tags, or 
abnormally bent or curved fingers (clinodactyly) [12, 80].  Non-isolated SB is defined as 
SB with another major, unrelated birth defect and without a syndromic diagnosis [12, 79, 
80].  Children with non-isolated SB most commonly have orofacial clefts, cardiac 
defects, and renal or abdominal wall anomalies [81, 82].  Approximately 15% to 25% of 
children with SB have non-isolated SB [81, 82, 160-162].  
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3.2.3 Spina Bifida and Hydrocephalus 
 One of the most common comorbidities associated with SB is hydrocephalus [20, 
56, 66, 86].  Hydrocephalus is an abnormal accumulation of cerebrospinal fluid in the 
ventricles of the brain that causes swelling and increased intracranial pressure [37, 49, 56, 
66, 85].  This increased pressure can cause central nervous system-related symptoms such 
as seizures and can cause death if untreated [56, 84].  Even if treated, hydrocephalus may 
be associated with chronic conditions such as seizures and cognitive and developmental 
disabilities [47, 85-87]. 
 Hydrocephalus is diagnosed in approximately 80 to 90% of children with SB who 
have a meningomyelocele [43, 66].  Meningomyeloceles are the most common and most 
severe form of SB [11, 41].  Among children with SB and hydrocephalus, approximately 
15% undergo immediate ventriculoperitoneal (VP) shunt placement at the same time as 
the repair of their SB defect [56].  As many as 80 to 90% of children eventually undergo 
surgical placement of a VP shunt [56]. 
 Hydrocephalous presents additional risks to a child with SB, most notably the 
risks of shunt infections and shunt failures [18, 20, 66, 85, 87, 92, 111, 163].  These 
complications may require hospitalizations for treatment, thus increasing hospital use and 
costs by children with SB and hydrocephalus.  Previous research found that about half of 
all children with SB and hydrocephalus required a shunt revision during their first year of 
life [20, 164].  The initial placement of a shunt increases the costs associated with SB and 
hydrocephalus [163].  Subsequent revisions for shunt failure or infections can further add 
to health care use and costs [12, 92, 101, 163]. 
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 In general, individuals who have multiple comorbidities have poorer health 
outcomes and higher health care costs than those without comorbidities [17].  Health 
resource use by individuals with multiple conditions may appear different when the 
conditions are examined separately as compared with examining the conditions together 
[17].  Thus, a concurrent examination of comorbidities is important to understanding 
health resource use among individuals with more than one health condition. 
3.2.4 Hospital Resource Use 
 Previous research has found that children with special heath care needs (CSHCN) 
use more health care services and have higher health care expenditures compared with 
children without special health care needs [13, 108, 109].  A study of CSHCN using the 
2000 Medical Expenditure Panel Survey Data (MEPS) reported that CSHCN had four 
times the number of hospital admissions and seven times the number of hospital days 
than children without special health care needs [13].  In addition, CSHCN accounted for 
over 52% of pediatric hospital days, while accounting for only 16% of the pediatric 
population [13].   
 Adequate insurance coverage is an important determinant of health resource use 
and may serve as a proxy for access to care [108, 127, 157, 165-167].  For CSHCN 
adequate health insurance may be the most critical determinant of access to health care 
[127].  Gaps in insurance coverage, especially multiple gaps, may also affect children’s 
access to health care [165].  Other characteristics such as maternal age and education, 
maternal race/ethnicity, and nativity may also influence access to care [125, 126, 133, 
135, 168, 169]. 
 
42 
 
 The severity of a child’s medical condition is also an important factor in health 
resource use [99, 157].  One study found that children with multiple medical conditions 
were eight times as likely to be high users of physician services as those without multiple 
conditions [99].  Another study reported that among CSHCN, those with more than one 
chronic condition were 27% more likely to be hospitalized in the course of a year than 
those with only one chronic condition [100].  The same study found that CSHCN with 
poor or fair perceived health were over twice as likely to be hospitalized in the course of 
a year as those with perceived good health [100]. 
 A number of studies have explored the economic health care burden for children 
with birth defects, a subset of CSHCN [2, 8, 12-15, 111].  Researchers using the 2004 
Agency for Healthcare Research and Quality (AHRQ) Healthcare Cost and Utilization 
Project (HCUP) Nationwide Inpatient Sample (NIS) data found that hospitalizations for 
birth defects were longer and more costly than hospitalizations unrelated to birth defects 
[8].  These researchers found that SB was a diagnosis in 28,300 separate hospital 
admissions nationwide, making it the sixth most commonly listed birth defect diagnosis 
among all hospitalizations [8].   
 In the following paragraphs, I provide a brief review of studies that have 
examined health resource use by persons with SB.  A study of 2003 Agency for 
Healthcare Research and Quality Healthcare Cost and Utilization Project Kids’ Inpatient 
Database (KID) data found that newborns with SB had an average length of stay for birth 
hospitalizations of 15.1 days [2].  In comparison, newborns with uncomplicated births 
had an average hospital stay of 2.1 days [2].  Ouyang et al. used 2001-2003 national 
private health MarketScan Commercial claims data to examine health resource use of 
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both children and adults with SB [14].  The researchers found that the majority of 
children with SB had at least one hospital re-admission in their first year of life following 
a birth hospitalization [14].  They also found that the highest percent of hospitalizations 
per year occurred in the first year of life [14]. 
 Another study used data from the 2000, 2003, 2006, and 2009 Kids Inpatient 
Databases to examine hospital care for individuals with SB, ages one to twenty years 
[111].  These researchers found that individuals with SB under twenty years of age were 
three times more likely to receive inpatient care at children’s hospitals and twice as likely 
to receive care in pediatric units compared with all children [111].  They also found that 
the most common reason for readmission was repair of a malfunctioning shunt for 
hydrocephalus [111].  In addition, the authors found that the proportion of children with 
SB covered by Medicaid rose from 45.1% in 2000 to 49.7% in 2009, similar to findings 
for the entire study sample [111]. 
 Other researchers examined nationally representative 2000 Medical Expenditure 
Panel Survey (MEPS) data and found that children with SB ages birth to 18 years had 
medical expenditures three times those of the average for special needs children [13].  
Another study used 2001-2003 national private health claims MarketScan Commercial 
data and found that average medical expenditures for the first 18 years of life were 
thirteen times higher for a child born with SB than for a child born without SB [14].  In 
the same MarketScan study, researchers explored changes in health care costs over the 
lifespan of individuals with SB.  They found that individuals with SB incurred an average 
of $49,602 in total expenditures during the first year of life compared with $15,911 
average yearly expenditures for ages 0-64 years [14]. 
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 Based on nationally weighted data from the Agency for Healthcare Research and 
Quality (AHRQ) Healthcare Cost and Utilization Project (HCUP) 2003 Kids’ Inpatient 
Database (KID), the mean hospital charges per neonatal admission for infants with SB 
was $65,342 [2].  In comparison, the mean hospital charge per neonatal admission for 
uncomplicated births was $1,844 [2].  Economic evaluations estimated lifetime direct 
costs (primarily medical) associated with SB at $279,000 per individual with SB, and 
lifetime total costs were estimated at $636,000, both reported in 2002 dollars [115, 116].  
A recent study reported the lifetime direct costs for a child with SB of approximately 
$730,000 in 2010 dollars [117].  
 Few studies describe health service use among children with SB in the presence 
of common comorbidities.  One study used the North Carolina Birth Defects Registry and 
Medicaid data to compare health care expenditures among North Carolina Medicaid-
enrolled children with SB with and without hydrocephalus for children birth through five 
years who were born between 1995 and 2002 [12].  The authors found that infants with 
SB who developed hydrocephalus had Medicaid health care expenditures 2.6 times 
higher than infants born with SB who did not develop hydrocephalus [12].  However, this 
study only examined expenditures for children insured by Medicaid. 
Gaps remain in our understanding of this economic burden.  To my knowledge, 
no peer-reviewed research has examined the number of hospitalizations, lengths of stay, 
and associated costs for children with SB with and without hydrocephalus and by isolated 
versus non-isolated SB.  Further, no studies have compared these factors during infancy 
and childhood, and across various health insurance payer types.   
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3.3 Study Objectives and Hypotheses 
 The purpose of this study was to examine the effect of hydrocephalus and other 
selected predisposing, enabling, and need characteristics on hospital use and costs among 
children with SB.  The research questions were: 
1. What are the differences in number of hospitalizations, lengths of stay, and 
associated costs among children with SB by the presence of hydrocephalus, 
age group, and payer type? 
2. What predisposing, enabling, and need characteristics are associated with number 
of hospitalizations, lengths of stay, and costs among children with SB by the 
presence of hydrocephalus?  
I hypothesized that children with SB and hydrocephalus would incur greater costs, 
have more hospitalizations, and spend more days in the hospital compared to children 
with SB without hydrocephalus, and that highest hospital use for all children with SB 
would be during infancy (from birth through one year) [12, 14, 17, 157].  
 Finally, I hypothesized that differences in hospital use and costs would vary based 
on predisposing characteristics (maternal nativity [135, 169, 170], maternal 
race/ethnicity, age, educational level, and marital status [125, 126, 168, 169, 171]), 
enabling characteristics (adequacy of prenatal care [132] and health care payer source 
[108, 125, 134, 157]), and need characteristics (preterm birth [172-174], isolated or non-
isolated SB, and the presence of hydrocephalus). 
3.4 Conceptual Framework  
 The Aday and Andersen Framework for the Study of Access to Medical Care 
provided the conceptual basis for this project [152, 156, 175, 176].  I adapted the Aday 
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and Andersen model to the research questions presented above, and included the specific 
predisposing, enabling, and need variables used in each component of the model.  This 
adapted model is shown in Figure 2.3 (Chapter 2, page 37). 
3.5 Study Design and Methods 
3.5.1 Study Design 
This study was a retrospective, statewide, population-based cohort analysis of 
inpatient hospital use and costs for children with SB from birth through four years born in 
Florida between January 1, 1998, and December 31, 2007.   
3.5.2 Data Acquisition and Study Sample 
I obtained data for this study from linked, longitudinal datasets provided by the 
FBDR and the Florida Bureau of Vital Statistics, both in the Florida Department of 
Health (FDOH), and the Florida Agency for Healthcare Administration (AHCA).  The 
Florida AHCA provided the hospital discharge data.  Infants with SB without 
anencephaly born in Florida between 1998 and 2007 were identified using the 
International Classification of Disease, Ninth revision; Clinical Modification (ICD-9-
CM) codes 741.00-741.93.  Hospital discharge data from January 1, 1998 through 
December 31, 2008, were used to allow for at least one year of hospitalizations for each 
infant with SB. 
Included infants were live-born in Florida to a mother who was a Florida resident 
at the time of delivery.  Infants who were adopted or prospectively adopted or who were 
born out of state were excluded by the FBDR.  Included infants also matched with an 
inpatient hospital discharge record during the first year of life.  Children who died at any 
point in the study period were included to capture the full extent of cost and hospital use 
 
47 
 
associated with the care for children with SB.  Death was included as a control variable in 
the analysis.  Figure 1.1 (Chapter 1, page 9) shows the process for identification of 
infants for the final study sample. 
3.5.3 Primary Outcomes of Interest: Number of Hospitalizations, Hospital Costs, and 
Lengths of Stay 
I examined three outcomes of interest related to the use of hospital resources: 1) 
number of admissions, 2) hospital costs, and 3) lengths of stay.  I examined these 
outcomes for the birth hospitalization, for post-birth hospitalizations during infancy, 
across all infancy, and for ages one to four years. 
3.5.3.1 Outcome of Interest #1: Number of Hospitalizations 
The first outcome of interest was the number of hospitalizations per child.  I 
reported total number of hospitalizations during infancy (birth through age one) and 
during ages one to four years separately.  I also categorized hospitalizations during the 
first year of life as either birth hospitalizations or post-birth hospitalizations.  I made this 
distinction because previous work found that birth hospitalizations among infants with 
SB have notably higher charges than subsequent infancy hospitalizations [14].  For birth 
hospitalizations, by definition, the number of hospitalizations was always one.  For other 
ages categories of number of hospitalizations (post-birth, all infancy, or ages one to four 
years), the number of hospitalizations was the total number of hospitalizations a child 
experienced during the respective period. 
I defined a hospitalization as a single episode of hospital care, whether or not the 
hospital admission included an accompanying inter-hospital transfer [177].  If hospital 
discharge records showed that an infant was admitted to a hospital on the same day the 
 
48 
 
infant was discharged from another hospital, the two admissions were merged into one 
hospitalization.  If a one-day difference existed between a discharge from one hospital 
and an admission to another hospital and the records included a “transfer” code, the two 
admissions were also merged into one hospitalization.  This definition provided a more 
accurate picture of a hospital experience and reduced the number of single day 
admissions in one facility that would result in lower average costs and lengths of stay 
[177]. 
3.5.3.2 Outcome of Interest #2: Hospital Costs 
The second outcome of interest was total hospital costs.  For birth 
hospitalizations, hospital costs were those costs incurred during the birth hospitalization 
only.  For other age categories of hospital costs (post-birth, all infancy, or ages one to 
four years), the costs are the total costs a child incurred during the respective period.   
I converted the total estimated hospital charges obtained from the Florida AHCA 
dataset to total estimated hospital costs, using the 2010 average all-payer inpatient 
hospital cost-to-charge ratio for the state of Florida, provided by AHRQ [178].  The 
average all-payer inpatient hospital cost-to-charge ratio among Florida hospitals ranged 
from 0.355 in 2001 (n=209 hospitals reporting) to 0.294 in 2008 (n=217 hospitals 
reporting).  This average all-payer cost-to-charge ratio suggested that hospitals’ costs 
averaged approximately 29-36% of the amount those hospitals billed to health care 
payers between 2001 and 2008 [178].  Because 2001 was the earliest year of data 
available, I used the cost-to-charge ratio for 2001 (0.355) to convert inpatient charges to 
estimated costs for the years 1998-2001.  I then adjusted total estimated hospital costs to 
2012 dollars using hospital industry data from the Producer Price Index, U.S. Department 
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of Labor [179].  I used the Producer Price Index, instead of the Consumer Price Index, 
because it measures real output and excludes services, imports, sales taxes, and 
distribution costs [180]. 
3.5.3.3 Outcome of interest #3: Length of stay 
The third outcome of interest was length of stay.  The Florida AHCA provided the 
length of stay for each admission for each child in the AHCA dataset.  I measured length 
of stay in days.  If a child had a reported hospitalization and associated charges, but a 
zero-day length of stay, I re-coded length of stay to one-day.  Twenty-four infancy 
hospitalizations and 18 hospitalizations during ages one to four years had a zero-day 
length of stay.  These 42 hospital admissions were re-coded to a one-day length of stay.   
For birth hospitalizations, length of stay was the number of hospitalized days for 
the birth hospitalization only.  For other age categories of hospitalizations (post-birth, all 
infancy, or ages one to four years), the length of stay was the total number of days a child 
was hospitalized during that period.  I referred to length of stay as number of hospitalized 
days when referring to aggregate hospitalizations. 
3.5.4 Primary Exposure of Interest: Hydrocephalus 
Hydrocephalus, a need characteristic, was the primary exposure of interest.  The 
presence of hydrocephalus was based on administrative coding and was not clinically 
verified.  I identified hydrocephalus by the ICD-9-CM codes 741.01- 741.03 from the 
FBDR dataset.  The selection of these ICD-9-CM codes for identification of 
hydrocephalus was informed by discussions with several expert clinicians from the 
Centers for Disease Control and Prevention’s (CDC) National Center on Birth Defects 
and Developmental Disabilities (NCBDDD).  I reported the presence of hydrocephalus as 
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a dichotomous variable.  In selected analyses, I also stratified hydrocephalus by isolated 
or non-isolated SB.  Thus, for selected analyses, I reported the variable “spina bifida and 
hydrocephalus” as “isolated SB with hydrocephalus”, “non-isolated SB with 
hydrocephalus”, “isolated SB without hydrocephalus”, and “non-isolated SB without 
hydrocephalus.” 
3.5.5 Stratification by Age of Child 
 I stratified findings for birth through four years into two categories.  First, I 
reported findings for all hospitalizations that were initiated when the child was <365 days 
old.  I refer to this category as infancy.  I created infancy as a separate category because 
the highest health care use and costs typically occur during the first year of life for 
children with SB [14].  I then collapsed outcomes for age one through four years into a 
separate, single age category to maintain an adequate sample size for meaningful results.  
I identified hospitalizations for age one through four years as hospitalizations that began 
when the child was between 365 and 1823 days old.  I obtained the age of the child in 
days from the Florida AHCA dataset “time to admission” variable. 
3.5.6 Covariables Measuring Predisposing, Enabling, and Need Characteristics 
 I categorized additional covariables as predisposing, enabling, and need 
characteristics.  These characteristics corresponded to the components of the Aday and 
Andersen conceptual model.  Consistent with the Aday and Andersen conceptual model, 
the following characteristics were considered predisposing characteristics: maternal age, 
maternal race/ethnicity, maternal nativity, parity, marital status, maternal education, and 
child’s age and sex.  Enabling characteristics included the variables that measured 
adequacy of prenatal care, residential rurality, and health insurance payer.  In addition to 
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hydrocephalus, need characteristics included isolated or non-isolated SB, preterm birth, 
level of nursery care at the birth hospital, an inter-hospital transfer during the birth 
hospitalization, and death.  I describe these variables and their coding below. 
3.5.6.1 Predisposing Characteristics of Mothers and Children 
Predisposing characteristics of mothers included maternal race/ethnicity, maternal 
age, education, maternal nativity, and marital status.  These data were obtained from the 
FBDR and Florida vital statistics.  I calculated maternal parity by adding the number of 
live born children still living and those live born but now deceased, as reported in the 
FBDR data. 
Predisposing characteristics of the child were sex and age.  I obtained the sex of 
the child from the FBDR data.  I calculated the child’s age in years using the “time to 
admission” variable in the Florida AHCA data, which was reported in days. 
3.5.6.2 Enabling Characteristics of Mothers and Children 
 Enabling characteristics included adequacy of prenatal care and rurality of 
maternal residential address, which were obtained from Florida vital statistics data.  
Expected health insurance payer, another enabling characteristic, was obtained from the 
Florida AHCA data.  I identified adequacy of prenatal care using the Kotelchuck Index.  
The Kotelchuck Index creates a ratio comparing the month in which prenatal care was 
initiated with the total number of prenatal visits prior to delivery to calculate four 
categories of prenatal care: inadequate (less than 50% of expected visits), intermediate 
(50-79%), adequate (80-109%), and adequate plus (110% or more) [181, 182].  The 
Kotelchuck scoring system considers scores less than 80% to be inadequate care [181, 
182].  For the purpose of this research, based on an examination of the data, and to ensure 
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adequate cell sizes for meaningful results, I reported adequacy of prenatal care as a 
binary variable.  I used the Kotelchuck cut point of 80% to classify adequate and 
adequate plus care as “adequate prenatal care,” and intermediate and inadequate care as 
“inadequate prenatal care.”   
 I identified maternal residential rurality by comparing the geocoded maternal 
residential addresses reported at birth with the 2000 U.S. Census data that reported 
rurality by block group level.  In the 2000 U.S. Census, the Census Bureau defined 
“urban” as all territory, population, and housing units located within an urbanized area or 
in an urban cluster [183].  Urban areas and urban clusters were described by the U.S. 
Census Bureau as densely settled areas consisting of core census block groups or blocks 
that had a population density of at least 1,000 people per square mile and surrounding 
census blocks that had an overall density of at least 500 people per square mile [183].  
The U.S. Census Bureau defined all territory, population, and housing units located 
outside of urban areas or clusters as “rural” [183].  The U.S. Census Bureau assigned a 
designation to each census block group identifying the geographic area as urban, an urban 
cluster area, or as rural.  Following consultation with spatial research experts at the 
University of North Carolina at Charlotte’s (UNC Charlotte) Department of Geography 
and Earth Sciences and examination of the data, I collapsed urban and urban cluster 
designations into a single “urban” category.  I reported maternal residential “rurality” as a 
dichotomous variable, “urban” or “rural,” to ensure adequate cell sizes for meaningful 
results.  As described in published research, the FDOH conducted the initial geocoding of 
the maternal residential addresses reported at birth [140].  Researchers in UNC 
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Charlotte’s Department of Geography and Earth Sciences improved the match of the 
initial geocoding to ultimately geocode 99.7% of the maternal addresses [140 
 I classified health insurance payers in two ways using hospital discharge data 
from the Florida AHCA.  First, I classified payers for the birth hospitalization as: 1) 
public, 2) private, or 3) self-insured, under-insured, or no insurance.  Second, I classified 
“payer type” across infancy.  “Payer type” was classified as: 1) public payers only for all 
hospitalizations; 2) private payers only for all hospitalizations; 3) self-insured, under-
insured, or no insurance only for all hospitalizations; or 4) multiple payer types.  Multiple 
payer types indicated that a child had different types of health insurance coverage across 
more than one hospitalization; for example, a private health insurance payer covered one 
hospitalization and a public payer covered a subsequent hospitalization.  Public payer 
sources included Medicare, Medicaid, KidCare (Florida’s state children’s health 
insurance program), and the Veterans Administration.  Private payer sources included 
private or employer-based insurance, including military coverage (CHAMPUS or 
TriCare).  The self-pay, no insurance or under-insured category was defined by the 
Florida AHCA as either no third party coverage or less than 30% estimated insurance 
coverage [184].  I did not report payer type for ages one to four years because children 
may have had multiple types of payers across the four-year period.  For example, some 
children had a consistent payer for all four years, while others had one or more changes 
in payer types.  These changes made it difficult to characterize each child by a single, 
meaningful payer type for ages one to four years. 
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3.5.6.3 Need Characteristics of Mothers and Children 
 In addition to hydrocephalus, need characteristics included isolated or non-
isolated SB, preterm birth (less than 37 weeks gestation), low birth weight (less than or 
equal to 2500 grams), plurality, and death.  Data for these variables were obtained from 
the FBDR and Florida vital statistics data.  I reported SB for each infant as a dichotomous 
variable, isolated or non-isolated.  I also stratified hydrocephalus by isolated or non-
isolated SB for selected analyses.  Infants were classified as having isolated SB if they 
met any of the following criteria: 1) had only the SB birth defect; 2) had the SB defect 
and another minor birth defect associated or not associated with SB, such as low set ears 
or skin tags; or 3) had the SB defect accompanied by a documented sequence of coded 
defects related to SB and no additional unrelated, coded major defects [79, 80], as 
verified by a clinical expert at the CDC’s NCBDDD.  Classification of isolated or non-
isolated SB was informed by discussions with expert clinical consultants from the CDC’s 
NCBDDD, as well as previous research [12, 79].  An expert clinician from the CDC’s 
NCBDDD manually reviewed approximately 15% of the study sample that required 
additional consideration because of multiple conditions.  For example, patent ductus 
arteriosus (PDA) is heart condition common among premature infants.  If an infant with 
SB had a PDA, the infant was considered to have isolated SB if the infant was premature, 
but non-isolated SB if the infant was born at term.  These and other similar situations 
required a case-by-case review.  I referenced surveillance guidelines from the National 
Birth Defects Prevention Network (NBDPN) for ICD-9-CM diagnostic codes for major 
birth defects [83].  Table A in the appendix lists ICD-9-CM diagnostic codes considered 
as major birth defects by the NBDPN for its surveillance and research purposes.   
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 I also considered the level of nursery care at the birth hospital as a need 
characteristic.  The American Academy of Pediatrics classifies level of nursery care at the 
birth hospital as Level I, II, or III [185, 186].  Level III nursery care provides the most 
sophisticated care for complex cases [185, 186].  I reported the level of hospital nursery 
care for the birth hospitalization, even if an infant was transferred at birth to a hospital 
with a higher level of nursery care.  I defined a birth hospitalization as a first 
hospitalization with age at admission of zero days or a first hospitalization with an age at 
admission of one day with an accompanying indication of hospital transfer [177].  I used 
the level of nursery care only in analyses that examined birth hospitalizations.   
  In addition, I considered an inter-hospital transfer at birth as a need characteristic 
because infants who are transferred at birth typically have more serious or complex 
medical conditions that require services that are not available at the birth hospital.  Inter-
hospital transfers were identified when hospital discharge records showed that an infant 
was admitted to a hospital on the same day the infant was discharged from another 
hospital, or if a one-day difference existed between a discharge from one hospital and an 
admission to another hospital and the infant’s records included an indication of a transfer 
[177].  Only inter-hospital transfers that occurred during the birth hospitalization were 
included in the analysis.  I did not include later transfers because the data did not include 
information on hospital level of pediatric care, a designation that could have helped 
identify need.  In addition, transfers later in life could have been return trips to local 
hospitals for continued care or for other medical reasons beyond the scope of this 
dissertation research.  I coded inter-hospital transfers as a dichotomous variable, transfer 
or no transfer. 
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  Finally, I reported the child’s death, which was categorized as no death as of 
December 31, 2008, neonatal death (death at <28 days), death during infancy (< 365 
days), or death following infancy (≥365 days) [187].  For multivariable analyses, I 
collapsed the death categories into a dichotomous variable, death or no death.  I collapsed 
the variable to ensure that cell sizes were adequate for meaningful results.  All reported 
deaths occurred within the study period of January 1, 1998 through December 31, 2008.   
3.5.7 Statistical Analyses  
 I conducted descriptive analyses for the predisposing, enabling, and need 
characteristics of the study population and health system.  I reported the mean, median, 
and range for total hospital costs, total number of hospitalizations, and total lengths of 
stay respectively for birth hospitalizations, all post-birth hospitalizations during infancy, 
all infancy hospitalizations, and all hospitalizations during ages one to four years.    
 I used bivariate analyses to examine number of hospital admissions, hospital 
costs, and lengths of stay by the presence or absence of hydrocephalus, by isolated or 
non-isolated SB, by payer type, and by other predisposing, enabling, and need 
characteristics.  I examined outcomes for hospitalizations during infancy and for ages one 
to four years.  I also examined birth and post-birth hospitalizations during infancy 
separately, because previous research suggested infants with SB use more hospital 
resources during birth hospitalizations than during later hospitalizations [14].  Chi-square 
analyses were conducted on the categorical variables to determine significance level 
using a p-value of <0.05.  Where appropriate, I used Fisher’s exact test to account for 
small cell sizes, using a p-value of <0.05 to determine statistical significance.  Because of 
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the skewness of the data for hospital use and costs, I conducted Wilcoxon Rank Sums 
tests to determine significance level using a p-value of <0.05. 
 For the multivariable analyses, I used Poisson regression and ordinary least 
squares (OLS) or generalized linear model (GLM) procedures, depending on the type and 
distributional qualities of the data [188].  To examine the number of hospitalizations, I 
used Poisson regression because the outcomes were finite count data.  Costs and lengths 
of stay presented analytic challenges because the variables were positively skewed.  This 
is a common challenge when analyzing health care expenditures, length-of-stay, and 
utilization of health care data [188].  For costs and lengths of stay, I applied a method 
described by Manning and Mullahy [188] to evaluate characteristics of the data, apply 
recommended algorithms, and selected the method most appropriate for estimating each 
model.  For analyses of lengths of stay for post-birth hospitalizations and for those during 
ages one to four years, I used a generalized linear model (GLM) procedure with a Poisson 
distribution.  For all other models, I used an ordinary least squares (OLS) procedure for 
the log of the outcome, using a normal distribution and robust standard error option.  
These calculations ensured more accurate effect estimates by increasing precision and 
reducing bias [188].  For the multivariable analyses, I reported effect estimates as 
unadjusted prevalence ratios (uPR), adjusted prevalence ratios (aPR) or the log-
transformed exp (β) and corresponding 95% confidence intervals (CI) to determine if the 
selected predisposing, enabling, and need factors were associated with hospital use and 
costs.  I reported exp (β) values when the continuous outcomes were log-transformed for 
analysis. 
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  I constructed models for: 1) hospital costs and length of stay for birth 
hospitalizations; 2) total number of admissions, total hospital costs, and total lengths of 
stay for post-birth infancy hospitalizations; 3) total number of admissions, total hospital 
costs, and total lengths of stay for all infancy hospitalizations; 4) total number of 
admissions, total hospital costs, and total lengths of stay for all hospitalizations ages one 
to four years.  I did not examine number of hospitalizations for birth hospitalizations 
because, by definition, that number was always one.   
 The goal of the multivariable analyses was to arrive at models that were theory-
based, informed by previous research, and parsimonious given the relatively small 
sample size; thus, selected predisposing, enabling, and need covariables were included in 
the final regression model.  I excluded parity because no theory or previous research 
supported its inclusion.  I excluded low birth weight because of its close correlation with 
preterm birth.  I excluded plurality because too few infants were part of multiple births to 
contribute meaningfully to the results.  I excluded transfers because of their correlation 
with level of nursery care in the birth hospital.  
 My final models included the following variables: predisposing characteristics: 
maternal age, maternal race/ethnicity, maternal nativity, marital status, maternal 
education, and child’s sex and age; enabling characteristics: adequacy of prenatal care, 
residential rurality, and health care payers; need characteristics coded hydrocephalus (the 
primary outcome of interest), isolated or non-isolated SB (reported separately and by 
presence of hydrocephalus), preterm birth, level of nursery care, and death. 
 I conducted three sensitivity analyses to observe for differences in selected 
characteristics among the study sample.  First, I examined for differences between infants 
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who a linked inpatient hospital discharge record and those who did not.  Second, I 
examined for differences between infants who had a recorded birth hospitalization and 
those who did not.  Third, I examined for differences in characteristics between infants 
who experienced an inter-hospital transfer as part of their birth hospitalization and infants 
who did not.  Infants with no linked discharge records, no birth hospitalization, or infants 
who were transferred may have been different in terms of their demographic 
characteristics, clinical experiences, or severity of medical conditions compared with 
other infants in the study population.  
 I assessed individual variables used in the multivariable analysis for 
multicollinearity.  There was no evidence of notable multicollinearity based on 
recommended maximum levels of the variance inflation factor [189, 190].   
 All analyses were conducted using SAS 9.2 statistical software (SAS Institute, 
Inc., Cary, NC).  This study was approved by the Institutional Review Boards at UNC 
Charlotte, the FDOH, and the CDC’s NCBDDD. 
3.6 Results 
3.6.1 Selection of the Sample  
 The FBDR data identified 914 Florida-resident infants who were born between 
January 1, 1998 and December 31, 2007 with an ICD-9-CM code indicating an NTD.  Of 
these 914 infants, 668 had ICD-9-CM codes for SB without anencephaly.  Of the 668 
infants with SB, 614 were successfully linked to at least one inpatient hospital discharge 
record.  These infants comprised the sample for analysis.  Figure 1.1 (Chapter 1, page 9) 
shows the process for selecting the study sample. 
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 Infants who did not have a linked hospital discharge record and were in the FBDR 
were more likely to be born to mothers who were less educated (p=0.0011) and foreign-
born (p<.0001), and of Hispanic ethnicity (p= 0.0044) than infants who matched with a 
hospital discharge record (results not shown).  There were no significant differences in 
maternal age, marital status, infant’s sex and birth weight, or death between infants who 
matched and did not match to hospital discharge records (results not shown).   
 Of the 614 infants who matched to hospital discharge records, 569 infants had a 
first hospitalization recorded in the Florida AHCA dataset that was also the infants’ birth 
hospitalization.  Infants with no birth hospitalization recorded in the Florida AHCA data 
may have been born at a Florida hospital that did not report data to the Florida AHCA, 
such as a military hospital or a birthing center.  They may also have been born at home, 
although home births are relatively rare (less than 1% of births nationally) [191].  Infants 
in the FBDR who did not have a birth hospitalization were more likely to be born to 
Hispanic mothers (p=0.0272) who were rural residents (p=0.0206) and who were not 
born in the United States (p=0.0008) (results not shown).  I found no significant 
differences in maternal age, maternal education, marital status, and infant’s sex and birth 
weight, and the presence or absence of hydrocephalus between infants with and without a 
birth hospitalization (results not shown).  Among infants without a birth hospitalization, 
64.4% had hydrocephalus (n=29) (results not shown).   
3.6.2 Descriptive Results 
3.6.2.1 Descriptive Characteristics of the Mothers and Children 
 Tables 3.1 and 3.2 show selected descriptive characteristics of the mothers and 
infants in this study (n=614).  About 53% (n=323) of infants were born to non-Hispanic 
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White mothers.  Most mothers were born in the United States (75.9%, n=466), had at 
least a high school diploma (76.2%, n=468), and had received “adequate” prenatal care 
(72.8%, n=447).  About 60% of mothers were married (n=368).  The majority of mothers 
lived in urban or urban cluster areas (85.5%, n=525).  
 About 20% (n=121) of infants were born low birth weight and 26.5% infants were 
born preterm (n=163).  About 57% of infants had hydrocephalus (n=349); 25.4% of 
infants had non-isolated SB (n=156).  Examining hydrocephalus by isolated or non-
isolated SB, 42.4% of infants had isolated SB with hydrocephalus (n=260); 14.9% had 
non-isolated SB with hydrocephalus (n=89).  About 32% of infants had isolated SB 
without hydrocephalus (n=198); 10.9% had non-isolated SB without hydrocephalus 
(n=67).  Just under 9% of the children died at any point during the study period (n=53), 
with the majority of deaths occurring during infancy (6.7%, n=41). 
 About 24% of infants were transferred to another hospital during their birth 
hospitalization (n=146).  Infants who had an inter-hospital transfer were more likely to be 
born to a mother who was born in the United States (p=0.0324) and to have non-isolated 
SB (p=0.0012) compared with infants who were not transferred.  Infants born at a 
hospital with Level III nursery care were less likely to be transferred at birth (p=0.0003).  
There were no differences between infants who were transferred and those who were not, 
based on maternal race/ethnicity, maternal age and education, maternal nativity or marital 
status, or on infant’s sex or gestational age (results not shown).  
3.6.2.2 Descriptive Results for Number of Hospitalizations  
 Table 3.3 shows descriptive results for number of hospitalizations for birth 
hospitalizations, all post-birth hospitalizations during infancy, all infancy 
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hospitalizations, and all hospitalizations during ages one to four years.  The average 
number of hospitalizations across all infancy was 2.4 (SD 1.7; median: 2.0; range: 1-12).  
Infants with more than one hospitalization during infancy had an average of 2.2 
hospitalizations following their birth hospitalization (standard deviation, SD: 1.7; 
median: 2.0; range: 1-11).  During ages one to four years, children with SB had an 
average total of 3.0 hospitalizations (SD 3.0; median; 2.0; range: 1-19).   
3.6.2.3 Descriptive Results for Hospital Costs  
 Table 3.3 also shows descriptive results for hospital costs for birth 
hospitalizations, all post-birth hospitalizations during infancy, all infancy 
hospitalizations, and all hospitalizations during ages one to four years.  Total costs across 
all infancy averaged $47,884 (standard deviation, SD $86,934; median; $26,825; range: 
$124-1,590,268).  The average cost of a birth hospitalization (mean: $30,557; SD: 
$52,148; median: $18,789; range: $124-706,793) was 2.3 times higher than the average 
cost for a post-birth hospitalization (number of hospitalizations: 2.2; total mean: $29,592; 
SD $64,931; total median: $11,286; total range: $720-883,476; mean for a single post-
birth hospitalization: $13,450).  Total costs for all hospitalizations during ages one to four 
years averaged $30,483 (SD $57,427; median; $11,593; range: $304-505,528).  The 
average cost per hospitalization for children with SB ages one to four years was $10,161 
or 24% less than a post-birth hospitalization during infancy.  
3.6.2.4 Descriptive Results for Length of Stay  
 Finally, Table 3.3 shows the descriptive results for lengths of stay for birth 
hospitalizations, all post-birth hospitalizations during infancy, all infancy 
hospitalizations, and all hospitalizations during ages one to four years.  Infants were 
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hospitalized for an average of 17.2 days for their birth hospitalization (standard deviation, 
SD: 23.2; median: 10.0; range: 1-221).  Post-birth hospitalizations averaged 14.2 total 
days (SD 24.7; median: 5.0; range: 1-255).  Average total number of hospitalized days 
across all infancy was 25.3 days (SD 34.4; median: 14.0; range: 1-476).  The average 
total number of hospitalized days for a child during ages one to four years was 14.8 days 
(SD 26.8; median: 6.0; range: 1-206).   
3.6.3 Bivariate Results for Primary Exposure of Interest Hydrocephalus 
 In response to research question one, the following sections describe the results 
for the number of hospitalizations, lengths of stay, and associated costs for children with 
SB.  Based on the research question, I report the findings by the presence of 
hydrocephalus, by age group, and by payer type.  
3.6.3.1 Bivariate Results for Number of Hospitalizations by Hydrocephalus and Age 
Group 
 Table 3.3 further shows hospital use and costs by the presence of coded 
hydrocephalus.  Infants with hydrocephalus were hospitalized significantly more often 
than those without hydrocephalus.  During the first year of life, infants without 
hydrocephalus had an average total of 1.9 hospitalizations (SD; 1.4; median: 2.0; range: 
1-12).  Infants with hydrocephalus had an average total of 2.7 hospitalizations (SD; 1.9; 
median: 2.0; range: 1-12) (p<0.0001).  Examining all post-birth infancy hospitalizations, 
infants without hydrocephalus were hospitalized an average total of 1.7 times (SD: 1.4; 
median: 1.0; range: 1-11).  Infants with hydrocephalus were hospitalized an average of 
total of 2.5 times (SD: 1.9; median: 2.0; range: 1-11) (p<0.0001).  
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 During ages one to four years, children with SB and hydrocephalus also had 
significantly more hospitalizations compared with children without hydrocephalus.  
Children without hydrocephalus averaged 2.4 total hospitalizations during ages one to 
four years (SD: 2.8; median: 1.0; range: 1-15).  Children with hydrocephalus had an 
average total of 3.2 hospitalizations (SD: 3.1; median: 2.0; range: 1-19) (p=0.0023).
 Table 3.4 shows the results for number of hospitalizations for infants with 
hydrocephalus, stratified by isolated vs. non-isolated SB.  In general, infants and children 
with simpler presentations of SB (isolated SB, without hydrocephalus, or both) were 
hospitalized significantly fewer times during infancy and ages one to four years than 
children with more complex presentations of SB (non-isolated SB, with hydrocephalus, 
or both).  Infants with isolated SB and no hydrocephalus were hospitalized least often, 
1.7 times (SD: 0.8; median: 1.5; range: 1-6).  Infants with non-isolated SB and 
hydrocephalus were hospitalized most often, 3.0 times (SD: 2.5; median: 2.0; range: 1-
12) (p<0.0001).  During ages one to four years, children with isolated SB and no 
hydrocephalus were hospitalized least often, 1.7 times (SD: 1.9; median: 1.0; range: 1-
12); infants with non-isolated SB and hydrocephalus were hospitalized most often, 4.0 
times (SD: 3.1; median: 3.0; range: 1-13) (p<0.0001). 
3.6.3.2 Bivariate Results for Hospital Costs by Hydrocephalus and Age Group 
 Table 3.3 also shows hospital costs by the presence of coded hydrocephalus for 
hospitalizations for all infancy hospitalizations and for all hospitalizations during ages 
one to four years.  Infants with hydrocephalus incurred significantly higher hospital costs 
compared with infants without hydrocephalus.  During the first year of life, average 
inpatient costs for infants with hydrocephalus were 53.4% higher than average costs for 
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infants without hydrocephalus [mean (median) with hydrocephalus: $56,345 ($38,253); 
mean (median) without hydrocephalus: $36,742 ($14,838); p<0.0001]. 
 I found the same pattern of higher costs among infants with hydrocephalus 
comparing birth and all post-birth hospitalizations.  Infants with hydrocephalus incurred 
average costs for their birth hospitalizations that were 51.5% higher than the cost for 
infants without hydrocephalus [mean (median) cost with hydrocephalus: $35,884 
($27,491); mean (median) cost without hydrocephalus: $23,711 ($6,615); p<.0001].  
Similarly, infants with hydrocephalus incurred 29.1% higher average costs for all post-
birth hospitalizations compared with infants without hydrocephalus [mean (median) with 
hydrocephalus: $32,338 ($13,787); mean (median) without hydrocephalus: $25,050 
($8,775); p=0.0006]. 
 For all hospitalizations during ages one to four years, children with hydrocephalus 
had significantly higher hospital costs compared with children without hydrocephalus, 
although the differences were smaller.  The costs for children with hydrocephalus were 
5.9% higher than children without hydrocephalus [mean (median) cost with 
hydrocephalus: $30,902 ($13,095); mean (median) cost without hydrocephalus: $29,177 
($9,223); p=0.0181]. 
 Table 3.4 shows the results for costs by the presence of hydrocephalus stratified 
by isolated vs. non-isolated SB.  Infants and children with simpler presentations of SB 
(isolated SB, without hydrocephalus, or both) had significantly lower hospital costs than 
those who had more complex presentations of SB (non-isolated SB with hydrocephalus).  
Infants with isolated SB and no hydrocephalus had the lowest average total costs (mean: 
$18,637; median: $11,974).  Costs for infants with non-isolated SB without 
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hydrocephalus (mean: $90,247; median: $36,787) were three to four times higher than 
costs for infants with isolated SB and no hydrocephalus (p<.0001).  During ages one to 
four years, average total costs for children with non-isolated SB without hydrocephalus 
were twice as high as total costs for children with isolated SB and no hydrocephalus 
($42,423 versus $20,584, respectively; p<0.0010). 
3.6.3.3 Bivariate Results for Length of Stay by Hydrocephalus and Age Group 
 Table 3.3 shows number of hospitalized days for infants and children ages one to 
four years by the presence of hydrocephalus.  During the first year of life, infants with 
hydrocephalus were hospitalized for a total average of 30.0 days (SD 30.1; median: 20.0; 
range 1-216) compared with 19.0 days (SD 38.6; median: 8.0; range: 1-476) for infants 
without hydrocephalus (p<0.0001).  Comparing birth and post-birth hospitalizations, 
infants without hydrocephalus were hospitalized for average of 13.2 days at birth (SD 
25.7; median: 5.0; range 1-221) compared with 20.2 hospitalized days (SD 20.6; median: 
15.0; range 1-149) for infants with hydrocephalus (p<0.0001).  For post-birth 
hospitalizations, infants without hydrocephalus were hospitalized for a total average of 
11.5 days (SD 26.1; median: 4.0; range 1-255), while infants with hydrocephalus were 
hospitalized for a total average of 15.9 days (SD 23.6; median: 7.0; range 1-206) 
(p=0.0044).  There were no significant differences been the average total number of 
hospitalized days for children with and without hydrocephalus during ages one to four 
years. 
 Table 3.4 shows the results for the total number of hospitalized days by the 
presence of coded hydrocephalus stratified by isolated vs. non-isolated SB.  Infants and 
children with simpler presentations of SB had significantly shorter lengths of stay than 
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those with more complex presentations of SB.  Infants with isolated SB and no 
hydrocephalus spent the fewest total days in the hospital, 11.5 days (SD: 18.6; median: 
7.0; range: 1-138).  Infants with non-isolated SB with or without hydrocephalus had over 
three times the number of total hospitalized days (mean: 37.0; SD: 30.0; median: 26.0; 
range: 1-125 and mean: 41.5; SD: 65.1; median: 23.0; range: 1-476, respectively) 
compared with infants with isolated SB without hydrocephalus (p<0.0001). 
3.6.4 Bivariate Results Stratified by Health Payer 
 Table 3.5 shows the outcomes of interest stratified by health payer for infancy 
hospitalizations.  At birth, infants insured by a public payer spent an average of 4.2 days 
longer in the hospital than infants insured by private insurance (public payer: 19.1 days, 
private payer: 14.9 days; p=0.0058).  Infants insured by a public payer had 5.3% higher 
average costs than infants insured by a private payer (public payer: $31,282; private 
payer: $29,712; p=0.0151).  Examining post-birth hospitalizations, infants with multiple 
payers were hospitalized significantly more often that infants insured by a private payer 
(multiple payers: 2.6 hospitalizations; private payer: 2.0 hospitalizations; p=0.0226). 
 Across all infancy hospitalizations, payer type was significantly associated with 
the number of hospitalizations, costs, and length of stay.  Infants with multiple payers 
were hospitalized on average 52% more often that infants covered by a private payer 
(multiple payers: 3.2 hospitalizations; private payer: 2.1 hospitalizations; p<.0001).  
Infants with multiple payers were hospitalized an average of 39%% fewer total days than 
infants covered by a private payer (multiple payers: 11.8 days; private payer: 19.4 days; 
p<.0001).  Finally, infants with multiple payers 36% lower average total hospital costs 
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compared with infants covered by private payers (multiple payers: $25,179; private 
payer: $39,049; p<0.0007).  
 The number of infants who were self-pay or under-insured was small (n=24 birth 
hospitalizations).  Among these twenty-four infants, sixteen who had a subsequent 
infancy hospitalization were re-classified into the “multiple payers” category after their 
initial hospitalization, indicating they obtained some type of health insurance after their 
initial hospitalization. 
3.6.5 Multivariable Results  
 In response to research question two, the following sections describe the 
associations between hospital use and cost and selected predisposing, enabling, and need 
characteristics among children with SB.  
3.6.5.1 Multivariable Results for Number of Hospitalizations and Hydrocephalus, 
Stratified by Isolated versus Non-Isolated Spina Bifida  
 Table 3.6 shows the aPR and 95% CIs for the association between total number of 
hospitalizations and hydrocephalus, stratified by isolated vs. non-isolated SB.  Both 
hydrocephalus and isolated vs. non-isolated SB are need characteristics.  In the adjusted 
models, infants with isolated SB and hydrocephalus were hospitalized 53% more often 
during infancy and 82% more frequently at ages one to four years than those with 
isolated SB without hydrocephalus.  Children with non-isolated SB with hydrocephalus 
were hospitalized 72% more often during infancy and over twice as often during ages one 
to four years compared with children with isolated SB without hydrocephalus.  Children 
with non-isolated SB with hydrocephalus were hospitalized 79% more often during 
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infancy and over twice as often during ages one through four years compared with 
children with isolated SB without hydrocephalus. 
3.6.5.2 Multivariable Results for Hospital Costs and Hydrocephalus, Stratified by 
Isolated versus Non-Isolated Spina Bifida 
 Table 3.7 shows the effect estimates and 95% CIs for the association between 
total estimated inpatient hospital costs and coded hydrocephalus, stratified by isolated vs. 
non-isolated SB.  In the adjusted models, total costs for infants with isolated SB with 
hydrocephalus were over twice as high as costs for infants with isolated SB without 
hydrocephalus.  Infants with non-isolated SB without hydrocephalus had over two times 
the total costs of those of children with isolated SB without hydrocephalus.  Infants with 
non-isolated SB with hydrocephalus had over three times the total costs than those of 
children with isolated SB without hydrocephalus.  There was no association however, 
between hydrocephalus, isolated or non-isolated SB, and average total costs for children 
ages one to four years.   
3.6.5.3 Multivariable Results for Length of Stay and Hydrocephalus, Stratified by 
Isolated versus Non-Isolated Spina Bifida  
 Table 3.8 shows the effect estimates and 95% CIs for total length or stay and 
coded hydrocephalus, stratified by isolated vs. non-isolated SB.  In adjusted models, 
infants isolated SB with hydrocephalus were hospitalized over twice as many days 
compared with infants with isolated SB without hydrocephalus.  Infants with non-isolated 
SB, with or without hydrocephalus, spent three times more days in the hospital than 
infants with isolated SB without hydrocephalus.  During ages one to four years, children 
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with non-isolated SB with hydrocephalus had over twice the number of hospitalized days 
compared with children with isolated SB without hydrocephalus. 
3.6.5.4 Multivariable Results for Number of Hospitalizations and Selected Predisposing, 
Enabling and Need Characteristics  
 Table 3.6 shows effect estimates and 95% CI for the selected predisposing, 
enabling, and need characteristics and their effect on number of hospitalizations.  In 
adjusted models, need characteristics had the most notable associations with numbers of 
hospitalizations.  In addition to the effects of hydrocephalus and isolated vs. non-isolated 
SB described in previous sections, infants who were born prematurely were hospitalized 
16% more frequently following their birth hospitalization than full-term infants.   
 Examining predisposing characteristics, infants born to Hispanic mothers had 
22% fewer post-birth hospitalizations than infants born to non-Hispanic White mothers.  
Across all infancy, infants born to non-Hispanic Black mothers had 14% fewer 
hospitalizations than those born to non-Hispanic White mothers.  Children ages one to 
four years born to non-Hispanic Black mothers had 25% fewer hospitalizations than 
children born to non-Hispanic White mothers.  Boys, ages one to four years, had 24% 
fewer hospitalizations than girls. 
 Among enabling characteristics, children ages one to four years with a rural 
residence at birth had 46% fewer hospitalizations than those living in urban areas.  
Infants who changed health care payers had 49% more hospitalizations than those who 
were insured only by a private payer. 
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3.6.5.5 Multivariable Results for Hospital Costs and Selected Predisposing, Enabling and 
Need Characteristics 
 Table 3.7 also shows the effect estimates and 95% CIs for selected predisposing, 
enabling, and need characteristics and their influence on hospital costs.  In addition to the 
effects of hydrocephalus and isolated vs. non-isolated SB described in previous sections, 
infants born preterm had 34% higher costs for their birth hospitalizations than those born 
at full-term.  Infants born at a hospital with a lower level of nursery care had 60% lower 
costs compared with those born at a hospital with a higher level of nursery care.  Infants 
who died during infancy had 79% higher hospital costs for post-birth hospitalizations 
compared with infants who survived.  Children who died after infancy had over three 
times the costs during ages one to four years than infants who survived. 
 Among predisposing characteristics, children born to non-Hispanic Black mothers 
had 31% higher average total costs during ages one to four years than those born to non-
Hispanic White mothers.  Examining enabling characteristics during ages one to four 
years, total costs were 54% lower for rural resident children than those living in urban 
areas. 
3.6.5.6 Multivariable Results for Length of Stay and Selected Predisposing, Enabling and 
Need Characteristics  
 Finally, Table 3.8 shows the effect estimates and 95% CI for selected 
predisposing, enabling, and need characteristics and their influence on length of stay.  
Need characteristics again had the most notable associations with this outcome.  In 
addition to the effects of hydrocephalus and isolated vs. non-isolated SB described in 
previous sections, infants born preterm had 32% more hospitalized days at birth than 
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infants born full-term.  Infants born at a hospital with a lower level of nursery care were 
hospitalized 46% fewer days at birth than those born at a hospital with Level III nursery 
care.  Children who died were hospitalized more than twice as many total days for post-
birth hospitalizations and more than five times the number of total days during ages one 
to four years than those who survived. 
 Among predisposing characteristics, infants born to Hispanic mothers spent 35% 
fewer days in the hospital for post-birth hospitalizations compared with infants born to 
non-Hispanic white mothers.  During infancy, boys had 43% fewer hospitalized days than 
little girls. 
 Among enabling characteristics, children with a rural residence had 72% fewer 
hospitalized days during ages one to four years than those with an urban residence.  
Infants with a public payer source had 31% more hospitalized days than infants with a 
private payer source. 
3.7 Discussion 
My dissertation research provided statewide, population-based information about 
the number of hospitalizations, lengths of stay, and total estimated hospital costs for 
hospitalizations initiated during infancy and during ages one to four years for Florida-
resident children born with SB.  I extended research in this area by quantifying the 
difference in health resource use by comorbid or other individual characteristics.  This 
information can inform program planning and policy development.   
Patterns of hospital use and costs differed substantially for infants and children 
who had hydrocephalus and those that did not, as well as by isolated vs. non-isolated SB.  
In addition, hospital use and costs differed by several other predisposing, enabling, and 
 
73 
 
need characteristics: maternal race/ethnicity, rural residence, health care payer, 
prematurity, and level of care of the birth hospital nursery.  
 In response to my first research question, infants with hydrocephalus were 
hospitalized significantly more often, spent more days in the hospital, and incurred higher 
total hospital costs than those without hydrocephalus.  Examining hospital use by both 
hydrocephalus and isolated vs. non-isolated SB, infants and children with the simplest 
presentation of SB (isolated without hydrocephalus) used the least hospital resources and 
incurred the lowest costs.  Infants and children with non-isolated SB used more hospital 
resources than children with isolated SB, regardless of the presence of hydrocephalus.  
Children ages one to four years with hydrocephalus had significantly more 
hospitalizations and higher costs compared with those without hydrocephalus.  These 
differences between infants and children with and without hydrocephalus and by isolated 
vs. non-isolated SB were expected because hydrocephalus and other birth defects add 
complexity and risk factors to SB that may result in the need for additional health care.  
Quantifying the extra resource use and cost for infants and children in these groups can 
assist state governments and program planners as they evaluate needs for services and 
forecast health care budget needs. 
Results for number of hospitalizations and costs are consistent with previous 
research that found that infants with hydrocephalus may require readmissions for shunt 
revision or infections, thus adding to the costs of SB [12, 18, 20, 66, 85, 87, 92, 101, 111, 
163, 164].  I am aware of no published research that has compared length of stay for 
children with and without hydrocephalus; however, results for length of stay are 
consistent with work that suggests comorbidities may result in more health resource use 
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[17, 192, 193].  In addition, I am aware of no published research that has compared 
results for hospital resource use by isolated vs. non-isolated SB. 
 Also in response to research question one, infants used more hospital resources 
and incurred greater costs during infancy compared with hospital use and costs during 
ages one to four years.  This expected pattern is consistent with previous research that 
found that children with SB use the most health care resources during infancy and 
particularly during their birth hospitalizations [14].  This information can help to identify 
needs for age-specific services in this special population.   
 The mean length of stay for birth hospitalizations in this study (17.2 days) was 
slightly higher than the 15.1 days previously reported using AHRQ HCUP 2003 KID data 
[2].  The difference could reflect differences in the ascertainment methods of infants with 
birth defects [113].  Differences in number of hospitalized days from previous research 
findings may also be the result of different methods for addressing the issue of inter-
hospital transfers and the effect of transfers on calculation of the number of hospitalized 
days [2, 177].  The findings for length of stay during infancy were almost double that of a 
previous study (10.5 day versus 5.9 days) [14].  The previous study was based on a small 
sample size (n=13 infants) and may not be comparable.   
 No direct comparisons were available for length of stay for ages one to four years.  
One previous study found an average length of stay of 5.5 days per hospitalization for 
children with SB ages 1-17 years [14].  The findings of this study (4.9 days) were slightly 
shorter. 
 Finally, in response to research question one, children who were self-pay or 
under-insured had fewer and shorter hospitalizations during infancy compared with 
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children with some health care coverage.  Among CSHCN, the most critical determinant 
of access to care is adequate health insurance coverage [127].  Families who must pay for 
health care out-of-pocket or who have inadequate insurance may need to limit the health 
care they seek for their infant with SB.  It would be useful for health care providers to 
make families aware of insurance options, including support provided by the Title V 
Maternal and Child Health Block Grant funds or through the Affordable Care Act [194].  
It important to acknowledge that the “multiple payers” category was primarily composed 
of infants who were self-pay or under-insured at birth and then obtained insurance 
coverage for a subsequent infancy admission (results not shown).  Numbers in the self-
pay or under-insured category were small, so findings for infants and children in these 
categories should be viewed with caution. 
 In response to my second research question, I observed several predisposing, 
enabling, and need characteristics that influenced hospital use and costs.  Four need 
characteristics were consistently associated with higher hospital use and costs for 
children with SB: the presence of hydrocephalus, non-isolated SB, prematurity, and a 
higher level of hospital nursery care at birth.  I also observed that certain predisposing 
characteristics (maternal race/ethnicity, sex of child) and enabling characteristics (rural 
residency and payer type) influenced hospital use and costs.   
 Among predisposing characteristics, infants born to mothers of minority racial or 
ethnic groups had significantly fewer hospital admissions during infancy and during ages 
one to four years than children born to non-Hispanic White mothers.  Mothers of 
minority racial or ethnic groups may experience barriers to accessing care for their 
children.  These include: personal barriers (health care beliefs, perceptions of need, or 
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language and other social and cultural influences); financial barriers (insufficient 
monetary resources or lack of health care insurance); and or structural barriers 
(transportation and geographic location of services).  While most predisposing factors are 
not mutable, a better understanding of the effects of certain predisposing factors, such as 
maternal ethnicity, on use of health care resources and costs may be useful.  For example, 
educational programs that promote appropriate use of hospital resources can reach out to 
mothers with unique needs or risks.  Similarly, programs and policies that focus on 
selected groups who would benefit from additional support to access care, including 
information on financial and other family support, would be helpful. 
 The most consistent statistically significant associations across all outcomes were 
among the need characteristics.  Examining need characteristics, in addition to those 
already reported for hydrocephalus and isolated vs. non-isolated SB, infants born preterm 
were hospitalized more often and incurred higher total costs during the first year of life 
compared with those born full-term.  Both prematurity and the presence of another major 
birth defect in addition to SB may present further medical challenges that result in 
increased hospital use and costs.  These findings are consistent with previous general 
research that found comorbidities can add to an individual’s use of health services [17, 
158, 192, 193].  In addition, infants with SB born at a hospital with a lower level of 
nursery care had fewer hospitalizations and incurred lower costs than infants born in a 
hospital with a high level of nursery care.  If an infant with SB is diagnosed prenatally, 
mothers may pre-select a delivery hospital that has a higher level of hospital nursery care, 
especially if the SB condition is severe or the infant has other major birth defects.  Infants 
treated in a hospital with a lower level of nursery care may have fewer medical needs 
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than those treated at a birth hospital with high level of nursery care.  Findings also may 
be associated with different fees charged by hospitals with different levels of nursery 
care. 
 Examining enabling characteristics, rural maternal residence was associated with 
fewer hospitalizations and lower costs for children during ages one to four years.  This 
expected finding was consistent with previous research that found infants in rural 
counties experienced fewer hospitalized days compared with those living in urban areas 
[195].  Increased travel time and distance, high transportation costs, and limited 
transportation resources may all be barriers to accessing health care [120, 121].  Families 
living in rural areas may experience more of these accessibility barriers than families 
living in urban areas [128, 136].  However, rural residence was not associated with 
number of hospitalizations during infancy.  This finding was inconsistent with previous 
research that found infants in rural counties experienced fewer hospitalizations compared 
with infants living in urban areas [195].  The complex nature of SB and perceived need 
for care may motivate mothers to seek care for their infants with SB, despite barriers 
associated with rural residence. 
 The results described in the previous paragraphs suggest that need characteristics 
may have the most influence on hospital use and costs among children in this study 
sample.  This finding is consistent with a previous study found that children with multiple 
medical conditions (an indication of need), were eight times as likely to be high users of 
physician services as those without multiple conditions [99].  Another study reported that 
among CSHCN, those with more than one chronic condition were 27% more likely to be 
hospitalized in the course of a year and those with poor or fair perceived health were over 
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twice as likely to be hospitalized than CSHCN with only one chronic condition or 
perceived good health [100]. 
 In summary, hydrocephalus and the isolated vs. non-isolated SB were associated with 
substantially higher hospital resource use and costs during infancy.  While still notable, 
the effects of hydrocephalus and isolated vs. non-isolated SB decreased during ages one 
to four years.  Birth hospitalizations were the greatest contributor to all infancy costs.  
The patterns of hospital use during post-birth hospitalizations were more similar to those 
of hospitalizations during ages one to four years than to birth hospitalizations.  Children 
with isolated SB with hydrocephalus were more like children with non-isolated SB with 
hydrocephalus in their use of hospital resources than they were like children with isolated 
SB without hydrocephalus.  Among predisposing, enabling, and need characteristics, 
need characteristics appeared to have the most influence on hospital resource use and 
costs for this study sample.  This dissertation extended research by quantifying the 
differences in hospital resource use and costs for infants and children with hydrocephalus 
and isolated vs. non-isolated SB. 
3.8 Strengths and Limitations 
3.8.1 Innovation and Strengths in the Research Topic 
 This study examined differences in hospital use and costs in a population-based, 
statewide study of unduplicated Florida children with SB insured by different health care 
payer types.  The study followed children for the first four years of life, which provided 
new opportunities to examine hospital use and costs and associated predisposing, 
enabling, and need characteristics over time.  The comparison of health care use, and cost 
findings in the presence and absence of hydrocephalus was also unique.  With the 
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exception of one study, which explored hospital expenditures for North Carolina children 
with SB and SB with hydrocephalus born 1995-2002 and continuously enrolled in 
Medicaid [12], no similar work related to comorbidities and SB existed.  Thus, each of 
these topics represents new or expanded areas of research. 
3.8.2 Innovation and Strengths in the Methodology  
 The study population for this research was an important strength in that it 
represented a diverse group of children.  The state of Florida was the fastest growing and 
fourth most populous state according to the 2000 U.S. Census [22, 23].  Florida was 
fourth in number of annual live births, second in number of live births to non-Hispanic 
Black women, and third in number of live births to Hispanic women, nationwide during 
the study period of 1998-2008 [22-24].  Florida also supports a statewide, population-
based birth defects registry and a statewide agency for the collection of hospital discharge 
data that provided information for this project.  This statewide, population-based study 
sample used linked, longitudinal data from the FBDR and the Florida AHCA, which 
provided a robust source of information for this project. 
 Additionally, this research incorporated several methods that are not frequently 
used in health services research for birth defects, and thus are both strengths and 
innovations.  First, the unit of study was the individual child, rather than the more typical 
observation level of hospital admission or other aggregate data level.  Second, the dataset 
provided access to hospital discharge data for children from multiple payer sources, 
rather than the more commonly researched single payer source.  This feature allowed for 
a more complete picture of hospital use across multiple payers.  This feature also 
provided the opportunity to observe changes in payer type through infancy.  Third, the 
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linked, longitudinal data provided the opportunity to follow each child through early 
childhood to give unique insights into the differences in hospital use and costs over time.  
Fourth, I converted the total hospital charges to estimated costs using the AHRQ 
Healthcare Cost and Utilization Project cost-to-charge ratio files, which are based on 
accounting reports from Centers for Medicare and Medicaid Services [178].  
Multiplication of the hospital charge by the cost-to-charge ratio results in an estimated 
hospital cost for those charges [178] and is a useful tool for making comparisons across 
cost and charge data.  In addition, I adjusted the costs to the current dollar value amount.  
 A final strength of this methodology is its ability to be replicated for other birth 
defects.  Health services researchers and public health researchers can use these methods 
to examine different types of birth defects in collaboration with other birth defect 
registries and state and federal agencies.  
 Regarding generalizability, the demographic findings of this study are similar to 
the characteristics of all Florida-born infants during with study period with a few 
exceptions.  Infants and children in the sample were significantly more likely to have 
been born preterm compared to all live-born infants in Florida born during the study 
period (27% preterm births compared to 11% in Florida, 2007) [27].  This finding is 
consistent with previous findings related to birth defects and prematurity [172, 196, 197].  
The study sample also included a slightly lower proportion of Hispanic mothers than 
found statewide in Florida (29% statewide compared to 25% in the study sample).  In 
addition, about 50% of infants with SB had only public insurance for all hospitalizations 
during infancy; about 43% of all births in Florida during the study period were insured by 
Medicaid [27].  These differences in the study sample versus the population 
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characteristics of Florida were expected or minor.  Thus, the results may be generalizable 
to the state. 
3.8.3 Limitations Inherent in the Data Sources 
 This research faced several limitations based on the data used.  Infants identified 
for this study were based on the passive surveillance methodologies for identifying 
infants with birth defects using ICD-9-CM codes.  Some birth defects surveillance 
systems actively identify birth defect diagnoses using modifications of the British 
Pediatric Association (BPA) Classification of Diseases [198, 199].  In contrast, passive 
birth defects surveillance systems, while widely used, do not actively verify the birth 
defect diagnosis by review of medical records, hospital charts, or nursery logs.  Passive 
surveillance techniques may lead to under-reporting or miss reporting of infants with 
birth defects or a specific defect type [27-29, 200, 201].  However, the FBDR’s overall 
completeness of ascertainment of birth defects has been estimated at 87%, with case 
ascertainment variation noted by specific defect [28, 29].  Because SB is relatively easy 
to detect, a passive surveillance system may be less of a limitation than with other birth 
defects that are more difficult to detect.  In the FBDR data, case ascertainment of infants 
with SB without anencephaly was 88.0% [29], a relatively high completeness of 
ascertainment of SB.  The presence of hydrocephalus and the presence of other major 
birth defects used in identifying children with isolated or non-isolated SB were also based 
on coded data rather than clinically verified data.  Finally, limited information on prenatal 
diagnosis is available in passive surveillance systems [27].  For Florida, there is no access 
to data on prenatal diagnosis for birth defects through the FBDR.  Further, because this 
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analysis used data from the FBDR, it is a state-specific study, which may limit 
generalizability to other states or regions of the country. 
 The nature of the study sample also presented a limitation because the sample size 
was not constant over the ten-year study period.  While the Florida AHCA provided ten 
years of hospital discharge data, the full ten years only applied to the children born in the 
first year of the study.  Each subsequent birth cohort had one less year of data, ending 
with the birth cohort of 2007, which had only one year of data.  The smaller sample size 
for each cohort decreased statistical power, thus reducing the opportunity to observe 
effects that may exist in the study sample.  To reduce this risk, I limited the analyses to 
the first four years of life. 
 Additionally, the principal payer source variable that was used in analyses of birth 
payer and payer types across the four years was an expected principal payer source.  It is 
not known if this was the actual payer source.  Furthermore, some infants may have dual 
payer sources (e.g., private and public payer) for a single hospitalization.  Such 
information is not generally reported with hospital discharge data.   
 Another limitation was the fact that the data were based on Florida hospital 
administrative data.  Administrative data may be at risk for error or inconsistent coding 
that could incorrectly code maternal residential addresses and hospital facility codes or 
introduce error in diagnostic coding.  This data did not include information on families 
that sought care out-of-state for their child.  Additionally, while approximately 290 
Florida hospitals report data to the Florida AHCA, not all are required to report, including 
one Shriner’s Hospital that provides care at no cost to patients, as well as long and short-
term psychiatric hospitals, inpatient residential treatment and rehabilitation facilities, and 
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military hospitals [202].  Thus, I was not able to capture access to care data on all the 
children within the Florida SB population under study.  However, because data from 108 
different Florida hospitals were represented in the data set [140] and most of the non-
reporting hospitals do not provide newborn care, the amount of data lost was likely 
limited.  Thus, the findings of this research may be generalizable at least to the state of 
Florida. 
 Administrative datasets may also be limited by missing observations.  Among the 
all covariables observed in this study, no covariable was missing more than 10% of its 
observations.  The covariable with the largest number of missing values was “adequacy 
of prenatal care”, that had 5.6% missing observations.  While deletion of missing data 
may reduce sample size, lower statistical power, and potentially introduce bias if the data 
is not missing at random [203], the numbers missing and deleted from analysis in this 
dataset were small and likely had no effect on the outcomes. 
 Lastly, the use of administrative data does not capture all aspects of an 
individual’s inclination to use health services resources.  Characteristics such as travel 
time and distance, family resources, employment status, and health beliefs and health 
literacy are not available in this administrative dataset; however, these are characteristics 
that may influence the use of hospital services.   
3.8.4 Limitations Inherent in Research Design 
 This research faced additional limitations resulting from the study design.  I could 
not directly compare hospital cost estimates from my dissertation with previous estimates 
for children with SB for several reasons.  First, costs are not equivalent to the charges or 
expenditures reported in previous research.  Second, some previous studies used a single 
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payer source, such as private health insurance or Medicaid, which can have different 
reimbursement rates for services.  Third, some previous studies did not adjust costs for 
inflation.  Fourth, some previous studies did not adjust costs for inflation or used different 
case ascertainment methods.  While acknowledging differences in charges, costs and 
expenditures, I addressed this limitation by converting charges to estimated hospital costs 
based on Florida’s average hospital cost-to-charge ratio using the most recent cost-to-
charge ratios from AHRQ Healthcare Cost and Utilization Project.  In addition, I adjusted 
costs to the most current dollar amount using hospital industry data from the Producer 
Price Index, U.S. Department of Labor to provide timely findings. 
 Further, I did not examine the reason for the hospitalization.  The hospitalization 
may have been directly related to a child’s SB diagnosis or could have been unrelated 
(such as an illness or accident).  This is limitation of study could result in overstated or 
underestimated SB costs. 
 Finally, I noted that total estimated hospital costs represent only one component 
of health care costs.  Thus, this research did not capture the full health care and societal 
cost burden associated with the care of SB during the first four years of childhood.  To 
better estimate the total cost of care for infants with SB, information on other cost 
components, such as outpatient costs and prescription drug costs, would be needed.  
These costs were included in the dataset; however, the data were not as complete as the 
inpatient charges data and thus were not used.  Professional fees, including physician 
charges, were also absent from the analysis because they are not commonly included in 
hospital discharge data and were not available in the Florida AHCA data set.  Inclusion of 
indirect costs, such as the value of care provided by the family within the home or the 
 
85 
 
value of lost parental work time, would also have contributed to a more complete 
understanding of the financial burden of this condition.  Because these types of data were 
not available, the findings of this study underestimate the total health care costs for 
children with SB. 
3.9 Implications for Public Health Practice and Research 
 This study suggests several points for consideration in the areas of public health 
and access to health care services.  First, this research suggests that the use of birth 
defects surveillance data combined with hospital discharge data can provide vital 
information about patterns and predictors of hospital use and costs for children with SB.  
An understanding of patterns and predictors of hospital use and costs may be important to 
inform health care planning by governmental providers such as federal, state, and local 
agencies, and particularly those serving CSHCN.  For example, cost information for 
children covered by public payers can help state-level planners develop economic 
forecasts for state health care programs serving CSHCN.  In addition, information about 
health resource use may help policy makers to assess new or changing needs for services 
among CSHCN. 
 Second, collaborative multi-state, population-based studies linking multiple birth 
defect registries and linked, longitudinal data would be useful to further examine hospital 
use and costs for SB and other birth defects.  Collaborative research projects would 
increase study sizes, thus increasing study power and potentially the ability to observe 
effects over time.  Continued support and expansion of the National Spina Bifida Patient 
Registry [204], as well as continued funding for the National Birth Defects Prevention 
Network, National Birth Defects Prevention Study, and state birth defects surveillance 
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systems to advance the knowledge of healthcare utilization among individuals with SB 
will be important for these efforts. 
 Third, the observed differences in health care use based on need were expected 
and do not necessarily indicate the disparities or inequities in care.  Primary prevention of 
SB continues to be the best way to reduce need.  Continued support of the mandatory 
folic acid fortification of the U.S. cereal grain supply is important to this goal [51, 52, 
116].  The enactment of new policies that support the fortification of corn masa flour with 
folic acid may help prevent further cases of SB, especially among the Hispanic 
population [205].   
 The observed differences in hospital use and costs based on maternal 
race/ethnicity, maternal nativity, and education, rural residency and payer type may be 
associated with different policies and reimbursement rates of the payers or may indicate 
disparities in access to and quality of care.  Each of these presents opportunity for further 
exploration. 
 Additional opportunities for future research include examination of hospital use 
and costs by other comorbidities associated with SB and across the lifespan.  Among 
CSHCN, adequate health insurance coverage is one of the most critical determinants of 
access to care.  Thus, further research to explore the different types of payer changes that 
occur during infancy and childhood would be important (e.g., identifying percentages and 
reasons for change from public to private payer or from private to public payer).  A better 
understanding of the predisposing, enabling, and need characteristics associated with 
changes in payer type and the effects of those changes on health care resource utilization 
and health outcomes would also be important to explore. 
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 In conclusion, my dissertation research provided estimates of health care resource 
utilization from birth to age four years for children born with SB in Florida between 1998 
and 2007.  My research also quantified differences in hospital use and cost by the 
presence of hydrocephalus and isolated vs. non-isolated SB and by birth and post-birth 
hospitalizations during infancy, for all infancy and for ages one to four years.  The use of 
quantified, summary measures of hospital use and costs may offer new opportunities to 
identify the impact of the commonly occurring comorbidities such as SB and 
hydrocephalus, on health care utilization and costs.  This information can assist in health 
service planning and financing for children with SB and other birth defects and 
associated comorbidities. 
 Finally, the findings of this study can help to inform research for other birth 
defects.  This dissertation research demonstrated that hospital discharge data and data 
collected by birth defects surveillance programs can be used to analyze differences in 
costs and payer status by selected diagnoses and sociodemographic information.  Health 
service researchers and other state birth defects surveillance programs may collaborate to 
conduct similar analyses and determine any patterns and differences in results.  A more 
complete understanding of the patterns of hospital use and costs associated with SB and 
other birth defects can inform program planning and policy development, which may 
ultimately contribute to reduced health costs, improved health care delivery and quality 
of care, and improved long-term quality of life  for families  and children born with SB or 
other similar birth defects. 
.
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Table 3.1  Selected characteristics of Florida-born children with spina bifida, with and without hydrocephalus, 1998-
2007   
Characteristics 
All infants  
(n=614) 
Without 
hydrocephalus 
(n=265)  
With 
hydrocephalus 
(n=349)  p-value 
n (%) n (%) n (%) 
Exposures of interest        
Hydrocephalus        
Yes 349 (56.8)      
No 265 (43.2)      
Spina Bifida 1          
Isolated  458 (74.6) 198 (74.7) 260 (74.5) 0.9509 
Non-isolated  156 (25.4) 67 (25.3) 89 (25.5)  
Spina Bifida and Hydrocephalus        
Isolated SB without hydrocephalus  198 (32.3)      
Non-isolated SB without hydrocephalus  67 (10.9)      
Isolated SB with hydrocephalus  260 (42.4)      
Non-isolated SB with hydrocephalus 89 (14.5)      
Predisposing characteristics        
Maternal age (in years)        
≤24 224 (36.5) 78 (29.4) 146 (41.8) 0.0062 
25-29 164 (26.7) 79 (29.8) 85 (24.4)  
>30 225 (36.6) 108 (40.8) 117 (33.5)  
Missing    1 (0.2)      
Maternal race/ethnicity        
Non-Hispanic White 323 (52.6) 136 (51.3) 187 (53.6) 0.2988 
Hispanic 153 (24.9) 73 (27.5) 80 (22.9)  
Non-Hispanic Black 128 (20.9) 54 (20.4) 74 (21.2)  
Other  10 (1.6) 2 (0.8) 8 (2.3)  
Maternal nativity        
Born in U.S. 466 (75.9) 198 (75.0) 268 (77.0) 0.5631 
Foreign-born 146 (23.8) 66 (25.0) 80 (23.0)  
Missing    2 (0.3)      
Maternal marital status        
Married 368 (59.9) 162 (61.1) 206 (59.0) 0.5978 
Not married 246 (40.1) 103 (38.9) 143 (41.0)  
Maternal parity        
First child 237 (38.7) 99 (37.4) 138 (39.5) 0.6073 
Second or subsequent child 376 (61.3) 165 (62.5) 211 (60.5)  
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Table 3.1 (continued)        
Characteristics 
All infants Without hydrocephalus 
With 
hydrocephalus  p-value 
n (%) n (%) n (%) 
Maternal education        
High school diploma or more  468 (76.2) 214 (81.7) 254 (73.8) 0.0226 
No high school diploma 138 (22.5) 48 (18.3) 90 (26.2)  
Missing 8 (0.01)      
Sex of infant        
Female 317 (51.6) 142 (53.6) 175 (50.1) 0.3980 
Male 297 (48.4) 123 (46.4) 174 (49.9)  
Enabling characteristics        
Prenatal care 2        
Adequate prenatal care   447 (72.8) 194 (77.9) 253 (76.4) 0.6754 
Inadequate prenatal care   133 (21.7) 55 (22.1) 78 (23.6)  
Missing  34 (5.5)      
Residential rurality 3        
Urban /urban cluster 525 (85.5) 226 (85.3) 299 (86.2) 0.7563 
Rural 87 (14.2) 39 (14.7) 48 (13.8)  
Missing 2 (0.3)      
Payer for birth hospitalization (n=569) 4          
Public payer  292 (47.6) 119 (44.9) 173 (49.6) 0.1912 
Private payer  253 (4.2) 116 (43.8) 137 (39.3)  
Self or uninsured  24 (3.9) 14 (5.3) 10 (2.9)  
No birth hospitalization 45 (7.3) 16 (6.0) 29 (8.3)  
Payer across all infancy 4          
Public payer only 306 (49.8) 123 (46.4) 183 (52.4) 0.1013 
Private payer only 236 (38.4) 114 (43.0) 122 (35.0)  
Self or uninsured only  8 (1.3) 5 (1.9) 3 (0.9)  
Multiple payers 64 (10.4) 23 (8.7) 41 (11.8)  
Need characteristics        
Preterm birth (< 37 weeks gestation)        
No 448 (73.0) 205 (77.9) 243 (69.8) 0.0247 
Yes 163 (26.5) 58 (22.1) 105 (30.2)  
Missing 3  (0.5)      
Low birth weight (< 2500 grams)        
No 492 (80.1) 206 (77.7) 286 (82.2) 0.1705 
Yes 121 (19.7) 59 (22.3) 62 (17.8)  
Missing 1 (0.2)      
        
        
 
90 
 
Table 3.1 (continued)        
Characteristics 
All infants Without hydrocephalus 
With 
hydrocephalus  p-value 
n (%) n (%) n (%) 
Plurality        
Singleton birth 593 (96.6) 252 (95.1) 341 (97.7) 0.0776 
Multiple birth 21 (3.4) 13 (4.9) 8 (2.3)  
Nursery level of  birth  hospital 5        
Level III 511 (83.2) 201 (76.1) 310 (89.3) <.0001 
Level I or II 100 (16.3) 63 (23.9) 37 (10.7)  
Missing 3 (0.5)      
Inter-hospital transfer 6        
No inter-hospital transfer 468 (76.2) 205 (77.4) 263 (75.4) 0.5642 
Inter-hospital transfer 146 (23.8) 60 (22.6) 86 (24.6)  
Death 7        
No death  561 (91.4) 239 (90.2) 322 (92.3) 0.2972 
Died during neonatal period 19 ( 3.1) 12 (4.5) 7 (2.0)  
Died during  infancy 22 ( 3.6) 10 (3.8) 12 (3.4)  
Died after infancy  12 ( 2.0) 4 (1.5) 8 (2.3)  
Note:  Presence of hydrocephalus and major birth defects used to identify non-isolated SB were based on coded data and not clinically 
verified.  Not all children are represented in each time point.  Columns may not add to 100% because of missing or unknown values.  
P-values in bold are considered statistically significant at <0.05. 
1 Isolated spina bifida is defined as SB with no additional major defects, other than the sequence of defects related to SB. 
2 Adequacy of prenatal care is determined using the Kotelchuck Index.  Based on Kotelchuck scoring, adequate and adequate plus 
were considered “adequate prenatal care”.   
3 Rural residence is identified using geocoded maternal residence and 2000 U.S. Census data. 
4 Payers are expected, but not confirmed, health care payers.  Public insurance included Medicare, Medicaid, KidCare, and Veterans 
Administration insurance.  Private included employer-based insurance, including military coverage (CHAMPUS/TriCare).  Self or 
under-insured defined as no insurance, no third party coverage, or less than 30%.  Multiple payer type means child had different types 
of health care payer sources over multiple hospitalizations. 
5 Level 3 is highest level of hospital nursery care.  Level 1 is the lowest level of hospital nursery care. 
6 Inter-hospital transfers occurred during birth hospitalization.  Transfers were identified when hospital discharge records showed that 
an infant was admitted to a hospital on the same day the infant was discharged from another hospital or if a one-day difference existed 
between a discharge from one hospital and an admission to another hospital and records indicated an accompanying transfer. 
7 All deaths occurred during study period, prior to December 31, 2008.  Neonatal deaths are deaths at < 28 days.  Infancy deaths < 365 
days.   
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 Table 3.3 Number of hospitalizations 1, number of hospitalized days 2, and estimated total costs 3  for Florida-born 
children with spina bifida with and without hydrocephalus by age category, 1998-2007  
Hospitalizations All children Without hydrocephalus 
With
hydrocephalus p-value
Birth hospitalizations 4 
Number of children with hospitalizations 569 249 320 
Total number of hospitalizations 569 249 320 
Mean (SD) total  number hospitalized days 17.2 (23.2) 13.2 (25.7) 20.2 (20.6) <0.0001 
Median (IQR) total number hospitalized days 10.0 (17.0) 5.0 (8.0) 15.0 (16.0) 
Range for  total  number  hospitalized days 1-221 1-221 1-149 
Mean (SD) total  inpatient costs ($) 30,557 (52,148) 23,711 (64,967) 35,884 (38,675) <0.0001 
Median (IQR) total inpatient costs ($) 18,789 (29.411) 6,615 (19,105) 27,491 (25,185) 
Range for total inpatient costs ($) 124-706,793 124-706,793 202-309,432 
Post-birth hospitalizations during infancy 
Number of children with hospitalizations 406 153 253 
Total number of hospitalizations 884 264 620 
Mean (SD) number of hospitalizations 2.2 (1.7) 1.7 (1.4) 2.5 (1.9) <.0001 
Median (IQR) number of hospitalizations 2.0 (2.0) 1.0 (1.0) 2.0 (2.0) 
Range for  number of hospitalizations 1-11 1-11 1-11 
Mean (SD) total  number hospitalized days 14.2 (24.7) 11.5 (26.1) 15.9 (23.6) 0.0044 
Median (IQR) total number hospitalized days 5.0 (11.0) 4.0 (6.0) 7.0 (16.0) 
Range for  total  number  hospitalized days 1-255 1-255 1-206 
Mean (SD) total  inpatient costs ($) 29,592 (64,931) 25,050 (77,901) 32,338 (55,636) 0.0006 
Median (IQR) total inpatient costs ($) 11,286 (19,758) 8,775 (11,908) 13,787 (27,546) 
 Range for total inpatient costs ($) 720-883,476 817-883,476 720-487,037 
All infancy hospitalizations  (< 1 year) 
Number of children with hospitalizations 614 265 349 
Total number of hospitalizations 1453 513 940 
Mean (SD) number of hospitalizations 2.4 (1.7) 1.9 (1.4) 2.7 (1.9) <.0001 
Median (IQR) number of hospitalizations 2.0 (2.0) 2.0 (1.0) 2.0 (2.0) 
Range for  number of hospitalizations 1-12 1-12 1-12 
Mean (SD) total  number hospitalized days 25.3 (34.4) 19.0 (38.6) 30.0 (30.1) <.0001 
Median (IQR) total number hospitalized days 14.0 (24.0) 8.0 (12.0) 20.0 (26.0) 
Range for  total  number  hospitalized days 1-476 1-476 1-216 
Mean (SD) total  inpatient costs ($) 47,884 (86,934) 36,742 (110,248) 56,345 (62,655) <.0001 
Median (IQR) total inpatient costs ($) 26,825 (39,039) 14,838 (21,203) 38,253 (37,778) 
Range for total inpatient costs ($) 124-1,590,268 124-1,590,268 445-500,210 
96 
Table 3.3 (continued) 
Hospitalizations All children Without hydrocephalus 
With
hydrocephalus p-value
Hospitalizations during years 1-4 
Number of children with hospitalizations  251 61 190 
Total number of hospitalizations 763 146 617 
Mean (SD) number of hospitalizations 3.0 (3.0) 2.4 (2.8) 3.2 (3.1) 0.0023 
Median (IQR) number of  hospitalizations  2.0 (3.0) 1.0 (1.0) 2.0 (3.0) 
Range for  number of hospitalizations 1-19 1-15 1-19 
Mean (SD) total  number hospitalized days  14.8 (26.8) 15.6 (34.8) 14.5 (23.8) 0.1601 
Median (IQR) total  number hospitalized days  6.0 (12.0) 5.0 (8.0) 6.0 (12.0) 
Range for  total  number hospitalized days 1-206 1-206 1-175 
Mean (SD) total  inpatient costs ($) 30,483 (57,427) 29,177 (64,877) 30,902 (55,004) 0.0181 
Median (IQR) total inpatient costs ($) 11,593 (22,733) 9,223 (21,535) 13,095 (25,194) 
Range for total inpatient costs ($) 304-505,528 812-361,726 304-505,528 
SD =standard deviation, IQR =interquartile range.  Note; Statistical significance at p < 0.05 (p-value based on Wilcoxon Rank Sum 
test  
Note:  Presence of hydrocephalus and major birth defects used to identify non-isolated SB were based on coded data and not clinically 
verified.  Not all children are represented in each time point.   
1 Hospitalizations refer to hospitalizations initiated, but not necessarily completed in age category.  Hospitalizations were assessed as 
continuous episodes of hospital care, regardless of whether a transfer took place.  Multiple admission records were merged into one if 
an infant was admitted to a hospital on the same day as a discharge from a previous admission, or if the infant was admitted to a 
hospital on the day after a previous discharge with an accompanying “transfer” code. 
2 Hospitalized days refers to the number of days that an infant spent in the hospital for all admissions initiated within the specified age 
category. 
3 Estimated costs in 2012 U.S. dollars.  Estimated costs calculated as total charges adjusted to Florida’s statewide average hospital 
cost-to-charge ratio (Agency for Healthcare Research and Quality, Health Care Utilization Project, 2012).  Inpatient charges include 
all hospital facility charges (excludes professional fees): pharmacy, medical and surgical supplies, laboratory, radiology and other 
imaging, cardiology, operating room, anesthesia, recovery room, emergency room (if an inpatient hospital admission originated in the 
emergency room), treatment or observation room (if a visit resulted in an inpatient hospital admission) charges (Agency for Health 
Care Administration, 2011). 
4 Birth hospitalizations defined as a first hospitalization with age at admission of 0 days or a first hospitalization with an age at 
admission of 1 day with an accompanying indication of hospital transfer. 
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CHAPTER 4: FACTORS ASSOCIATED WITH TIMELINESS OF 
SURGICAL REPAIR OF SPINA BIFIDA 
4.1 Introduction 
The Institute of Medicine considers adherence to standard clinical guidelines, 
including timeliness of care, a core component of its framework of quality care [102].  
Timely care is important to reduce comorbidities among children with birth defects and 
can contribute to improved quality of life and lower health care use and costs [16, 17, 
105, 206, 207].  Understanding factors associated with timely care among infants with 
birth defects is useful because birth defects are a leading contributor of disability and 
pediatric hospitalizations in the U.S. and account for more than $2.6 billion in annual 
hospital costs [2, 6, 8, 208]. 
This research focuses on one type of major birth defect, spina bifida (SB), and 
reports the proportion of Florida-born infants who had timely surgical repair of this birth 
defect.  This study also examines predisposing, enabling, and need characteristics 
associated with timely surgical repair.  Findings from this study can contribute to our 
understanding of adherence to recommended standards of care for timely surgical repair 
of SB.  Results of this research also add to our understanding of factors that may result in 
differences in timing of surgical repair and help to inform health education, program 
planning and development, and management and treatment protocols. 
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4.2 Literature Review 
4.2.1 Epidemiology of Neural Tube Defects and Spina Bifida 
Spina bifida (SB), one type of major birth defect, is a neural tube defect that 
results from a failure of the caudal neural tube to fuse early in embryonic development.  
Spina bifida occurs when the caudal neural tube does not close completely at some point 
along the spine between the cervical and sacral regions [10, 11].  Spina bifida occulta 
(“closed”) occurs when a small gap in the spine exists, but no opening occurs on the 
back, thus the spinal cord and nerves remain essentially intact [10, 11, 41].  This type of 
SB presents few health care problems and may not be diagnosed at birth [43]. 
Meningoceles are an “open” type of SB in which a sac of cerebral fluid is exposed 
through an opening on the infant’s back, but no part of the spinal cord is herniated into 
the sac [11].  This form of SB results in little nerve damage and is typically associated 
with only minor disabilities [11, 209]. 
Meningomyeloceles are also “open” SB defects; however, they involve the 
herniation of both the meninges (the membranes that surround the central nervous 
system) and the spinal cord into a sac outside the vertebral column [10, 43, 209].  
Meningomyeloceles are the most serious and most common presentation of SB and often 
result in significant disability [11, 41].  A 2012 National Birth Defects Prevention Study 
used population-based birth defects surveillance data from a ten-state area to examine 
infants with various presentations of SB [42].  The researchers found that 85.6% of 
infants with SB had the subtypes of SB that included myelomeningocele, meningocele, 
and myelocele [42].  Other research reports as many as 90% of children with SB have the 
subtype myelomeningocele [11, 41]. 
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 Spina bifida may present as a single condition in a newborn or SB may be 
accompanied by other conditions diagnosed at birth or later in life.  Isolated SB is SB 
with the single SB malformation or SB with commonly associated malformations, such 
as hydrocephalus, orthopedic problems, including scoliosis and lower limb issues, or 
defects of the urinary system [12, 46, 79, 80, 94].  Isolated SB also includes SB with 
other minor anomalies, such as low set ears, skin tags, or curved fingers (clinodactyly) 
[12, 80].  Non-isolated SB is defined as SB with another major, unrelated malformation 
and without a syndromic diagnosis [12, 79, 80].  Approximately 15% to 25% of infants 
with SB have non-isolated SB [81, 82].  Children with SB and other birth defects most 
commonly have orofacial clefts, cardiac defects, and renal or abdominal wall anomalies 
or have defects that occur as a part of a recognized genetic syndrome [81, 82] 
 Spina bifida affects approximately 1,500 live-born U.S. infants each year [1] and 
typically requires life-long, multidisciplinary health care.  According to the Florida Birth 
Defects Registry (FBDR) data, an average of 70 infants with SB were born each year in 
the state of Florida between 1998 and 2007 [27]. 
4.2.2 Management and Treatment of Spina Bifida 
Fifty years ago, infants born with SB received only palliative care because of a 
lack of viable options for clinical treatment [46, 60-62].  New medical and surgical 
interventions now provide hope for both survival and improved quality of life and health 
outcomes for children born with SB [49, 63, 64].   
The Spina Bifida Association’s publication Guidelines for Spina Bifida Health 
Care Services throughout the Lifespan comes closest to providing standardized 
guidelines for the care of individuals with SB [65].  Postnatal surgical closure of the 
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defect within the first 48 hours of life is the current recommended standard of treatment 
for SB, particularly for infants with myelomeningocele [65].  Surgical closure includes 
closing the opening in the spinal column as well as restoring skin and muscle tissues that 
cover the site [66].  Prompt closure of the site is important because it prevents infection 
from developing in the exposed nerves and tissues [66].  Prompt surgical repair also 
protects the exposed nerves and structures from additional trauma [66, 67].  Surgical 
closure, however, does not restore function lost because of damage to exposed neural 
tissue. 
A growing body of research suggests an alternate prenatal surgical repair of the 
SB defect [68-73].  The Management of Myelomeningocele Study (MOMS) conducted a 
randomized control trial in 2003 to compare the safety and efficacy of prenatal surgical 
repair of the SB defect with that of postnatal repair [68, 74].  Prenatal surgical repair was 
associated with a reduced need for shunt placement for treatment of hydrocephalus and 
improved mobility in early childhood [56, 68].  After recruiting 183 of the projected 200 
participants, researchers halted the trial because of the efficacy of the prenatal repair [68].  
Related to my dissertation research, no Florida hospitals participated in the Management 
of Myelomeningocele Study clinical trials [68, 74]. 
 Prenatal surgical repair of SB, however, may pose risks to both the mother and 
fetus.  Risks include abruption of the placenta and uterine scarring among mothers, and 
preterm births among infants [56, 68].  Additionally, the number of facilities in the 
United States that can perform the surgery is limited [75].  Thus, the adoption of prenatal 
surgical repair of SB is not yet widespread [56, 76, 77].  The Spina Bifida Association 
recommends caution in the acceptance of a new standard of care based on a single study 
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[75] with a sample size that is small and not representative of the U.S. population.  The 
post-natal surgical repair of SB therefore remains the primary method of initial treatment. 
4.2.3 Timeliness of Surgical Repair for Infants with Spina Bifida 
Experts convened by the Centers for Disease Control and Prevention (CDC) 
named timeliness of services a public health research priority for selected birth defects, 
including orofacial clefs, craniosynostosis, congenital heart defects, and Down syndrome 
[33-36].  In addition to being a core component of the Institute of Medicine’s quality of 
care framework, timely care is important in the reduction of comorbidities among 
children with birth defects and can contribute to improved quality of life and lower health 
care use and costs [12, 16, 17, 102-105]. 
Timely post-natal surgical repair of SB reduces the risk of injury to the exposed 
neural tissues and reduces the risk of central nervous system or other infections [56].  
Timely repair of SB has also been associated with a reduction in the risk of 
comorbidities, including infection of a ventriculoperitoneal shunt [18], neurogenic 
bladder [16], and neurodevelopmental delays [19].  In addition, mortality rates appear 
lower if SB repair occurs in the first 36-48 hours of life [18, 20, 21]. 
However, timely care among children with birth defects remains an understudied 
area.  To my knowledge, no peer-reviewed research exists on adherence to recommended 
standards of care of timely surgical repair of SB among infants with SB.  Further, no 
studies report factors associated with the timing of the initial surgical repair for infants 
with SB.  An understanding of timely surgical repair of SB is useful because early 
surgical repair may reduce mortality and also decrease the likelihood of certain 
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comorbidities associated with SB, such as neurogenic bladder, neurodevelopmental 
delays, and ventriculoperitoneal shunt infections [16, 18-21, 107].   
4.3 Study Objectives and Hypotheses 
The purpose of this study was to examine the timeliness of initial surgical repair 
and factors associated with surgical repair of the SB lesion among infants with SB.  This 
study reported the proportion of infants with SB who had a surgical repair within the 
recommended 48 hours of birth and those who had a repair later, more than 48 hours after 
birth through the end of the first year of life.  This research also examined predisposing, 
enabling, and need characteristics associated with timely repair.  The research questions 
were: 
1. What proportion of infants (birth through one year) with spina bifida, who had
surgical repair, had a timely surgical repair of the SB lesion (within 48 hours of 
birth)? 
2. What predisposing, enabling, and need characteristics were associated with
timely surgical repair of SB? 
Based on previous research, I hypothesized that differences in timely surgical 
repair would vary based on predisposing characteristics (maternal nativity [169, 170], 
maternal race/ethnicity [168, 169, 171]), enabling characteristics (adequacy of prenatal 
care [132] and payer type [108, 125, 127, 134]), and need characteristics (preterm birth, 
nursery level of care at the birth hospital, and presence of comorbidities, such as 
hydrocephalus [17, 157]). 
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4.4 Conceptual Framework 
The Aday and Andersen Framework for the Study of Access to Medical Care 
provided the conceptual basis for this project [152, 156, 175, 176].  I adapted the Aday 
and Andersen model to the research questions presented above and included the specific 
predisposing, enabling, and need variables used in each component of the model (the 
model is shown in Chapter 2, Figure 2.3, page 37). 
4.5 Study Design and Methods 
4.5.1 Study Design 
This study was a retrospective, statewide, population-based cohort analysis of 
timeliness of surgical repair for infants with SB born in Florida between January 1, 1998, 
and December 31, 2007.   
4.5.2 Data Acquisition and Study Sample 
Data for this study were obtained from linked, longitudinal datasets provided by 
the Florida Birth Defects Registry (FBDR) within the Florida Department of Health 
(FDOH), Florida Bureau of Vital Statistics within the FDOH, and the Florida Agency for 
Health Care Administration (AHCA), which provided the hospital discharge data.  
Infants with SB without anencephaly born in Florida between 1998 and 2007 were 
identified using the International Classification of Disease, 9th revision; Clinical 
Modification (ICD-9-CM) codes 741.00-741.93.  Hospital discharge data from January 1, 
1998 through December 31, 2008, were used to allow for at least one year of 
hospitalizations for each infant with SB. 
Infants who were adopted or prospectively adopted or who were born out of state 
were excluded by the FBDR.  Included infants were live-born in Florida to a mother who 
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was a Florida resident at the time of delivery and matched with an inpatient hospital 
discharge record during the first year of life.  Infants had to have a birth hospitalization to 
be included in the study to determine whether or not the infant had SB surgical repair 
during the first 48 hours of birth.  Infants without a recorded birth hospitalization were 
excluded to reduce error in the analysis because repairs may have occurred at a hospital 
that did not report hospital discharge data.  A total of 290 Florida hospitals reported data 
to the Florida AHCA during the study period; children with SB were hospitalized in 108 
of those reporting hospitals [140].  Non-reporting hospitals included long and short-term 
psychiatric hospitals, inpatient residential treatment and rehabilitation facilities, and 
military hospitals in Florida, as well as one non-profit Shriner’s Hospital that provided 
care at no cost to patients [202].   
Infants who died during the neonatal period (the first 28 days of life) were 
excluded from the bivariate and multivariable analyses.  Infants who died during the 
neonatal period likely had more severe or complex medical conditions than infants who 
survived the neonatal period.  Thus, their experience of surgical repair may not be typical 
of infants with SB.  Infants who died later in infancy or during childhood were retained in 
the bivariate and multivariable analysis to capture the full extent of factors associated 
with timely surgical repair among infants with SB who had a repair.  Figure 1.1 in 
Chapter 1 (page 9) shows the process for identification of infants for the final study 
sample. 
4.5.3 Primary Outcome of Interest: Timeliness of Surgical Repair 
The primary outcome of interest was timely surgical repair of the infant’s SB 
defect among those infants who had a repair recorded in the hospital discharge data at 
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any point during the first year of life.  The ICD-9-CM procedural codes 0351 
(meningocele repair) and 0352 (myelomeningocele repair) were used to identify surgical 
repair of SB.  Discussions with several expert clinical consultants from the CDC’s 
National Center on Birth Defects and Developmental Disabilities (NCBDDD) informed 
the selection of these ICD-9-CM procedural codes. 
 Using the Spina Bifida Association’s recommended guideline of surgical repair 
within 48 hours of birth [65], infants were considered to have timely repair if the hospital 
discharge data time-to-procedure code for the repair was on day 0, 1, or 2 of an infant’s 
life (i.e., within first 48 hours of life).  Surgical repair on day three or later was 
considered untimely repair.  I coded each infant with a binary variable as having had 
timely or untimely surgical repair. 
4.5.4 Primary Exposures of Interest: Isolated or Non-Isolated Spina Bifida and 
Hydrocephalus 
 The primary exposure of interest was a need characteristic, isolated or non-
isolated SB.  I reported SB for each infant as a dichotomous variable, isolated or non-
isolated SB.  Infants were classified as having isolated SB if they met any of the 
following criteria: 1) had only the SB birth defect; 2) had the SB defect and another 
minor birth defect, such as low set ears or skin tags; or 3) had the SB defect accompanied 
by a documented sequence of defects related to SB and no additional unrelated major 
defects [79, 80].  Classification of each infant as having isolated or non-isolated SB was 
informed by discussions with expert clinical consultants from the CDC’s NCBDDD, as 
well as previous research [12, 79].  Expert clinical consultants from the CDC’s 
NCBDDD manually reviewed approximately 15% of the study sample that required 
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additional consideration because of multiple conditions.  For example, patent ductus 
arteriosus (PDA) is a heart condition common among premature infants.  If an infant with 
SB had a PDA, the infant was considered to have isolated SB if the infant was premature, 
but non-isolated SB if the infant was born at term.  These and other similar situations 
required a case-by-case review.  I referenced surveillance guidelines from the National 
Birth Defects Prevention Network (NBDPN) for ICD-9-CM diagnostic codes for major 
birth defects [83].  Appendix A lists ICD-9-CM diagnostic codes considered as major 
birth defects by the NBDPN for its surveillance and research purposes.   
A secondary exposure of interest was the presence of hydrocephalus, also a need 
characteristic.  Hydrocephalus was identified by ICD-9-CM codes 741.01- 741.03.  
Discussions with several expert clinical consultants from the CDC’s NCBDDD informed 
the selection of these ICD-9-CM codes.  I reported the presence of hydrocephalus as a 
dichotomous variable, yes or no.  Hydrocephalus cannot be used as a direct predictor of 
timely repair because an infant may be born with hydrocephalus or may develop 
hydrocephalus following surgical repair or at a later date [66].  However, the presence of 
hydrocephalus may serve as a proxy for the more severe forms of SB, based on the high 
percent of children with myelomeningoceles who have hydrocephalus [11, 41, 210, 211].  
Previous research has found that 80% to 90% of infants with myelomeningocele have a 
chance of developing hydrocephalus that requires placement of a ventriculoperitoneal 
shunt at birth or sometime thereafter [11, 41, 42, 210, 211]. 
4.5.5. Covariables Measuring Predisposing, Enabling, and Need Characteristics 
 I categorized additional covariables as predisposing, enabling, and need 
characteristics, corresponding to components of the Aday and Andersen conceptual 
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model.  Consistent with the Aday and Andersen conceptual model, I considered the 
following predisposing characteristics: maternal age, maternal race/ethnicity, maternal 
nativity, parity, marital status, maternal education, and infant’s sex.  Enabling 
characteristics included the variables that measured adequacy of prenatal care, residential 
rurality, and health insurance payer.  Need characteristics included preterm birth, level of 
nursery care at the birth hospital, an inter-hospital transfer during the birth 
hospitalization, and the presence or absence of hydrocephalus, and isolated or non-
isolated SB.  I describe these variables and their coding in detail in the paragraphs that 
follow. 
4.5.5.1 Predisposing Characteristics of Mothers and Infants 
Predisposing characteristics of mothers included maternal race/ethnicity, age, 
education and nativity and marital status.  This information was obtained from the FBDR 
and Florida vital statistics data.  I calculated maternal parity by adding the number of 
live-born infants still living and those live-born now deceased as reported in the FBDR 
data. 
Predisposing characteristics of infants were sex and age.  The sex of the infant 
was obtained from the FBDR data.  I calculated the age of the infant using the time to 
admission variable in the Florida AHCA (hospital discharge) data, which was reported in 
days. 
4.5.5.2 Enabling Characteristics of Mothers and Infants 
 Enabling characteristics included adequacy of prenatal care and rurality of 
maternal residential address at delivery, using data obtained from the FBDR and Florida 
statistics data, and the expected health insurance payer, which was obtained from the 
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Florida AHCA (hospital discharge) data.  Adequacy of prenatal care was determined 
using the Kotelchuck Index.  The Kotelchuck Index creates a ratio comparing the month 
in which prenatal care is initiated with the total number of prenatal visits prior to delivery 
to calculate four categories of prenatal care: inadequate (less than 50% of expected 
visits), intermediate (50-79%), adequate (80-109%), and adequate plus (110% or more) 
[181, 182].  The Kotelchuck scoring system considers scores less than 80% to be 
inadequate care [181, 182].  Based on an examination of these data and to ensure 
adequate cell sizes for meaningful results, I reported adequacy of prenatal care as a 
binary variable.  I used the Kotelchuck cut point of 80% to classify “adequate” and 
“adequate plus” care as “adequate” prenatal care, and “intermediate” and “inadequate” 
care as “inadequate” prenatal care. 
 I identified maternal residential rurality by comparing the geocoded maternal 
residential addresses reported at birth with the 2000 U.S. Census data that reported 
rurality by block group level.  In the 2000 U.S. Census, the Census Bureau defined 
“urban” as all territory, population, and housing units located within an urbanized area or 
in an urban cluster [183].  Urban areas and urban clusters were described by the U.S. 
Census Bureau as densely settled areas consisting of core census block groups or blocks 
that had a population density of at least 1,000 people per square mile and surrounding 
census blocks that had an overall density of at least 500 people per square mile [183].  
The U.S. Census Bureau defined all territory, population, and housing units located 
outside of urban areas or clusters as “rural” [183].  The U.S. Census Bureau assigned a 
designation to each census block group identifying the geographic area as urban, an urban 
cluster area, or as rural.  Following consultation with spatial research experts at UNC 
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Charlotte Department of Geography and Earth Sciences and examination of the data, I 
collapsed urban and urban cluster designations into a single “urban” category.  I reported 
maternal residential “rurality” as a dichotomous variable, “urban” or “rural”, to ensure 
adequate cell sizes for meaningful results. 
 Health insurance payer was the expected payer source for the birth 
hospitalization.  I defined a birth hospitalization as a first hospitalization with an age at 
admission of zero days or a first hospitalization with an age at admission of one day with 
an indication of hospital transfer [177].  I classified health insurance payers for the birth 
hospitalization as: 1) public, 2) private, or 3) self-insured, under-insured, or no insurance.  
Public payer sources included Medicare, Medicaid, KidCare (Florida’s state children’s 
health insurance program), and Veteran’s Administration insurance.  Private payer 
sources included private or employer-based insurance, including military coverage 
(CHAMPUS or TriCare).  The self-pay, no insurance or under-insured category was 
defined by the Florida AHCA as either no third party coverage or less than 30% 
estimated insurance coverage [184]. 
4.5.5.3 Need Characteristics of Mothers and Infants 
 Need characteristics included preterm birth (less than 37 weeks gestation), low 
birth weight (less than 2500 grams), and plurality, all obtained from Florida vital 
statistics data.  I reported low birth weight (1500-2499 grams) and very low birth weight 
(125-1499 grams) separately in the descriptive findings, but collapsed the two categories 
into one low birth weight category in subsequent analyses because of small cell sizes. 
 I also considered the level of nursery care at the birth hospital as a need 
characteristic.  The American Academy of Pediatrics classifies level of nursery care at the 
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birth hospital as Level I, II, or III [185, 186].  Level III nursery care provides the most 
sophisticated care for complex cases [185, 186].  I reported the level of hospital nursery 
care for the birth hospitalization, even if an infant was transferred at birth to a hospital 
with a higher level of nursery care, in order to most accurately represent an infant’s initial 
hospital experience.  I defined a birth hospitalization as a first hospitalization with age at 
admission of zero days or a first hospitalization with an age at admission of one day with 
an accompanying indication of hospital transfer [177].   
 Inter-hospital transfers were identified when hospital discharge records showed 
that an infant was admitted to a hospital on the same day the infant was discharged from 
another hospital or if a one-day difference existed between a discharge from one hospital 
and an admission to another hospital [177].  Only inter-hospital transfers that occurred 
during the birth hospitalization were observed.  Inter-hospital transfers were coded as no 
transfer, transfer by day three of life, or transfer after day 3 of life.  
  Finally, I reported the death of infants in the study sample, categorized as no 
death, infancy death (≤ 365 days), or death following infancy (>365 days and before 
December 31, 2008).  Because of small cell sizes, I did not include death as a covariable 
in bivariate or multivariable analyses. 
4.5.6 Statistical Analyses 
 Descriptive analyses were conducted for the predisposing, enabling, and need 
characteristics.  I reported the mean, median, and range in days for time-to-repair among 
the infants who had a surgical repair during the first year of life.  
 Bivariate analyses examined repair in less than or equal to 2 days versus greater 
than two days by predisposing, enabling, and need characteristics.  I conducted chi-
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square analyses to determine significance level using a p-value of <0.05.  Where 
appropriate, I used Fisher’s exact test to account for small cell sizes.  I also compared 
mean time-to-repair by isolated or non-isolated SB, the presence of hydrocephalus, and 
the experience of an inter-hospital transfer.  I used the Wilcoxon rank sum test to report 
p-values because of the skewed nature of the continuous outcome. 
 For the multivariable analysis, I used a modified log-linear Poisson regression 
with a robust variance estimate to examine how selected predisposing, enabling, and need 
characteristics were associated with timely surgical repair of SB.  Poisson regression is a 
form of the generalized linear model that provides directly interpretable results in 
analysis of dichotomous variables, especially when the outcome of interest is not rare 
[187, 212, 213].  I computed effect estimates, unadjusted prevalence ratios (uPR) and 
adjusted prevalence ratios (aPR), and corresponding 95% confidence intervals for each 
covariable to assess the magnitude and precision of the effect estimates.   
 For the multivariable analysis, I constructed models for: 1) all infants with a 
recorded surgical repair, 2) infants with a recorded surgical repair and with isolated SB, 
and 3) infants with a recorded surgical repair and non-isolated SB.  I also constructed 
models comparing timely surgical repair for infants 4) with hydrocephalus and 5) without 
hydrocephalus.  The multiple models allowed me to observe the influence of the two 
exposures of interest independently and to confirm the results of the model containing all 
the covariables. 
 The goal of modeling was to arrive at models that were theory-based, informed by 
previous research, and parsimonious given the relatively small sample size; thus, selected 
predisposing, enabling, and need covariables were included in the final regression model.  
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I excluded parity because no theory or previous research supported its inclusion.  I 
excluded low birth weight because of its close correlation with preterm birth.  I excluded 
plurality because too few infants were part of multiple births to contribute meaningfully 
to these results.  Finally, I excluded transfers because of their correlation with level of 
nursery care in the birth hospital.  Because I excluded infants who died during the 
neonatal period, I did not control for death in the multivariable analysis.  I also ran 
models separately for each of the categories of theory-based characteristics (predisposing, 
enabling, and need). 
 I conducted sensitivity analyses to observe for differences in selected 
characteristics among the study sample.  First, I examined for differences between infants 
who had a recorded birth hospitalization and those who did not.  Second, I examined 
differences in characteristics between infants who experienced an inter-hospital transfer 
as part of their birth hospitalization and infants who did not.  Infants with no birth 
hospitalization or infants who were transferred may have been different in terms of their 
clinical experiences or severity of medical conditions compared to other infants in the 
study population.  I did not examine differences between infants with and without a 
surgical repair because so many factors that could not be measured in the data set may 
have contributed to the absence of a recorded repair, including fetal repair or repair at an 
out-of-state hospital or at a Florida hospital that did not report data to the Florida AHCA.  
 I assessed individual variables used in the multivariable analysis for 
multicollinearity.  There was no evidence of notable multicollinearity based on 
recommended maximum levels of the variance inflation factor [189, 190].   
 
127 
Analyses were conducted using SAS 9.2 statistical software (SAS Institute, Inc., 
Cary, NC).  This study was approved by the Institutional Review Boards at the University 
of North Carolina Charlotte, the FDOH, and at the CDC’s NCBDDD. 
4.6 Results 
4.6.1 Study Population 
The FBDR data identified 914 Florida-resident infants who were born between 
January 1, 1998, and December 31, 2007, with an ICD-9-CM code indicating a neural 
tube defect.  Of these 914 infants, 668 had ICD-9-CM codes associated with the neural 
tube defect, SB without anencephaly.  Of the 668 infants with SB without anencephaly, 
614 linked to at least one inpatient hospital discharge record.  
Infants in the FBDR who did not have a linked hospital record were significantly 
more likely to be born to mothers who were less educated (p=0.0011), foreign-born 
(p<.0001), and of Hispanic ethnicity (p= 0.0044) than infants who had a linked hospital 
record (results not shown).  There were no significant differences in maternal age, marital 
status, infant’s sex and birth weight, or death between infants with or without a linked 
hospital record (results not shown). 
Of the 614 infants with a linked hospital record, 569 infants had a first 
hospitalization recorded in the Florida AHCA dataset that was also the infant’s birth 
hospitalization.  Infants in the FBDR who did not have a linked birth hospitalization were 
more likely to be born to younger mothers (p=0.0034), mothers who were rural residents 
(p=0.0206), and mothers were not born in the United States (p=0.0031) (results not 
shown).  I found no significant differences in maternal race/ethnicity, maternal education, 
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marital status, and infant’s sex and birth weight between infants with and without a birth 
hospitalization (results not shown). 
 Among the 569 infants with a birth hospitalization, 299 had a recorded SB repair 
and no death in the neonatal period.  This group of 299 comprised the final sample for 
analysis. 
4.6.2 Descriptive Results 
4.6.2.1 Descriptive Characteristics of the Mothers and Infants  
 Table 4.1 shows the descriptive characteristics of the mothers and infants in this 
study.  Among all infants with a birth hospitalization (n=569), 301 (52.9%) had a 
recorded surgical repair of the primary defect and two died during the neonatal period, 
leaving a study sample of 299 infants.  About 61% (n=181/299) of mothers were married.  
Most mothers were born in the United States (76.6%, n=229/299), had at least a high 
school diploma (74.9%, n=224/299), and received adequate prenatal care (75.9%, 
n=227/299).   
 About 54% (n=161/299) of infants were born to non-Hispanic White mothers.  
About 11% (n=32/299) of infants were born low birth weight (1500-2499 grams) and 
2.7% were born very low birth weight (n=8/299); 25.4% (n=76/299) of infants were born 
preterm.  About 80% (n=240/299) of infants had hydrocephalus and 20.4% (n=61/299) 
had non-isolated SB.   
 Among the 299 infants, 27.8% (n=83) had an inter-hospital transfer during their 
birth hospitalization.  About 96% of those transfers (n=80/83) occurred by day three of 
the infant’s life.  Infants who had an inter-hospital transfer were more likely to have non-
isolated SB (p=0.0037) and to have private insurance (p=0.0368) than infants who were 
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not transferred (results not shown).  Infants born at a hospital with Level III nursery care 
were less likely to be transferred at birth (p<0.0001) (results not shown).  There were no 
differences between infants who were transferred and those who were not, based on 
maternal race/ethnicity, maternal age and education, maternal nativity or marital status, or 
sex or gestational age of the infant (results not shown). 
4.6.2.2 Descriptive Results for Time-to-Repair for Spina Bifida 
 Table 4.2 shows the descriptive results for time-to-repair.  Mean time-to-repair for 
all infants was 11.3 days (standard deviation, SD, 37.0 days) and median time-to-repair 
was 1.0 day (interquartile range, IQR, 3.0 days).  While mean time-to-repair varied, 
infants with isolated SB, non-isolated SB, and hydrocephalus all had a median time-to-
repair of 1.0 day.  The range for time-to-repair was 0 to 305 days.   
 Table 4.3 shows time-to repair by categories.  Of the 299 infants with a repair, 
68.6% (n=205) of infants had the surgical repair by day two of life.  About 15% 
(n=45/299) of infants had a surgical repair between days three and seven.  About 16% 
(n=49/299) of infants had a surgical repair after day seven, but before the end of their 
first year of life. 
4.6.3 Bivariate Results 
4.6.3.1 Bivariate Results for the Primary Exposures of Interest: Isolated or Non-Isolated 
SB and Hydrocephalus 
 Table 4.1 presents the results of bivariate analysis for the dichotomous outcomes 
of timely (<48 hours after birth, day 0-2) or untimely repair (after day 2).  Examining the 
primary outcome of interest, the variable isolated or non-isolated SB was not 
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significantly associated with time of repair (p=0.2373).  However, the presence of 
hydrocephalus was significantly associated with having a timely repair (p<0.0001). 
 Table 4.2 presents the results for time-to-repair, stratified by isolated or non-
isolated SB and by the presence of hydrocephalus.  The variable isolated or non-isolated 
SB did not significantly affect the timeliness of SB repair; however, there was a 
significant difference in average time-to-repair comparing infants with and without 
hydrocephalus (p<0.0001).  Infants with hydrocephalus experienced a mean time-to-
repair of 5.3 days (SD: 21.3); infants without hydrocephalus experienced a mean time-to-
repair of 35.5 days (SD: 66.4 days).  Median values were 1.0 day (IQR, 1.5 days) for 
infants with SB with hydrocephalus and 5.0 days (IQR, 36.0 days) for infants with SB 
without hydrocephalus. 
4.6.3.2 Bivariate Results for Predisposing, Enabling, and Need Characteristics 
Table 4.1 also presents the results of bivariate analysis comparing predisposing, 
enabling, and need characteristics between infants with and without a timely repair.  I 
observed no associations between the timing of repair and the predisposing or enabling 
characteristics.  Among need-related characteristics, infants who were born preterm 
(p=0.0486) and born in a hospital with Level III nursery care (p=0.0012) had a greater 
likelihood of a timely SB repair.  From Table 4.1, the rate of timely repair among infants 
who were born preterm was 77.6% (number of preterm births with timely repair/total 
number of preterm births; n=59/76) compared to slightly lower percentage of 65.5% for 
full-term infants (number of term births with timely repair/total number of term births; 
n=146/223).  Also calculated from Table 4.1, infants who were born in a hospital with 
Level III nursery care had a much higher percent of infants with a timely repair  
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(178/245=72.7%) compared with infants born in a hospital with a lower level of nursery 
care (27/54= 50%). 
4.6.4 Multivariable Results 
4.6.4.1 Multivariable Results for the Primary Exposures of Interest: Isolated or Non-
Isolated SB and Presence of Hydrocephalus, for All Infants  
 Table 4.4 shows the unadjusted (uPR) and adjusted (aPR) prevalence ratios (PR) 
and 95% confidence intervals (CI) for models that include the exposures of interest 
(hydrocephalus and isolated or non-isolated SB) and all other selected predisposing, 
enabling, and need covariables.  The variable isolated or non-isolated SB was not 
statistically associated with a timely repair in either the unadjusted or the adjusted models 
(aPR=0.99, 95% CI: 0.80-1.21).  Infants with SB and hydrocephalus, however, was 
associated with about an 80% increased likelihood for timely repair in both adjusted and 
unadjusted models [(uPR=1.82, 95% CI: 1.33-2.50) and (aPR=1.80, 95% CI: 1.31-2.48)]. 
4.6.4.2 Multivariable Results for Predisposing, Enabling, and Need Characteristics for 
All Infants 
 Table 4.4 further shows the unadjusted and adjusted PR and 95% CI for the 
selected predisposing, enabling, and need characteristics for all infants, including the 
need characteristics and exposures of interest, isolated or non-isolated SB and 
hydrocephalus.  When the model was adjusted for all predisposing, enabling, and need 
characteristics, the only characteristic associated with timely repair was health payer 
status (other than the exposure of interest hydrocephalus that was reported in section 
4.6.4.1).  Infants who were self-pay or underinsured were more likely to have a timely 
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repair (aPR:  1.39, 95% CI: 1.07-1.82).  However, this finding was based on only 13 
observations and should be interpreted with caution. 
4.6.4.3 Multivariable Results for Infants Stratified by the Presence of Hydrocephalus 
Table 4.4 also shows the unadjusted and adjusted PR and 95% CI for the variable 
isolated or non-isolated SB and for selected covariables, comparing models of infants 
with and without hydrocephalus.  The primary exposure of interest, isolated or non-
isolated SB, was not associated with timely repair among infants with or without 
hydrocephalus. 
Examining predisposing, enabling, and need characteristics, infants with or 
without hydrocephalus who were self-pay or under-insured were more likely to undergo 
timely repair (with hydrocephalus: aPR=1.37, 95% CI: 1.14-1.65; without hydrocephalus: 
aPR=4.20, 95% CI: 1.46-12.1).  However, these results are based on very small sample 
sizes and should be interpreted with caution.  There were three differences between the 
adjusted models for infants with and without hydrocephalus.  Among infants without 
hydrocephalus, younger maternal age (aPR=2.46, 95% CI: 1.10-5.48) and inadequate 
prenatal care (aPR=3.93, 95% CI: 1.36-11.3) were associated with timely repair, 
compared with mothers who were 25 and older or who had adequate prenatal care.  
Infants without hydrocephalus born to mothers of a racial or ethnic minority group were 
less likely to undergo a timely repair (Hispanic: aPR=0.34, 95% CI: 0.13-0.87; non-
Hispanic Black: aPR=0.22, 95% CI: 0.06-0.82) compared with infants born to non-
Hispanic White mothers (referent group).  No predisposing, enabling, or need 
characteristics were associated with timely repair among infants with hydrocephalus, 
except for the self-pay status, which was based on a small cell size.  
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4.6.4.4 Multivariable Results for Infants Stratified by Isolated or Non-Isolated SB 
 Table 4.5 shows the unadjusted and adjusted PR and 95% CI for the exposure of 
interest hydrocephalus and selected covariables, comparing models of infants by isolated 
or non-isolated SB.  In the adjusted models, infants with isolated SB and hydrocephalus 
were 85% more likely to have a timely repair (aPR=1.85, 95% CI: 1.27-2.70) compared 
with infants with isolated SB without hydrocephalus.  In contrast, there was no 
association between hydrocephalus and timely repair among infants with non-isolated 
SB. 
 Table 4.5 also shows the unadjusted and adjusted PR and 95% CI for the selected 
predisposing, enabling, and need characteristics, comparing infants with isolated or non-
isolated SB.  Infants with isolated or non-isolated SB who were self-pay or under-insured 
were more likely to have timely repair (isolated SB: aPR=1.40, 95% CI: 1.05-1.85; non-
isolated SB: aPR=3.01, 95% CI: 1.05-8.66) compared with infants who had a private 
payer; however, these findings are based on very small sample sizes and should be 
interpreted with caution.  Infants born preterm with isolated SB had a marginally greater 
likelihood of timely repair (aPR=1.17, 95% CI: 0.99-1.38) compared with infants born at 
full-term.  Infants who were born preterm with non-isolated SB had a lower likelihood of 
a timely repair (aPR=0.38, 95% CI: 0.15-0.97) compared with infants born at full-term.  
Among infants with non-isolated SB, infants born to unmarried mothers were much more 
likely to have a timely repair (aPR=2.29, 95% CI: 1.36-3.86) compared to mothers who 
were married. 
4.7 Discussion 
4.7.1 Discussion of Timeliness of SB Repair  
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 This study examined the timeliness of surgical repair among infants with SB and 
factors associated with timely repair of SB.  I found that among infants who had a 
surgical repair, 68.6% had their repair within the recommended 48 hours of birth.  The 
mean time-to-repair was 11.3 days, while the median time-to-repair was 1.0 days, 
suggesting that a small number of infants had substantially longer times to their surgical 
repair. 
 Previous studies that examined time-to-repair for SB are sparse, and these studies 
were conducted with infants born in the 1970s or 1980s [18, 20, 214].  Thus, findings 
from these studies may be outdated.  One study of long-term outcomes for 101 infants 
born with meningomyelocele born between 1971 and 1981 observed that 56.4% of 
infants in the study had a surgical repair within 48 hours of life; 66.3% had a repair 
within the first week of life [20].  A hospital-based study of 110 infants born with 
myelomeningocele between 1978 and 1982 found that 47.3% of the infants had repair 
within 48 hours of birth, an additional 29.1% by the first week of life, and 10.9% between 
one week and ten months of life [214].  Researchers conducting a study of hydrocephalus 
that included 31 infants with myelomeningoceles treated between 1984 and 1987 found 
that surgical closure of meningomyeloceles occurred on average by 2.4 days [18].   
 The studies just described used small convenience samples.  Further, these studies 
focused on infants with myelomeningocele, so exact comparisons cannot be made to this 
study.  In contrast, I used ICD-9-CM codes that do not distinguish between diagnoses of 
myelomeningocele, meningocele, and myelocele.  Thus, my study sample included 
infants who were more severely affected by SB as well as infants less severely affected.  
Findings from my research suggest that a higher percent of infants had surgical repair of 
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SB within the first two days of life (68.6%) than in previous research, which indicated an 
improvement in time to repair among infants with SB [20, 214].  Because infants with 
less severe forms of SB (meningoceles) may not require immediate surgical repair, the 
68.6% of repairs in two days or less may underestimate the percentage of timely repairs 
for infants with more severe forms of SB (myelomeningoceles).  This finding may 
indicate an even greater improvement in timely repair among infants with the most 
serious presentations of SB. 
4.7.2 Discussion of Effects of Hydrocephalus and Isolated or Non-Isolated SB on Timely 
Surgical Repair of Spina Bifida 
 I expected that non-isolated SB might delay the surgical repair of SB because of 
the increased complexity of medical care an additional major birth defect might require.  
However, the variable isolated or non-isolated SB was not associated with the timing of 
the SB repair.  This finding was unexpected.  The additional diagnoses associated with 
non-isolated SB may not require the type of care that would influence surgical repair of 
SB.  For example, certain heart conditions may be treated with drug therapy, or certain 
chromosomal defects or heart conditions may be monitored until further management and 
treatment becomes necessary after several months of life.  Other conditions, such as 
orofacial clefts (cleft lip with or without cleft palate and cleft palate alone), may require 
surgical intervention, but not necessarily in the first few days of life and usually are not 
life threatening.  The broad categories of isolated and non-isolated SB may not provide 
adequate detail to observe for the effects of comorbid conditions on the timely repair of 
SB.  
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 In contrast, infants who had hydrocephalus were consistently more likely to have 
a timely repair than infants who did not have hydrocephalus.  It is unlikely that 
hydrocephalus predicted timely repair.  Instead, hydrocephalus, which appears in 80% to 
90% of infants with myelomeningocele [11, 41, 42, 56, 66], may serve as a proxy for the 
myelomeningocele presentation of SB.  As previously described, myelomeningocele is 
the most serious form of SB and typically requires prompt surgical repair; thus, this 
finding of timely repair among infants with hydrocephalus is consistent with the degree 
of severity of SB and recommended treatment [11, 41, 42, 56, 66].  
4.7.3 Discussion of Effects of Other Covariables on Timely Surgical Repair of Spina 
Bifida 
 In the bivariate analysis, I found that infants born preterm or born in a hospital 
with Level III nursery care were more likely to have a timely surgical repair.  The rate of 
timely repair among preterm infants (a need characteristic) was substantially higher than 
among full term infants (77.6% versus 65.5%).  Infants who were born in a hospital with 
Level III nursery care (a need characteristic) had a much higher rate of timely repair than 
infants who were born in a hospital with a lower level of nursery care (72.7% versus 
50%).  The higher rate of timely repair among preterm infants may be associated with 
delivery at hospitals with higher levels of nursery care and the availability of more 
sophisticated treatment options [173, 174]. 
 In adjusted multivariable analysis, few predisposing, enabling, or need 
characteristics were associated with timely surgical repair.  First, somewhat 
unexpectedly, infants who were self-pay or under-insured were more likely to have a 
timely surgical repair compared with infants with private insurance (an enabling 
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characteristic).  I expected under-insured infants to have a delay in timely repair, based 
on previous research that found that adequate insurance was the most critical determinant 
of access to care among children with special health care needs [127].  This finding 
should be interpreted with caution, however, as the number of infants who were self-pay 
or under-insured was very small (n=13).  This finding highlights the need for additional 
population-based research among children who have different health care payers across 
multiple hospitalizations, to examine the influence of changes in payer status on health 
resource use and health outcomes. 
 In the stratified models, the presence of hydrocephalus and non-isolated SB may 
indicate that these infants have more severe or complex medical conditions.  Among 
infants with hydrocephalus or non-isolated SB, there were few notable associations 
among predisposing and enabling characteristics and timeliness of SB repair.  While, 
maternal marital status and payer status had statistically significant associations, the cell 
sizes for each were small and should be interpreted with caution.  However, among 
infants with isolated SB or without hydrocephalus (possibly less severe or less complex 
medical conditions), several predisposing and enabling characteristics were associated 
with the timeliness of surgical repair including maternal age, maternal race/ethnicity, and 
adequacy of prenatal care.  In this study, the infants with the most complex presentations 
of SB had fewer factors that influenced time-to-repair, while infants with less complex 
presentations had more factors that influenced time-to-repair.  These findings may 
suggest that in the face of increased clinical need, the effects of predisposing and 
enabling factors may be limited.  In this study sample, timely SB repair may be critical to 
an infant’s survival and thus becomes an important predictor of timing of the repair.  The 
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fact that the infants in this study were already hospitalized, and thus had access to care, 
may also reduce the effect of predisposing and enabling characteristics. 
 In summary, findings of this study suggest that the clinical need for repair, 
indicated by the presence of hydrocephalus, is the most important factor in predicting 
timely surgical repair of SB.  Premature birth and the level of nursery care at the birth 
hospital may also influence timely repair.  While most infants had a timely surgical 
repair, the difference between mean and median time-to-repair among all infants suggests 
that a small group of infants experienced a notably delayed repair. 
4.8 Strengths and Limitations 
4.8.1 Innovation and Strengths in the Research Topic 
 This study examined differences in the timely surgical repair of SB in a 
population-based, statewide study of unduplicated Florida infants insured by different 
health care payer types.  The study reported the proportion of infants who had repair 
within the recommended 48 hours following birth.  This study also examined 
predisposing, enabling, and need characteristics associated with timely repairs.  No 
previous studies have examined adherence to the recommended guidelines for surgical 
repair of SB and its associated factors.  Therefore, these topics represent new or expanded 
areas of research. 
4.8.2 Innovation and Strengths in Methodology  
 The study population for this research was an important strength in that it 
represented a diverse group of infants.  The state of Florida was the fastest growing and 
fourth most populous state according to the 2000 U.S. Census [22, 23].  Florida was 
fourth in number of annual live births, second in number of live births to non-Hispanic 
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Black women, and third in number of live births to Hispanic women, nationwide during 
the study period of 1998-2008 [22-24].  The state of Florida also supports a statewide, 
population-based birth defects registry and a statewide agency for the collection of 
hospital discharge data that provided information for this project.  The statewide, 
population-based study population used in this study included linked, longitudinal data 
from the FBDR and the Florida AHCA, and thus provided a robust, diverse source of 
information for this project. 
 Additionally, this research incorporated several methods that are not frequently 
used in health services research for birth defects and thus are both strengths and 
innovations of the project.  First, because of the nature of the data, the unit of analysis for 
this project was the individual infant, rather than the more typical observation of 
aggregate level data, such as the hospital visit.  Secondly, the dataset provided access to 
hospital discharge data for infants from multiple payer sources, rather than the more 
commonly researched single payer source.  This allowed for a more complete picture of 
timeliness of surgical repair across multiple payers.   
 A final strength of this methodology is its ability to be replicated by health 
services researchers and public health researchers examining different types of birth 
defects in collaboration with other birth defect registries and state and federal agencies.  
This research could also be replicated using hospital discharge or paid claims data, such 
as Medicaid, from other states and federal and state public health agencies.  These 
methods underscore the value of collaboration between local, state and federal public 
health agencies, academic universities, and public health and health services researchers. 
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Regarding generalizability, the demographic findings are similar for all Florida-
born infants during the study period with a few exceptions.  Compared to all infants born 
in Florida 1998-2007, the study population included a slightly lower proportion of 
Hispanic mothers (29% statewide compared to 24% in the study sample), a higher 
proportion of  preterm births (26% compared to 11%) and a slightly higher proportion of 
infants with public payer sources (51% compared to 43%)[27].  The higher percentage of 
preterm births was consistent with previous research that has reported an association 
between low birth weight and prematurity among infants with birth defects [167, 172, 
196].   
4.8.3 Limitations  
 Several limitations were due to the inherent nature of administrative data.  The 
FBDR identified infants for this study using passive surveillance methodologies for 
identifying infants with birth defects.  While widely used, passive birth defects 
surveillance systems do not actively verify the birth defect diagnosis by review of 
medical records, hospital charts, or nursery logs.  In addition, limited information on 
prenatal diagnosis is available in passive birth defects surveillance systems [27].  While 
passive surveillance techniques may lead to under-reporting or miss reporting of infants 
with birth defects or a specific defect type [27-29, 200, 201], the FBDR’s overall 
completeness of ascertainment of birth defects has been estimated at 86.6%, with case 
ascertainment variation noted by specific defect [28, 29].  Because SB is relatively easy 
to detect, passive surveillance may be less of a limitation than with other birth defects 
that are more difficult to detect.  In the FBDR data, case ascertainment for SB without 
anencephaly was 88.0% [29].  In addition, because this analysis used data from the 
 
141 
 
FBDR, it is a state-specific study, which may limit generalizability to other states or 
regions of the country. 
 Another limitation was the use of hospital administrative data.  Administrative 
data may be at risk for error or inconsistent coding that could incorrectly code hospital 
facility codes or introduce error in diagnostic or procedural coding.  These data did not 
include information on families that sought care out-of-state for their infant.  
Additionally, while approximately 290 Florida hospitals report data to the Florida 
AHCA, not all are required to report, including one non-profit Shriner’s Hospital that 
provides care at no cost to patients, as well as long and short-term psychiatric hospitals, 
inpatient residential treatment and rehabilitation facilities, and military hospitals in 
Florida [202].  The lack of reporting to the Florida AHCA meant I was not able to capture 
data on all the infants within the Florida SB population under study.  However, because 
data from 108 different Florida hospitals are represented in the data set [140] and because 
most of the non-reporting hospitals do not provide newborn care, the amount of data lost 
was likely very limited and thus the findings of this research may be generalizable at least 
to the state of Florida. 
 Another limitation in the use of administrative data was its lack of additional 
information that could have contributed further insights into the timely repair of SB.  For 
example, I was unable to determine if an infant was prenatally diagnosed with SB.  I also 
did not know from the data if an infant had prenatal surgical repair of SB.  While 
information on prenatal surgical repair of SB was not available from the dataset, I believe 
that no prenatal repairs occurred within the study sample in Florida after February 2003.  
For the duration of the Management of Myelomeningocele clinical trial (February 2003 
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through December 2010), all cases of fetal repair of myelomeningocele were referred to 
one of the three research centers: The Children’s Hospital of Philadelphia in Philadelphia, 
PA;  Vanderbilt University in Nashville, Tennessee; and the University of California San 
Francisco in San Francisco, CA [68].  All other pediatric surgery centers in the United 
States not participating in the study agreed not to perform fetal surgery for SB for the 
duration of the clinical trial (February 2003 through December 2010) [68].  The 
Management of Myelomeningocele clinical trial overlapped the January 1, 1998 – 
December 31, 2008 study period of this research and thus limited the number of infants 
that might have had prenatal SB repair in Florida.  The effects of this concurrent research 
on the outcomes of this study are unknown. 
In addition to having no information on prenatal diagnosis and prenatal surgical 
repair, the administrative data used in this study did not provide information on other 
factors, such as possible medical contraindications to the repair or insights into the 
family’s decision-making processes related to the care of their infant.  Personal family 
decisions could potentially affect where and when the surgery took place.  A family, for 
example, might choose care in a location with family nearby or might request a referral to 
a specific pediatric hospital.  
Finally, ICD-9-CM codes differentiate between SB with and without 
hydrocephalus and include indicators for the spinal level of the SB lesion.  However, 
ICD-9-CM codes do not specifically differentiate between myelomeningocele, 
meningocele, and myelocele cases.  While myelomeningoceles typically require 
immediate surgical repair, other presentations, such as meningoceles, may not need 
urgent repair.  This lack of differential diagnoses limited the exploration of SB repair by 
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type and severity, and thus limits interpretation of the findings.  The new ICD-10-CM 
codes that will be implemented October 1, 2014, do not provide any updates in 
differentiation of SB by type [215].  Future research that uses active birth defects 
surveillance systems that can provide additional clinical information and differential 
diagnoses on larger study populations, may contribute to a better understanding of factors 
associated with timely repair of SB. 
4.9 Implications for Public Health Practice and Research 
The findings of this study have several implications for public health policy and 
practice.  First, the results reinforce the value and importance of having prenatal care and 
prenatal diagnosis of SB.  Delivery of an infant with SB in a hospital with Level III 
nursery care was associated with timely repair among infants who had a repair.  This 
suggests that access to an appropriate level of health care may improve the opportunity 
for a timely repair among infants with SB and potentially reduce the risk of long-term 
comorbidities [16, 18-21, 56].  Health care providers should clearly communicate the 
value of maternal serum alpha-fetoprotein screening for SB, which typically is offered to 
all pregnant mothers during their second-trimester [216].  Prenatal diagnosis of SB can 
facilitate appropriate counseling [217, 218] and possible planning for the infant’s birth 
location and experience.  Programs that advocate for SB awareness, such as the Spina 
Bifida Association of Central Florida’s 2012 campaign: Redefining Spina Bifida [219], 
are important for increasing public awareness of SB and perhaps reducing barriers to 
prenatal screening.  
The study of the timeliness of surgical repair of SB warrants further research on 
several fronts.  First, an analysis of a national hospital use dataset with individual-level 
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data is needed to provide nationwide information on the proportion of infants with SB 
who undergo surgical repair.  MarketScan® Commercial and Medicaid databases provide 
de-identified, patient-level data across both private and public payer sources [220], thus 
making them possible resources for nation-wide research.  Research that uses data from 
the Agency for Healthcare Research and Quality's (AHRQ) Healthcare Cost and 
Utilization Project (HCUP), including the Kids' Inpatient Database (KID), would not 
provide individual-level data, but could provide further insights to SB repair [221].  
Knowledge of the proportion of infants who had surgical repair of SB can provide a 
baseline comparison for later population-based studies.  Additional population-based 
research that examines timeliness of care, the different presentations of SB, and 
associations with later health outcomes could provide valuable information that informs 
both clinical practice and standards of care.  An understanding of patterns and predictors 
of timely care, including timely repair of SB, are important to inform efforts by public 
health practitioners, health care planners and coordination of delivery of services by 
governmental providers, such as federal, state, and local agencies, particularly those 
serving CSHCN [13]. 
 Second, collaborative multi-state, population-based studies linking multiple birth 
defect registries and linked, longitudinal data would be useful to examine both proportion 
and timeliness of surgical repair of SB and related factors.  Collaborative research 
projects would increase study sizes, thus increasing study power and potentially the 
ability to observe effects over time.  Continued support and expansion of the National 
Spina Bifida Patient Registry [204], as well as continued funding for the National Birth 
Defects Prevention Network, National Birth Defects Prevention Study, and state birth 
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defects surveillance systems to advance the knowledge of health care utilization among 
individuals with SB will be extremely important for these efforts.  
 Third, qualitative research could be important to gaining a deeper understanding 
of family or parental attitudes and opinions that may influence decisions and timing 
related to surgical repair of SB.  A better understanding of qualitative findings, such as 
feelings, attitudes, pressures and fears, prenatal experiences, and reasons for SB repair or 
reasons for selecting a particular hospital for SB repair, could inform methods for better 
communication during this difficult time of decision-making. 
 Finally, the findings of study can help to inform research for other birth defects, 
particularly those that require surgical repair.  Birth defects, such as gastroschisis (a 
defect of the abdominal wall) and orofacial clefts, typically require surgical repairs, and 
like SB, may have multiple presentations and factors that influence their surgery and its 
timing.  A better understanding of current practices and factors related to the repair of SB 
and other major birth defects requiring surgical repair can improve access to care and 
adherence to standards of timeliness of care.  Increased access to appropriate and timely 
care may improve mortality and reduce associated morbidities for this population of 
children, thus reducing health costs and increasing long-term quality of life and health 
outcomes. 
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Table 4.1  Selected characteristics for Florida-born infants with spina bifida by timing of primary surgical repair of 
spina bifida, 1998-2007  
Characteristics 
All infants 1 
(n=299) 
Timing of surgical repair 
p-value 
Timely Repair 
Day 0-2 
(n=205, 68.6%) 
Untimely Repair 
After Day 2 
(n=94, 31.4%) 
n (%) n (%) n (%) 
Exposures of interest 
Spina bifida 2  
Isolated  238 (79.6) 167 (81.5) 71 (75.5) 0.2373 
Non-isolated  61 (20.4) 38 (18.5) 23 (24.5) 
Hydrocephalus 
Yes 240 (80.3) 180 (87.8) 60 (63.8) <0.0001 
No 59 (19.7) 25 (12.2) 34 (36.2) 
Predisposing characteristics 
Maternal age (in years) 
<25 116 (38.8) 83 (40.5) 33 (35.1) 0.6712 
25-29 86 (28.8) 57 (27.8) 29 (30.9) 
>30 97 (32.4) 65 (31.7) 32 (34.0) 
Maternal race/ethnicity 
Non-Hispanic White 161 (53.8) 113 (55.1) 48 (51.1) 0.8684 
Hispanic 73 (24.4) 50 (24.4) 23 (24.5) 
Non-Hispanic Black 60 (20.1) 39 (19.0) 21 (22.3) 
 Other  5 (1.7) 3 (1.5) 2 (2.1) 
Maternal nativity 
Born in U.S. 229 (76.6) 161 (78.5) 68 (72.3) 0.2401 
Foreign-born 70 (23.4) 44 (21.5) 26 (27.7) 
Maternal marital status 
Married 181 (60.5) 120 (58.5) 61 (64.9) 0.2964 
Not married 118 (39.5) 85 (41.5) 33 (35.1) 
Maternal parity 
First child 114 (38.1) 73 (35.6) 41 (43.6) 0.1857 
Second or subsequent child 185 (61.9) 132 (64.4) 53 (56.4) 
Maternal education 
High school diploma or more 224 (74.9) 154 (76.2) 70 (74.4) 0.8565 
No high school diploma 71 (23.7) 48 (23.8) 23 (24.5) 
Sex of infant 
Female 155 (51.8) 109 (53.2) 46 (48.9) 0.4963 
Male 144 (48.2) 96 (46.8) 48 (51.1) 
Enabling characteristics 
Prenatal care  3 
Adequate prenatal care  227 (75.9) 153 (74.6) 74 (78.7) 0.4636 
Inadequate prenatal care 58 (19.4) 42 (20.5) 16 (17.0) 
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Table 4.1 (continued) 
Characteristics 
All infants 1 
Timing of surgical repair 
p-value Timely Repair Day 0-2 
Untimely Repair 
After Day 2 
n (%) n (%) n (%) 
Enabling characteristics 
Prenatal care  3 
Adequate prenatal care  227 (75.9) 153 (74.6) 74 (78.7) 0.4636 
Inadequate prenatal care 58 (19.4) 42 (20.5) 16 (17.0) 
Missing 14 (4.7) 10 (4.9) 4 (4.3) 
Residential rurality 4 
Urban /urban cluster 254 (85.0) 171 (83.4) 83 (88.3) 0.2729 
Rural 45 (15.0) 34 (16.6) 11 (11.7) 
Payer for birth hospitalization 5 
Public payer 158 (52.8) 111 (54.2) 47 (50.0) 0.2746 
Private payer 128 (42.8) 83 (40.5) 45 (47.9) 
Self or uninsured 13 (4.4) 11 (5.4) 2 (2.1) 
Need characteristics 
Preterm Birth (< 37 weeks gestation) 
Yes 76 (25.4) 59 (28.8) 17 (18.1) 0.0486 
No 223 (74.6) 146 (71.2) 77 (81.9) 
Birth Weight (in grams) 
Normal weight  (≥2500) 259 (86.6) 178 (86.8) 81 (86.2) 0.4855 
Low birth weight (1500-2499) 32 (10.7) 23 (11.2) 9 (9.6) 
Very low birth weight (<1500) 8 (2.7) 4 (20.) 4 (4.3) 
Singleton birth 
Yes 293 (98.0) 201 (98.1) 92 (97.9) 0.9195 
No 6 (2.0) 4 (1.9) 2 (2.1) 
Level of nursery care at birth  hospital 6 
Level III 245 (81.9) 178 (86.8) 67 (71.3) 0.0012 
Level I or II 54 (18.1) 27 (13.2) 27 (28.7) 
Inter-hospital transfer 7 
No inter-hospital transfer 216 (72.2) 154 (75.1) 62 (66.0) 0.1466 
Transfer within 3 days of birth 80 (26.8) 50 (24.4) 30 (31.9) 
Transfer after 3 days 3 (0.01) 2 (2.1) 1 (0.5) 
Death 8 
No death   286 (95.6) 195 (95.1) 91 (96.8) 0.7880 
Death during infancy 5 (1.7) 4 (2.0) 1 (1.1) 
Death during ages 1-4 years 8 (2.7) 6 (2.9) 2 (2.1) 
Note: Columns may not add to 100% because of missing or unknown values.  P-values in bold are considered statistically significant at 
<0.05.  Presence of hydrocephalus and major birth defects used to identify non-isolated SB were based on coded data and not 
clinically verified.   
1 Excludes infants with death during neonatal period (≤ 28 days). 
2 Isolated spina bifida is defined as SB with no additional major coded defects, other than the sequence of defects related to SB. 
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3Adequacy of prenatal care is determined using the Kotelchuck Index.  Based on Kotelchuck scoring, adequate and adequate plus are 
considered “adequate prenatal care”.   
4 Rural residence is identified using geocoded maternal residence and 2000 U.S. Census data. 
5  Public insurance included Medicare, Medicaid, KidCare, and Veterans Administration insurance.  Private included employer-based 
insurance, including military coverage (CHAMPUS/TriCare).  Self or under-insured defined as no insurance or no third party 
coverage or less than 30%. 
6 Level 3 is highest level of hospital nursery care.  Level 1 is the lowest level of hospital nursery care. 
7 Inter-hospital transfers were identified when hospital discharge records showed that an infant was admitted to a hospital on the same 
day the infant was discharged from another hospital or if a one-day difference existed between a discharge from one hospital and an 
admission to another hospital. 
8  Infants who died during the neonatal period (≤ 28 days) were excluded from this analysis.  All deaths occurred during study period, 
January 1, 1998, through December 31, 2008. 
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Table 4.2  Time to primary surgical repair of spina bifida for Florida-born infants by isolated or non-isolated SB and 
presence of hydrocephalus, 1998-2007  
Characteristics N 
Time-to-repair (days) 
p-value
Mean (SD) Median (IQR) Range 
All infants 299 11.3 (37.0) 1.0 (3.0) 0-305 
Spina bifida 1 
Isolated  238 12.1 (40.2) 1.0 (3.0) 0-305 0.3249 
Non-isolated  61 7.9 (19.8) 1.0 (4.0) 0-129 
Hydrocephalus 
Yes 240 5.3 (21.3) 1.0 (1.5) 0-212 <0.0001 
No 59 35.5 (66.4) 5.0 (36.0) 0-305 
Hydrocephalus and SB 
No hydrocephalus with isolated SB 47 42.0 (72.7) 5.0 (48.0) 0-305 <0.0001 
No hydrocephalus with non-isolated SB 12 9.6 (15.2) 2.0 (11.0) 0-44 
Hydrocephalus with isolated SB 191 4.7 (21.4) 1.0 (2.0) 0-212 
Hydrocephalus with non-isolated SB 49 7.5 (20.9) 1.0 (3.0) 0-129 
N, number.  SD, standard deviation.  IQR, interquartile range.  P-value significant at 0.05 using Wilcoxon rank sum test. 
Note: Presence of hydrocephalus and major birth defects used to identify non-isolated SB were based on coded data and not clinically 
verified.   
1 Isolated spina bifida was defined as SB with no additional coded major defects, other than the sequence of defects related to SB. 
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Table 4.3  Spina bifida repair for Florida-born infants by day of repair and by isolated or non-isolated SB and presence 
of hydrocephalus, 1998-2007 (n=299) 
Characteristics 
Day of SB repair 
p-value Day 0-2 Day 3-7 After Day 7 
n (%) n (%) n (%) 
All infants with SB 205 (68.6) 45 (15.1) 49 (16.4) 
Spina bifida 1         
Isolated  167 (70.2) 33 (13.9) 38 (16.0) 0.4375 
Non-isolated  38 (62.3) 12 (19.7) 11 (18.0) 
Hydrocephalus 
Yes 180 (75.0) 31 (12.9 29 (12.1) <0.0001 
No 25 (42.4) 14 (23.7) 20 (33.9) 
Hydrocephalus and SB 
No hydrocephalus with isolated SB 18 (38.3) 12 (25.5) 17 (36.2) <0.0001 
No hydrocephalus with non-isolated SB 7 (58.3) 2 (16.7) 3 (25.0) 
Hydrocephalus with isolated SB 149 (78.0) 21 (11.0) 21 (11.0) 
Hydrocephalus with non-isolated SB 31 (63.3) 10 (20.4) 8 (16.3) 
N, number.  P-value significant at 0.05 using chi-square test. 
Note: Presence of hydrocephalus and major birth defects used to identify non-isolated SB were based on coded data and not clinically 
verified.   
1 Isolated spina bifida was defined as SB with no additional coded major defects, other than the sequence of defects related to SB. 
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Table 4.5  Unadjusted and adjusted modified Poisson regression results for the association of selected characteristics 
with a timely repair1  of spina bifida among Florida-born infants by isolated or non-isolated SB, 1998-2007 
Characteristics 
Isolated SB 2 
 (n=238) 
Non-isolated SB 
 (n=61) 
Unadjusted 
model 
Adjusted 
model 
Unadjusted 
model 
Adjusted 
model 
uPR (95% CI) aPR (95% CI) uPR (95% CI) aPR (95% CI) 
Exposures of interest 
Hydrocephalus 
No 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 
Yes 2.01 (1.38-2.91) 1.85 (1.27-2.70) 1.28 (0.72-2.27) 1.50 (0.86-2.59) 
Predisposing characteristics 
Maternal age (in years) 
<25 1.09 (0.91-1.30) 1.04 (0.83-1.31) 0.93 (0.62-1.37) 0.83 (0.49-1.40) 
25-29 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 
>30 0.97 (0.80-1.18) 1.02 (0.83-1.26) 0.92 (0.61-1.39) 0.99 (0.66-1.47) 
Maternal race/ethnicity 
Non-Hispanic White 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 
Hispanic 1.01 (0.82-1.25) 1.07 (0.84-1.36) 0.95 (0.63-1.45) 1.77 (0.84-3.74) 
Non-Hispanic Black 1.02 (0.81-1.27) 0.95 (0.74-1.21) 0.59 (0.24-1.42) 0.66 (0.33-1.33) 
Other 1.10 (0.62-1.96) 1.14 (0.65-1.98) 
Maternal nativity 
Born in U.S. 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 
Foreign-born 0.97 (0.78-1.20) 0.91 (0.73-1.13) 0.76 (0.44-1.31) 0.86 (0.35-2.14) 
Maternal marital status 
Married 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 
Not married 1.06 (0.89-1.26) 1.01 (0.81-1.24) 1.30 (0.90-1.88) 2.29 (1.36-3.86) 
Maternal education 
High school diploma or more 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 
< High school diploma 1.00 (0.82-1.23) 0.91 (0.72-1.14) 0.94 (0.58-1.54) 0.91 (0.56-1.50) 
Sex of infant 
Female 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 
Male 0.90 (0.75-1.07) 0.92 (0.78-1.08) 1.12 (0.77-1.63) 1.08 (0.74-1.57) 
Enabling characteristics 
Prenatal care  3 
Adequate prenatal care 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 
Inadequate prenatal care 1.16 (0.96-1.40) 1.07 (0.87-1.32) 0.76 (0.44-1.31) 0.65 (0.34-1.24) 
Residential rurality 4
Urban/urban cluster 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 
Rural 1.12 (0.90-1.39) 1.11 (0.89-1.39) 1.06 (0.40-1.49) 0.99 (0.66-1.51) 
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Table 4.5 (continued) 
Characteristics 
Isolated SB 2 Non-isolated SB 
Unadjusted 
model 
Adjusted 
model 
Unadjusted 
model 
Adjusted
model 
uPR (95% CI) aPR (95% CI) uPR (95% CI) aPR (95% CI) 
Payer for birth hospitalization 5 
Public payer 1.14 (0.96-1.36) 1.05 (0.87-1.29) 0.86 (0.59-1.25) 0.65 (0.37-1.13) 
Private payer  1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 
Self or uninsured 1.22 (0.94-1.60) 1.40 (1.05-1.85) 1.51 (1.25-1.84) 3.01 (1.05-8.66) 
Need characteristics 
Preterm Birth (< 37 weeks gestation) 
No 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 
Yes 1.27 (1.08-1.50) 1.17 (0.99-1.38) 0.63 (0.29-1.33) 0.38 (0.15-0.97) 
Level of birth  hospital nursery care 6 
Level III 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 1.00 (1.00) 
Level I or II 0.65 (0.46-0.92) 0.76 (0.55-1.06) 0.78 (0.44-1.39) 0.77 (0.40-1.49) 
PR=prevalence ratio, 95% CI= 95% confidence interval.  SB=spina bifida.  Values in bold are statistically significant.  Adjusted 
model is adjusted for all covariates. 
Note: Presence of hydrocephalus and major birth defects used to identify non-isolated SB were based on coded data and not clinically 
verified.  
1 Timely repair defined as repair of SB on day 0, 1, or 2 of life. 
2 Isolated spina bifida was SB with no additional coded major defects, other than the sequence of defects related to SB. 
3Adequacy of prenatal care was determined using the Kotelchuck Index.  Based on Kotelchuck scoring, adequate and adequate plus 
were considered “adequate prenatal care”; inadequate and intermediate care were considered inadequate.   
4 Rural residence was identified using geocoded maternal residence and 2000 U.S. Census data. 
5 All payers were expected payers.  Public insurance included Medicare, Medicaid, KidCare, and Veterans Administration insurance.  
Private included employer-based insurance, including military coverage (CHAMPUS/TriCare).  Self or under-insured defined as no 
third party coverage or less than 30% estimated insurance coverage.  
6 Level 3 is highest level of hospital nursery care.  Level 1 is the lowest level of hospital nursery care.  
 
CHAPTER 5: FACTORS ASSOCIATED WITH TRAVEL TIME AND DISTANCE TO 
ACCESS HOSPITAL CARE AMONG CHILDREN WITH SPINA BIFIDA 
 
 
5.1 Introduction 
 The Institute of Medicine’s quality of care framework includes equity in access to 
care as a fundamental measure of quality health care [102].  Lack of access or inequity in 
access, based on inadequate health insurance coverage, poverty or on such characteristics 
as race/ethnicity, age, education, disability, or location of residence may result in 
increased morbidity and increased mortality among individuals with health care needs 
[102, 118, 141, 222].  In particular, children with special health care needs (CSHCN), a 
category that includes children with birth defects, face significant barriers to accessing 
health care compared to children without special health care needs [13, 128, 157, 223-
227].   
 This research focuses on one type of major birth defect, spina bifida (SB), to 
examine travel time and distance to access inpatient hospital care.  This research also 
explores predisposing, enabling, and need factors associated with travel time and distance 
to access hospital care.  Findings from this study can help identify geographic barriers 
and suggest ways to improve access to hospital care for children with SB and other 
special needs.
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5.2 Literature Review  
5.2.1 Access to Health Care 
The Healthy People 2020 program overseen by the U.S. Department of Health and 
Human Services included access to care in their series of Maternal-Infant-Child Health 
(MICH) goals [31].  MICH Goal 30.2 states that Healthy People 2020 programs will 
“increase the proportion of children with special health care needs who have access to a 
medical home” [31].  MICH Goal 31 states that another objective of Healthy People 2020 
is to “increase the proportion of children with special health care needs who receive their 
care in family-centered, comprehensive, coordinated systems” [31].  Similarly, the Spina 
Bifida Association’s 2012 Congressional Policy Agenda calls for ensured access to care 
for individuals with SB, especially through provision of adequate insurance [32]. 
Previous literature has described five interdependent dimensions of access to care 
[119-121].  Those dimensions include availability, accessibility, accommodation, 
affordability, and acceptability [119-121].  Availability is associated with the adequacy of 
health care personnel, facilities, and special services [120, 121].  Accommodation 
describes the relationship the health care providers’ organizational plans to accept clients, 
and clients’ perceptions of the plans’ suitability and appropriateness [120, 121].  
Affordability addresses health care costs, clients’ abilities to pay those costs, as well as 
clients’ perceptions of the value of the costs [120, 121].  Acceptability is the relationship 
between attitudes of clients and providers about personal and practical characteristics that 
influence both seeking and providing care [120, 121].  The final dimension of access to 
care is accessibility.  Accessibility describes the relation between the location of the 
health care service or provider and the potential health care client, and examines 
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measures such as transportation resources, travel time and distance, and travel costs [120, 
121].  The dimension of accessibility is the focus of this research.   
 A number of studies have explored barriers to accessing health care for children 
[122-128].  Barriers to care can fall into the categories of personal barriers, financial 
barriers, or organizational (structural) barriers [129], generally paralleling the dimensions 
of access to care [121].  Personal barriers result from individual perceptions of health 
care need or personal health beliefs.  Personal barriers may also include cultural and 
social influences, such as language barriers and expectations of care [127, 129].  
Financial barriers occur when an individual has insufficient monetary resources or health 
insurance coverage to access care adequate health care [108, 127, 129-131].  
Organizational or structural barriers are factors related to the health care system and 
include such characteristics as capacity, transportation, and geographic location of 
resources [129, 132].  Factors in each of these three categories (personal, financial, or 
organizational and structural) can influence the ability of an individual to access health 
care.  The inability to access health care can result in missed or delayed opportunities for 
health services and can ultimately result in poorer health outcomes with higher health 
care costs [127]. 
 Personal and financial barriers are commonly reported barriers to accessing care 
for children with or without special health care needs and include low income, minority 
status, and lack of insurance [125, 130, 133, 134].  A 2001 study of Latino children found 
that children of immigrant parents were less likely to have insurance and less likely to 
access routine health care than Latino children of US-born parents [135].  Studies have 
found that CSHCN are particularly likely to face barriers with accessing health care [122, 
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124-128, 130].  Among CSHCN, adequate insurance has been reported to be the most 
critical determinant of access to care [127]. 
Less research exists on organizational or structural barriers to accessing health 
care, and specifically for children with birth defects, a subset of CSHCN.  Using the 2001 
National Household Travel Survey, researchers found that the average distance traveled 
to access medical or dental care in the United States was 10.2 road miles or 22.0 minutes 
[136].  This study also found that rural residents traveled 31.4% longer time to access 
care than residents of urban areas [136].  Specifically examining access to care for 
CSHCN, researchers used 2000-2002 data from the National Survey of Children with 
Special Health Care Needs and found that CSHCN who lived in rural areas were less 
likely to be seen by a pediatrician than children living in urban areas [128].  Another 
study using data from the 2005-2006 National Survey of Children with Special Health 
Care Needs found that geographic disparities existed for CSHCN in the western and 
northeastern regions of the United States [137]. 
While a number of studies have used survey data to examine access to care for 
CSHCN and specifically for children with birth defects, a subset of CSHCN [123, 128, 
137], fewer studies have used GIS methods to examine access to care.  Using a statewide, 
population-based birth defects registry data and geographic information system (GIS) 
methods, researchers found geographic disparities in access to pediatric genetic clinics 
among children born with major structural or chromosomal anomalies in Texas between 
1999 and 2004 [138].  Using a statewide, population-based birth defects registry and 
survey data in North Carolina, a qualitative study of perceived barriers to care among 
mothers of children with orofacial clefts born between 2001 and 2004 found multiple 
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perceived barriers to accessing care, including location of services and lack of 
transportation [124].  Using data from the same North Carolina survey, researchers found 
that approximately 48% of mothers who responded traveled more than one hour to access 
care for their children with clefts [123].  In another study, researchers used a statewide, 
population-based study using Texas birth defects registry data and GIS methods to 
examine mortality among infants with congenital heart disease born in Texas between 
1996 and 2003.  These researchers found no association between increased mortality 
rates and home distance to a cardiac center [139].  Using linked Florida birth defects 
registry and hospital discharge data from 1998-2007, researchers calculated one-way 
travel time and distance to access hospital care for infants with spina bifida [140].  
Researchers found that 56.4% of infants traveled less than 30 minutes to access hospital 
care, while 22.4% traveled more than 60 minutes to access hospital care [140].  
Collectively, these studies contribute to our understanding of the role that structural 
barriers play in accessing health care, especially for CSHCN, including children with 
birth defects.  The findings of these studies suggest that geographic location is associated 
with the use of health care services.  These studies also suggest that CSHCN may travel 
longer times and distances than individuals without these conditions in the general 
population to access health care. 
Notwithstanding previous research, the role of geography and health remains an 
important and under-researched component to understanding heath [141].  Few studies 
have examined the role of geography and access to health care among children with birth 
defects.  Siffel et al. examined the role of GIS methods in birth defects surveillance [143].  
These researchers indicated that “place” is the least researched of the three 
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epidemiological components (person, place, and time) [142] because of the challenges 
inherent in geographic research methods.  These challenges include standardizing and 
defining spatial features and maintaining individual confidentiality [143].  Siffel et al. 
(2006), however, recommended an expanded and wide-ranging use of GIS in 
collaborative birth defects research to better understand the role of place in birth defect 
interventions [143].  Similarly, Kirby (2006) noted that the evaluation of the spatial 
component of disease occurrence, specifically intellectual and developmental disabilities, 
could address previously unanswered issues related to spatial distribution of incidence, 
prevalence, or of distribution of appropriate health care providers or health services use 
[144]. 
 One recent study used GIS-methods to examine the geographic distribution of low 
birth weight prevalence at both the county and census tract level for all singleton infants 
live-born in 2000 in the state of Georgia [228].  A similar study used GIS-methods to 
investigate trends and spatial clusters of low birth weight rates over 11 years at the 
county level in the state of Georgia [229].  To date, researchers have used GIS methods to 
examine risk factors or geographic distribution of birth defects [145-148, 150, 228-230]; 
however, limited research has used GIS methods to examine access to care for children 
with birth defects [138-140]. 
5.2.2 Description of Spina Bifida 
 Spina bifida (SB), one type of major birth defect, is a neural tube defect that 
results from a failure of the caudal neural tube to fuse early in embryonic development.  
SB has been called one of the most severe birth defects that remains compatible with life 
[231].  The severity of impairment caused by SB is directly related to the size and 
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position of the defect along the spinal column, which thus affects a child’s mobility and 
ability to maintain bowel and bladder control [44-46, 82, 97].  A child with SB is also at 
risk for comorbidities associated with SB, such as hydrocephalus, neurogenic bladder and 
decreased renal function, orthopedic problems including scoliosis and lower limb issues, 
and obesity [46, 62].  A child with SB may also face challenges with educational, social, 
and psychological development [47] and typically requires life-long, multidisciplinary 
health care.  However, CSHCN (a category that includes children with SB) face 
substantial barriers to accessing heath care services compared with children with no 
special health care needs [13, 128, 157, 223-227]. 
5.2.3 Spina Bifida: Isolated and Non-isolated 
 Spina bifida may present as a single condition in a newborn or may be 
accompanied by other conditions diagnosed at birth or later in life.  Isolated SB is SB 
with the single SB malformation or SB with sequential or associated malformations, such 
as hydrocephalus, hip dislocation, or defects of the urinary system [12, 79, 80].  Isolated 
SB may also include SB with other minor anomalies, such as low set ears, skin tags, or 
abnormally bent or curved fingers (clinodactyly) [12, 80].  Non-isolated SB is defined as 
SB with another major, unrelated birth defect and without a syndromic diagnosis [12, 79, 
80].  Children with non-isolated SB most commonly have orofacial clefts, cardiac 
defects, and renal or abdominal wall anomalies [81, 82].  Approximately 15% to 25% of 
cases of SB are non-isolated and occur with another anomaly not related to the central 
nervous system or its associated defects [81, 82, 160-162].  
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5.2.4 Spina Bifida with Hydrocephalus 
One of the most common comorbidities associated with SB is hydrocephalus [56, 
66].  Hydrocephalus is an abnormal accumulation of cerebrospinal fluid in the ventricles 
of the brain that may cause swelling and increased intracranial pressure [37, 49, 50, 56, 
66, 85].  This increased pressure can cause multiple central nervous system-related 
symptoms and may result in seizures, brain damage, and if untreated, death [56, 84].  
Even when treated, hydrocephalus may be associated with chronic conditions, including 
cognitive and developmental disabilities [47, 85-87].  Hydrocephalus is diagnosed in 
approximately 80 to 90% of children with SB whose defect type is a meningomyelocele 
[43, 66] and is the leading cause of death among children with SB [21].  Among children 
with spina bifida with hydrocephalus, approximately 15% undergo immediate 
ventriculoperitoneal (VP) shunt placement in conjunction with the repair of their SB 
defect, and as many as 80-90% eventually undergo surgical placement of the VP shunt 
[56].  
In general, individuals who have multiple comorbidities have poorer health 
outcomes and higher health care costs than those without comorbidities [17].  Health 
resource use by individuals with multiple conditions may appear different when the 
conditions are examined separately as compared with examining the conditions together 
[17].  Thus, a concurrent examination of comorbidities is important to understanding 
health resource use among individuals with more than one health condition. 
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5.3 Study Objectives and Hypotheses 
 The purpose of this study is to examine the effect of hydrocephalus and other 
selected predisposing, enabling, and need characteristics on travel time and distance to 
access hospital care among children with SB.  The research questions are: 
 1. What are the differences in average time and distance traveled to access 
hospital care for children with SB by the presence of hydrocephalus, payer type, and age 
group? 
 2. What predisposing, enabling, and need characteristics are associated with 
average time and distance traveled to access hospital care for children with SB by the 
presence of hydrocephalus?  
 Based on previous research, I hypothesize that differences in average time and 
distance travelled to access hospital care will vary based on predisposing characteristics 
(e.g., maternal race/ethnicity and educational level), enabling characteristics (e.g., health 
payer and rural residence), and need factors ( e.g., premature birth and presence of 
hydrocephalus)  [125-128, 132, 133, 135, 137, 157]. 
5.4 Conceptual Framework 
 The Aday and Andersen Framework for the Study of Access to Medical Care 
provided the conceptual basis for this project [152, 156, 175, 176].  The Aday and 
Andersen Framework for the Study of Access to Medical Care is shown in Chapter 2 
(Figure 2.2, page 36).  I adapted the Aday and Andersen model to the research questions 
presented above and included the specific predisposing, enabling, and need variables 
used in each component of the model (this model is shown in Chapter 2, Figure 2.3, page 
37). 
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5.5 Study Design and Methods 
5.5.1 Study Design  
 This study was a retrospective, statewide, population-based cohort analysis of 
inpatient hospital use for children with SB ages birth to four years born in Florida 
between January 1, 1998, and December 31, 2007.  
5.5.2 Data Acquisition and Study Sample  
 Data for this study were obtained from linked, longitudinal datasets provided by 
the Florida Birth Defects Registry (FBDR) within the Florida Department of Health 
FDOH), Florida Bureau of Vital Statistics, also within the FDOH, and the Florida 
Agency for Healthcare Administration (AHCA), which provided the hospital discharge 
data.  Infants with SB without anencephaly born in Florida between 1998 and 2007 were 
identified using the International Classification of Disease, 9th revision; Clinical 
Modification (ICD-9-CM) codes 741.00-741.93.  Hospital discharge data from January 1, 
1998, through December 31, 2008, were used to allow for at least one year of data for 
hospitalizations for each infant. 
 Included infants were live-born in Florida to a mother who was a Florida resident 
at the time of delivery and who matched with an inpatient hospital discharge record 
during the first year of life.  Infants who were adopted or prospectively adopted or who 
were born out of state were excluded by the FBDR.  Figure 1.1 (Chapter 1, page 9) shows 
the process for identifying infants and children for the final study sample. 
5.5.3 Primary Outcomes of Interest: Travel Time and Distance 
 The FDOH first geocoded the maternal residential address at the time of the 
infant’s birth, using information from the birth certificate and hospital addresses from the 
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AHCA data.  The FDOH successfully geocoded 90.7% of maternal addresses [140].  The 
University of North Carolina at Charlotte (UNC Charlotte) Department of Geography and 
Earth Sciences further geocoded addresses at the street and ZIP-code level to successfully 
geocode a total of 99.7% of maternal residential addresses [140].  The UNC Charlotte 
Department of Geography and Earth Sciences also geocoded at the street level all Florida 
hospitals where children with SB were hospitalized, 1998 through 2008 [140].   
The Geography and Earth Sciences Department at UNC Charlotte used GIS 
methods to calculate the primary outcomes of interest, travel time and distance, to access 
hospital care.  Using 2007 data from the Florida Department of Transportation, 
colleagues in the UNC Charlotte Department of Geography and Earth Sciences created a 
road network that incorporated different road types, including interstate highways, state, 
county and local roads.  Topological modeling incorporated turn restrictions to enhance 
the validity of travel time and distance measures.  Travel time for each road segment was 
computed as the length of that road segment divided by the maximum allowable driving 
speed on that segment of road in 2007.  
The one-way shortest and fastest route from maternal residential address at 
infant’s birth (origin) to the hospital where care was received (destination) was estimated 
using the Dijkstra algorithm [140, 232-234].  The Dijkstra algorithm is included in the 
software package of ArcGIS (ESRI, Redlands, CA).  ArcGIS is a commercial software 
system used for GIS analysis.  
Hospitalizations were defined as single admissions that involved no inter-hospital 
transfers.  Some researchers merge data from two hospitalizations that are linked by an 
inter-hospital transfer.  The combined admissions are then reported as a single hospital 
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experience [177].  However, I did not merge hospital data based on transfers.  I examined 
hospitalizations separately to capture information each episode of travel, and thus 
reduced error and more accurately measured the travel time and distance associated with 
accessing care for each hospitalization. 
 I measured one-way travel time and distances in minutes and miles, respectively.  
Mean, medians, ranges, and total travel time and distance were reported for children 
during infancy and for ages one to four years old and by the presence of hydrocephalus 
and payer type for infancy.   
 Based on my examination of the data and informed by categories used by 
previous relevant studies of time and distance for birth defects or other medical 
conditions [123, 138, 140, 148, 235-237], and to maintain adequate cell sizes for 
meaningful results and to be able to directly compare with previous research, I collapsed 
categories for time and distance.  I reported one-way travel time in four categories: 0-30 
minutes, 31-60 minutes, 61 to 90 minutes, and more than 90 minutes.  Similarly, I 
reported one-way travel distance in categories of 0-30 miles, 31-60 miles, 61 to 90 miles, 
and more than 90 miles.  For the multivariable analysis, I dichotomized travel time and 
distance into categories of greater than 30 minutes and less than 30 minutes (and greater 
or less than 30 miles) per one-way trip.  I based this decision on the sample size, the 
observed median travel time and distance for these data, previous literature, and in 
consultation with GIS and birth defects experts.  
5.5.4 Exposures of Interest:  Hydrocephalus and Isolated or Non-Isolated Spina Bifida 
 Hydrocephalus, a need characteristic, was the primary exposure of interest.  I 
identified hydrocephalus by the ICD-9-CM codes 741.01- 741.03 from the FBDR dataset.  
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The selection of these ICD-9-CM codes was informed by discussions with several expert 
clinicians from the Centers for Disease Control and Prevention’s (CDC) National Center 
on Birth Defects and Developmental Disabilities (NCBDDD).  I reported the presence of 
hydrocephalus as a dichotomous variable. 
 The variable isolated or non-isolated SB, also a need characteristic, was another 
exposure of interest.  Spina bifida was reported for each infant as a dichotomous variable, 
isolated or non-isolated SB.  Infants were classified as having isolated SB if they met any 
of the following criteria: 1) only the SB birth defect; or 2) had only the SB defect and 
another minor birth defect associated or not associated with the SB, such as low set ears 
or skin tags; or 3) had only the SB defect accompanied by a documented sequence of 
related defects and no additional unrelated major defects [79, 80], as verified by a clinical 
expert at the CDC’s NCBDDD.  Classification of having isolated or non-isolated SB was 
informed by discussions with expert clinicians from the CDC’s NCBDDD and by 
previous research [12, 79].  The classification of isolated or non-isolated SB referenced 
ICD-9-CM codes for major birth defects listed in the surveillance guidelines by the 
National Birth Defects Prevention Network (NBDPN) [83].  Expert clinical consultants 
from the CDC’s NCBDDD manually reviewed approximately 15% of the study sample 
that required additional consideration because of multiple conditions.  For example, 
patent ductus arteriosus (PDA) is heart condition common among premature infants.  If 
an infant with SB had a PDA, the infant was considered to have isolated SB if the infant 
was premature, but non-isolated SB if the infant was born at term.  These and other 
similar situations required a case-by-case review.  I referenced surveillance guidelines 
from the National Birth Defects Prevention Network (NBDPN) for ICD-9-CM diagnostic 
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codes for major birth defects [83].  Table A in the appendix lists ICD-9-CM diagnostic 
codes considered as major birth defects by the NBDPN for its surveillance and research 
purposes.   
5.5.5 Covariables Measuring Predisposing, Enabling, and Need Characteristics 
 I categorized additional covariables as predisposing, enabling, and need 
characteristics.  These characteristics corresponded to the components of the Aday and 
Andersen conceptual model.  Consistent with the Aday and Andersen conceptual model, 
the following characteristics were considered predisposing characteristics: maternal age, 
maternal race/ethnicity, maternal nativity, parity, marital status, maternal education, and 
child’s sex.  Enabling characteristics included the variables that measured adequacy of 
prenatal care, residential rurality, and health insurance payer.  In addition to the primary 
exposures of interest, hydrocephalus and isolated or non-isolated SB, need characteristics 
also included preterm birth and level of nursery care at the birth hospital.  I describe these 
variables and their coding in detail in the paragraphs that follow.  
5.5.5.1 Predisposing Characteristics of Mothers and Children 
 Predisposing characteristics of mothers included maternal race/ethnicity, maternal 
age and education, maternal nativity, and marital status.  This information was obtained 
from the FBDR and Florida statistics data.  Maternal parity was calculated by adding the 
number of live born children still living and those live born now deceased as reported in 
the FBDR data. 
 Predisposing characteristics of the child were sex and age.  The sex of the child 
was obtained from the FBDR data.  The child’s age was calculated in years using the 
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time to admission variable in the Florida AHCA (hospital discharge) data, which was 
reported in days. 
5.5.5.2 Enabling Characteristics of Mothers and Children   
 Enabling characteristics included adequacy of prenatal care, obtained from 
Florida vital statistics data, rurality of maternal residential address, also obtained from 
Florida vital statistics data and using information from the U.S. Census Bureau, and 
health insurance payer, which was obtained from the Florida AHCA (hospital discharge) 
data.  Adequacy of prenatal care was determined using the Kotelchuck Index.  The 
Kotelchuck Index creates a ratio comparing the month in which prenatal care was 
initiated with the total number of prenatal visits prior to delivery to calculate four 
categories of prenatal care: inadequate (less than 50% of expected visits), intermediate 
(50-79%), adequate (80-109%), and adequate plus (110% or more) [181, 182].  The 
Kotelchuck scoring system considers scores less than 80% to be inadequate care [181, 
182].  For the purpose of this research, based on an examination of the data, and to ensure 
adequate cell sizes for meaningful results, I reported adequacy of prenatal care as a 
dichotomous variable.  I used the Kotelchuck cut point of 80% to classify adequate and 
adequate plus care as “adequate prenatal care”, and intermediate and inadequate care as 
“inadequate prenatal care.”   
 I identified maternal residential rurality by comparing the geocoded maternal 
residential addresses reported at birth with the 2000 U.S. Census data that reported 
rurality by block group level.  All maternal residential addresses that had been geocoded 
could be identified as urban, urban clusters, or rural [140].  In the 2000 U.S. Census, the 
U.S. Census Bureau defined “urban” as all territory, population, and housing units 
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located within an urbanized area or in an urban cluster [183].  “Urban areas” and “urban 
clusters” were described by the U.S. Census Bureau as densely settled areas consisting of 
core census block groups or blocks that had a population density of at least 1,000 people 
per square mile and surrounding census blocks that had an overall density of at least 500 
people per square mile [183].  The U.S. Census Bureau defined all territory, population, 
and housing units located outside of urban areas or clusters as “rural” [183].  The U.S. 
Census Bureau assigned a designation to each census block group identifying the 
geographic area as urban, an urban cluster area, or as rural.  Following consultation with 
spatial research experts at the UNC Charlotte Department of Geography and Earth 
Sciences and upon examination of the data, I collapsed urban and urban cluster 
designations into a single “urban” category.  I then reported maternal residential 
“rurality” as a dichotomous variable, “urban” or “rural”, to ensure adequate cell sizes for 
meaningful results. 
 Health insurance payers were classified in two ways using hospital discharge data 
from the Florida AHCA.  First, payers for the birth hospitalization were classified as: 1) 
public, 2) private, or 3) self-insured, under-insured, or no insurance.  Second, payer type 
was reported across infancy and across ages one to four years.  Payer type was classified 
as: 1) public payers only for all hospitalizations, 2) private payers only for all 
hospitalizations, 3) self-insured, under-insured, or no insurance only for all 
hospitalizations, or 4) multiple payer type.  Multiple payer type indicated that a child had 
different types of health insurance coverage types across more than one hospitalization; 
for example, one hospitalization was covered by a private health insurance payer and a 
subsequent hospitalization was covered by a public payer.  Separate payer types were 
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reported for hospitalizations during infancy and for hospitalizations during ages one to 
four years.  Public payer sources included Medicare, Medicaid, KidCare (Florida’s state 
children’s health insurance program), and Veteran’s Administration insurance.  Private 
payer sources included private or employer-based insurance, including military coverage 
(CHAMPUS or TriCare).  The self-pay, no insurance or under-insured category was 
defined by the Florida AHCA as either no third party coverage or less than 30% 
estimated insurance coverage [184].    
5.5.5.3 Need Characteristics of Mothers and Children 
In addition to the exposures of interest, hydrocephalus and isolated or non-
isolated SB, the need characteristics also included preterm birth (less than 37 weeks 
gestation), low birth weight (less than or equal to 2500 grams), and plurality, which were 
all obtained from Florida vital statistics data.   
I also considered the level of nursery care at the birth hospital as a need 
characteristic.  The American Academy of Pediatrics classifies level of nursery care at the 
birth hospital as Level I, II, or III [185, 186].  Level III nursery care provides the most 
sophisticated care for complex cases [185, 186].  I reported the level of hospital nursery 
care for the birth hospitalization, even if an infant was transferred at birth to a hospital 
with a higher level of nursery care.  I defined a birth hospitalization as a first 
hospitalization with age at admission of zero days or a first hospitalization with an age at 
admission of one day with an accompanying indication of hospital transfer [177].  I used 
the level of nursery care only in analyses that examined birth hospitalizations.   
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  Finally, I reported the child’s death, which was categorized as no death as of 
December 31, 2008, death during infancy (birth through one year), or death between ages 
one to four years.   
5.5.6 Statistical Analyses 
 I conducted descriptive analyses for the predisposing, enabling, and need 
characteristics of the study population and health system.  I reported the means, median, 
and ranges in minutes and miles for one-way travel time and distance.  I reported the 
means, medians, and ranges separately for birth hospitalizations, post-birth 
hospitalizations during infancy, all infancy hospitalizations, and hospitalizations during 
ages one to four years.  I collapsed data from children ages one to four years into a single 
category to ensure adequate sample sizes for meaningful results. 
  Bivariate analyses examined one-way travel time and distance of more or less 
than or equal to 30 minutes or 30 miles, respectively, by selected predisposing, enabling, 
and need characteristics.  Among infants, one-way travel time and distance for birth and 
post-birth hospitalizations were reported separately from all infancy hospitalizations, 
because experiences of travel to birth hospitalizations maybe unique from subsequent 
hospitalizations.  Chi-square analyses were conducted on the categorical variables to 
determine significance level using a p-value of <0.05.  Where appropriate, I used Fisher’s 
exact test to account for small cell sizes, using a p-value of <0.05 to determine statistical 
significance.  Because of the skewness of the continuous measures of travel time and 
distance, I conducted Wilcoxon Rank Sums tests to determine significance level using a 
p-value of <0.05. 
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 For the multivariable analyses, logistic regression models were used to calculate 
unadjusted odds ratios (uOR), adjusted odds ratios (aOR), and corresponding 95% 
confidence intervals (CI) to determine if the selected predisposing, enabling, and need 
factors were associated with one-way travel time and distance of more or less than or 
equal to 30 minutes or 30 miles, respectively, to access hospital care.  I used logistic 
regression because of the dichotomous nature of the outcomes: travel time of less than or 
equal to 30 minutes (reference) vs. greater than 30 minutes, and travel distance of less 
than or equal to 30 miles (reference) vs. greater than 30 miles.   
 The goal of the multivariable analyses was to arrive at models that were theory-
based, informed by previous literature, and parsimonious given the relatively small 
sample size; thus, selected predisposing, enabling, and need covariables were included in 
the final regression model.  Low birth weight was excluded because of its close 
correlation with preterm birth.  Plurality was excluded because too few infants were part 
of multiple births to contribute meaningfully to the results.  The following variables were 
included in the final regression models: hydrocephalus, isolated or non-isolated SB, 
maternal age, maternal race/ethnicity, and maternal nativity, marital status, parity and 
education, adequacy of prenatal care, residential rurality, health care payer, child’s sex, 
preterm birth, and child’s death.  Logistic regression models were created for each of the 
categories of theory-based factors (predisposing, enabling, and need) and with all 
variables included except for low birth weight and plurality as previously mentioned.  
Analysis was conducted both including and excluding the children who died during the 
study period (prior to December 31, 2008).  I included all children to capture as much  
information as possible on one-way travel time and distance, but also conducted an  
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analysis excluding children who died to reduce error in measurement of time and 
distance.  For models that included children who died, death was included as a 
dichotomous covariable.   
Individual variables used in the multivariable analysis were assessed for 
multicollinearity [189, 190].  I conducted sensitivity tests to examine differences in 
children with and without hydrocephalus and among infants who had or did not have a 
birth hospitalization.  I also used the likelihood ratio test to examine for differences in 
model fit with and without the variable hydrocephalus.   
All analyses were conducted using SAS 9.2 statistical software (SAS Institute, 
Inc., Cary, NC).  This study was approved by the Institutional Review Boards at UNC 
Charlotte, the FDOH, and the CDC’s NCBDDD. 
5.6 Results 
I conducted several initial statistical tests to examine the data.  There was no 
evidence of notable multicollinearity based on recommended maximum levels of the 
variance inflation factor [189, 190].  Results of the likelihood ratio test comparing the full 
model for infancy with and without the variable for hydrocephalus showed no significant 
difference in the models (p=0.0771).  However, my final model was informed by theory 
and previous research.  Thus, the final model included the variable for hydrocephalus. 
Among the covariables, some covariables were missing no observations; no 
covariable was missing more than 10% of its observations.  The covariable with the 
largest number of missing values was “adequacy of prenatal care”, an enabling 
characteristic, which had 5.6% missing observations. 
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5.6.1 Descriptive Results 
5.6.1.1 Selection of Study Sample 
 The FBDR data identified 914 Florida-resident infants who were born between 
January 1, 1998 and December 31, 2007, with an ICD-9-CM code indicating a neural 
tube defect.  Of these 914 infants, 668 had ICD-9-CM codes for SB without anencephaly.  
Of the 668 infants with SB, 614 linked to at least one hospital discharge record.  Infants 
who did not have a linked hospital discharge record and were in the FBDR were more 
likely to be born to younger mothers of Hispanic origin and foreign-born and were more 
likely to have  lower educational levels than the infants who matched with a hospital 
discharge record (data not shown).  No significant differences were found for maternal 
age, marital status, infant’s sex and birth weight between the infants who matched and 
did match to hospital discharge records (data not shown).   
 From the time of the infant’s delivery, 612 infants had a maternal residential 
address that could be geocoded.  These infants comprised the sample for analysis.  Figure 
1.1 (Chapter 1, page 9) shows the process for selecting the study sample.  Figures 5.1 and 
5.2 are Florida maps that show the distribution of the geomasked maternal residential 
addresses of the infants at the time of delivery.  Geomasking is a GIS method that alters a 
geocoded location in such a way that maintains individuality confidentiality, while 
preserving the relationship between geocoded locations [238, 239].  The maps show a 
greater number of children in urban areas, and fewer children in the rural panhandle 
section of northwest Florida and in the south central Everglades area, as expected.  Figure 
5.3 shows the locations of the hospitals used by infants and children with SB during the 
study period.   
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 One-way travel time and distance to access a birth hospital were reported 
separately for the 569 infants who had a birth hospitalization.  Infants without a birth 
hospitalization reported in the AHCA data were more likely to be born to younger 
mothers who were rural residents and not born in the United States (data not shown).  No 
significant differences were found in maternal race/ethnicity, maternal education, marital 
status, and infant’s sex and birth weight between children with and without a birth 
hospitalization (results not shown). 
5.6.1.2 Descriptive Characteristics of the Mothers and Children 
 Table 5.1 shows the descriptive characteristics of the mothers and infants in this 
study (n=612).  About 53% (n=321) of infants were born to non-Hispanic White mothers.  
About 60% (n=366) of mothers were married.  Most mothers were native-born in the 
United States (75.8%, n=464), had at least a high school diploma (76.1%, n=466), and 
had received “adequate” prenatal care (72.7%, n=445).  Approximately 86% (n=525) of 
mothers lived in urban or urban cluster areas, and 14.2% (n=87) of mothers lived in rural 
areas.  About 20% (n=120) of infants were born low birth weight and 26.5% (n=162) 
were born preterm.  About 26% of infants (n=156) had non-isolated SB.  Approximately 
57% (n=347) of infants had hydrocephalus.   
 Less than 10% of the study population (8.5%, n=52) died at any point during the 
study period.  Among the 52 infants who died, 41 (78.8%)  (6.7% of the 612) died during 
infancy and an additional 11 (21.1%)  (1.8% of the 612) died between the ages of one and 
four years. 
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5.6.1.3 Descriptive Results for One-Way Travel Time  
 Table 5.2 shows descriptive one-way travel time results for birth, post-birth, and 
all infancy hospitalizations, and for hospitalizations during ages one to four years.  
Infants had an average one-way travel time of 41.9 minutes and median of 20.3 minutes 
(standard deviation, SD: 64.9 minutes; and range: 1-571 minutes) to access care at a birth 
hospital.  Infants had an average one-way travel time of 50.5 minutes and median of 28.0 
minutes (SD: 66.5 minutes; range: 2.4-732 minutes) for all post-birth hospitalizations 
during infancy .The average one-way travel time for all infancy hospitalizations was 45.1 
minutes with a median of 25.9 minutes (SD: 54.6 minutes; range: 2.4-494 minutes).   
 Table 5.3 shows findings for one-way travel time and distance by child’s age.  
During the first year of life, 56.3% (n=345) of infants had a one-way travel time of 30 
minutes or less to access hospital care, while 43.6% (n=267) of infants had a one-way 
travel time of more than 30 minutes.  Approximately 22% (n=136) of infants traveled 
longer than 60 minutes to access hospital care.   
 For children with SB ages one to four years (n=251 children), average one-way 
travel time was 39.8 minutes and the median was 22.7 minutes (SD: 46.0 minutes and 
range: 2.4-285.6 minutes).  Approximately 61% (n=154) of children traveled 30 minutes 
or less to access hospital care, while 38.6% (n=97) traveled more than 30 minutes to 
access care.  Approximately 21% (n=53) of children ages one to four traveled longer than 
60 minutes.  
 Figures 5.4 and 5.5 are Florida maps indicating average one-way travel patterns 
for hospitalizations during infancy and ages one to four years, respectively.  These two 
maps suggest that some children traveled significant distances to receive hospital care.  
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The maps also suggest that some children were not hospitalized at the hospital closest to 
their maternal residence at birth. 
5.6.1.4 Descriptive Results for One-Way Travel Distance 
Table 5.2 also shows one-way travel distance for birth, post-birth, and all infancy 
hospitalizations, and for hospitalizations during ages one to four years.  Infants traveled 
one-way an average distance of 32.2 miles and a median distance of median 13.0 miles 
(SD: 53.8 miles; range: 0.6-433 miles) to access care at a birth hospital.  Infants traveled 
one-way an average distance of 38.5 miles and a mean distance of 19.7 miles (SD: 54.3 
miles; range: 1.3-598 miles) for all post-birth hospitalizations during infancy.  The one-
way travel for all infancy hospitalizations was an average distance of 34.5 miles and a 
median distance of 18.1 miles (SD: 45.4 miles; range: 1.2-404 miles).  During ages one to 
four years, average one-way travel distance was 38.2 miles and median one-way travel 
distance was 19.4 miles (SD: 50.1 miles; range: 1.3-325 miles).  Approximately 64% of 
children ages one to four (n=161) traveled 30 miles or less to access hospital care, while 
35.9% traveled more than 30 miles.  About 20% (n=51) of children ages one to four 
traveled more than 60 miles to access hospital care. 
5.6.2 Bivariate Results   
5.6.2.1 Bivariate Results for Demographic Characteristics 
Table 5.4a presents the results of bivariate analysis comparing infants who 
traveled more than 30 minutes to access hospital care with those who traveled less than or 
equal to 30 minutes.  Among infants who traveled less than or equal to 30 minutes, 
41.2% (n=142) were born to mothers who were non-Hispanic White; 30.7% (n=106) 
were Hispanic; and 26.1% (n=90) were non-Hispanic Black.  Infants born to mothers in 
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racial/ethnic minority groups traveled significantly shorter times than infants born to non-
Hispanic White mothers (p<0.0001).  Compared with infants who traveled 30 minutes or 
less to access hospital care, infants who traveled more than 30 minutes were more likely 
to have mothers who were married (p=0.007), born in the United States (p=0.0002), and 
were rural residents (p<0.0001).  Finally, infants who traveled more than 30 minutes were 
more likely to have hydrocephalus (p=0.038) or to have non-isolated SB (p=0.003). 
 Table 5.4b shows the results of bivariate analysis comparing children ages one to 
four years who traveled 30 minutes or less to access hospital care with those who traveled 
more than 30 minutes (Table 5.4b).  Among children who traveled 30 minutes or less, 
40.3% (n=62) were born to mothers who were non-Hispanic White; 29.2% (n=45) were 
Hispanic; and 26.6% (n=41) were non-Hispanic Black.  Mothers in racial/ethnic minority 
groups traveled significantly shorter times to access care for their children than non-
Hispanic White mothers (p=0.0149).  These was modest evidence that children who 
traveled more than 30 minutes were more likely to have mothers who lived in rural areas 
(p=0.0604).  No other characteristics were statistically significant.  
5.6.2.2 Bivariate Results by Hydrocephalus and Isolated or Non-Isolated Spina Bifida 
 Table 5.2 further shows the one-way travel time and distance results by the 
presence of comorbidities and by isolated or non-isolated SB for birth, post-birth, and all 
infancy hospitalizations, as well as hospitalizations during ages one to four years.  Infants 
with hydrocephalus or with non-isolated SB or with both hydrocephalus and non-isolated 
SB all experienced significantly longer average one-way travel times and distances 
compared to infants with isolated SB without hydrocephalus.  One-way mean and median 
travel times for infants without hydrocephalus were statistically different compared to 
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infants with hydrocephalus.  Infants without hydrocephalus traveled 37.3 (mean) and 24.1 
(median) minutes one-way to access hospital care, while infants with hydrocephalus 
traveled 51.0 (mean) and 27.4 (median) minutes to access hospital care (p=0.009).  
Similarly, mean and median travel distances for infants without hydrocephalus were 28.0 
and 16.3 miles, respectively, while infants with hydrocephalus had 39.4 (mean) and 20.8 
(median) miles (p=0.004).   
 Observing infancy hospitalizations by birth and post-birth admissions, the 
presence of hydrocephalus, non-isolated SB, and non-isolated SB with hydrocephalus 
were all significantly associated with longer one-way travel times and distances to birth 
hospitalizations (Table 5.2).  Among post-birth hospitalizations, non-isolated SB was 
associated with both longer one-way travel time and distance (time: p=0.0170; distance 
p=0.0135) and non-isolated SB with hydrocephalus was associated with longer one-way 
travel distance (p=0.0337).  The presence of hydrocephalus was not significantly 
associated with one-way travel time or distance for post-birth hospitalizations (Table 5.2) 
 One way mean and median travel times for infants with isolated SB was 42.3 and 
24.2 minutes, respectively, while infants with non-isolated SB experienced travel times of 
53.2 (mean) and 31.8 (median) minutes (p=0.001).  Similarly, one-way mean and median 
travel distances for infants with isolated SB were 32.1 and 16.6 miles, respectively, while 
infants with non-isolated SB traveled 41.3 (mean) and 24.6 (median) miles (p=0.001).  
These findings suggest that infants with more complex presentations of SB that include 
another major birth defect (non-isolated SB) travel more time and distance to access 
hospital care. 
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 Notably, infants who had both hydrocephalus and non-isolated SB traveled the 
longest time and distance to access hospital care: one-way mean of 60.8 minutes and 
median of 34.2 minutes (SD: 72.4; range: 5-494 minutes) and one-way mean of 48.5 
miles and median of 26.9 miles (SD: 61.1; range: 3-404 miles).  Both one-way travel time 
and distance were significantly different from infants who did not have either of these 
conditions.  The average one-way travel time and distance to access hospital care for 
children ages one to four years did not differ based on the presence of hydrocephalus or 
isolated or non-isolated SB 
5.6.2.3 Stratified by Health Care Payer 
 Table 5.4c shows results for one-way travel time and distance when stratified by 
payer for birth hospitalization and by for payer types across all infancy admissions.  
There were no statistically significant differences in one-way average travel time and 
distance across payers and payer types. 
5.6.4 Multivariable Results 
5.6.3.1 Multivariable Results for Primary Exposures of Interest (Presence of 
Hydrocephalus and Isolated or Non-Isolated SB) 
 Table 5.5a shows the unadjusted and adjusted OR and 95% CI for the exposures 
of interest and the average one-way travel time to access birth and post-birth 
hospitalizations.  In the adjusted models, the presence of hydrocephalus was not 
significantly associated with one-way travel time to either birth or post-birth 
hospitalizations.  The presence of non-isolated SB, however, was associated with longer 
one-way travel times for both types of hospitalizations (birth: aOR=0.50, 95% CI: 0.32-
0.79 and post-birth: aOR=0.61, 95% CI: 0.38-0.96). 
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 Table 5.5b shows the unadjusted and adjusted OR and 95% CI for the exposures 
of interest and the average one-way travel time to access all infancy hospitalizations.  In 
the adjusted models, the primary exposure of interest, hydrocephalus, was not 
significantly associated with one-way travel time across all infancy admissions 
(aOR=0.78, 95% CI: 0.54-1.13).  However, non-isolated SB was associated with 
decreased odds of traveling 30 minutes or less compared to infants with isolated SB 
(aOR=0.58. 95% CI: 0.38-0.89).   
 Table 5.5c shows unadjusted and adjusted OR and 95% CI for the exposures of 
interest and the average one-way travel time to access hospitalizations for children ages 
one to four years.  In the unadjusted and adjusted models, neither hydrocephalus nor non-
isolated SB was significantly associated with one-way travel time to access hospital care 
during ages one to four years (hydrocephalus: aOR=0.77, 95% CI: 0.39-1.51; non-
isolated SB: aOR=0.86, 95% CI: 0.46-1.60).   
5.6.3.2 Multivariable Results for Predisposing Characteristics 
 Maternal minority race/ethnicity was associated with about two times shorter one-
way travel times for both birth and post-birth hospitalizations during infancy (Hispanic: 
aOR=2.31, 95% CI: 1.29-4.15 birth and aOR=2.10, 95% CI: 1.13-3.93 post-birth; non-
Hispanic Black: aOR=2.33, 95% CI: 1.38-3.93 birth and aOR=1.82, 95% CI: 1.02-3.24 
post-birth).  For all infancy hospitalizations, infants born to mothers of maternal 
racial/ethnic minority groups consistently had increased odds of one-way shorter drive 
times compared with infants born to non-Hispanic White mothers (Hispanic: aOR=2.32, 
95% CI: 1.31-4.10; non-Hispanic Black: aOR=2.50, 95% CI: 1.49-4.18).  During ages 
one to four years, children born to mothers of racial/ethnic minority groups had nearly 
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three times  shorter one-way travel times compared with infants born to non-Hispanic 
White mothers (Hispanic mothers: aOR=2.79, 95% CI: 1.11-6.97; non-Hispanic Black 
mothers: aOR=2.86, 95% CI: 1.32-6.20).   
 Lower level of maternal education (< high school education) was associated with 
decreased odds of traveling less than or equal to 30 minutes to access hospital care for 
birth hospitalizations (aOR=0.58, 95% CI: 0.35-0.98) than mothers with a high school 
education.  Across all infancy hospitalizations, lower level of maternal education was 
barely associated with lower odds of traveling 30 minutes or less (aOR=0.61, 95% CI: 
0.37-0.99).  No other predisposing characteristics were associated with travel time to 
access hospital care during infancy or ages one to four years. 
5.6.3.3 Multivariable Results for Enabling Characteristics 
 Infants whose mothers were rural residents were consistently more likely to travel 
longer times to access hospital care for both birth and post-birth hospitalizations than 
infants whose mothers lived in urban areas (birth: aOR=0.54, 95% CI: 0.21-0.62; post-
birth: aOR=0.43, 95% CI: 0.24-0.79).  Across all infancy, infants living in rural areas 
were 63% more likely to travel more than 30 minutes to access hospital care (aOR=0.37, 
95% CI: 0.22-0.63) than infants living in urban areas.  Surprisingly, rural residence was 
not statistically associated with one-way travel time for hospitalizations during ages one 
to four years. 
 No single payer type had a statistically significant effect on travel time during 
infancy, however, having multiple health payers across all infancy hospitalizations was 
marginally associated with lower odds of traveling of less than or equal to 30 minutes to 
access hospital care (aOR=0.51, 95% CI: 0.27-0.97).  No other enabling characteristics 
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were associated with travel time to access hospital care during infancy or ages one to 
four. 
5.6.3.4 Multivariable Results for Need Characteristics 
Parents of infants who were born preterm were 67% more likely to have shorter 
one-way travel times for birth hospitalization (aOR=1.67, 95% CI: 1.07-2.60) compared 
to infants who were not born preterm (Table 5.5a).  Across all infancy hospitalizations, 
parents of infants who were born preterm birth were almost two times more likely to 
travel 30 minutes or less (aOR=1.88, 95% CI: 1.22-1.93), compared to infants who were 
not born preterm (Table 5.5b).  No other need characteristics were associated with one-
way travel time to access hospital care during ages one to four (Table 5.5c). 
5.6.3.5 Multivariable Results Comparing Separate Models for Predisposing, Enabling, 
and Need Characteristics 
In models that examined travel time by independent categories of predisposing, 
enabling, and need factors, I found no notable differences when compared to the full 
model.  When modeling only the predisposing characteristics, hydrocephalus was not 
associated with travel time, however,  non-isolated SB was associated with lower odds of 
traveling 30 minutes or less (aOR=0.51, 95% CI: 0.34-0.75).  When modeling only the 
enabling characteristics, hydrocephalus was not associated with travel time, however, 
non-isolated SB was again associated with lower odds of traveling 30 minutes or less 
(aOR=0.58, 95% CI: 0.39-0.86).  Finally, when modeling only need characteristics, both 
hydrocephalus (aOR=0.69; 95% CI: 0.49-0.96) and non-isolated SB (OR=0.60, 95% CI: 
0.41-0.87) were associated with lower odds of traveling 30 minutes or less to access 
hospital care. 
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5.6.3.6 Multivariable Results Comparing Models with and without Hydrocephalus 
 Lastly, Table 5.5e shows unadjusted and adjusted OR and 95% CI for all 
covariables by the presence and absence of hydrocephalus for all infancy hospitalizations.  
When comparing the adjusted models for: 1) all infants with SB, 2) infants with SB and 
with hydrocephalus, and 3) infants with SB without hydrocephalus, there were few 
notable differences across the three models.  Infants born to mothers of racial/ethnic 
minority groups and infants born preterm had consistently lower odds of shorter one-way 
travel times in each model, while rural residency was consistently associated with longer 
one-way travel times.  Among infants with SB and hydrocephalus, higher maternal parity 
was associated with increased odds of traveling 30 minutes or less to access hospital care 
(aOR=1.78; 95% CI: 1.03-3.09), however, no association existed in the model with 
infants with no hydrocephalus or in the model with all infants.  Lower level of maternal 
education was associated with odds of traveling longer to access hospital care among 
infants with hydrocephalus (aOR=0.42; 95% CI: 0.22-0.83) and in the model with all 
infants (OR=0.61; 95% CI: 0.37-0.99), but no association was found in the model with 
infants without hydrocephalus. 
5.7 Discussion 
5.7.1 Discussion of Travel Time and Distance by Age Category 
 This research examined travel time and distance to access hospital care for 
children born with spina bifida (SB) during infancy (from birth through one year) and 
ages one to four years.  Results showed infants with SB traveled about 7% shorter one-
way average times and distances to access care for their birth hospitalization than to 
access care for all infancy hospitalizations.  During ages one to four years, average one-
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way travel to access hospital care was slightly longer than travel during infancy.  
Comparing infancy hospitalizations to hospitalizations during ages one to four years, 
approximately the same percentage of children traveled over 60 minutes to access 
hospital care (22.2% of infants; 21.1% of children ages one to four years). 
Examining one-way travel time and distance to access hospital care, children with 
SB, from birth through age four, traveled longer times and greater distances to access 
hospital care than travel reported to accessing health care in general populations [136, 
240].  Findings from this study were consistent with studies that examined travel times 
and distances in populations of CSHCN [123, 138-140].  Modest differences with 
previous literature that examined geographic access to care among children with birth 
defects may be the result of differences in birth defects ascertainment methods, state 
population density and state-specific differences in the geographic distribution of health 
care facilities or services.  Longer average travel times and distances for children, ages 
one to four years compared to infancy travel may reflect different patterns of health 
services needed and used by slightly older children, or may indicate intrastate residential 
relocations that could not be accounted for in this study.  No empirical studies are 
available for comparison of differences of travel time and distance to access hospital care 
by child’s age, including ages one to four years. 
5.7.2 Discussion of Effects of Hydrocephalus and Isolated or Non-Isolated SB on Travel 
Time and Distance 
Further addressing the first research question in terms of differences in travel time 
and distance for children by the presence of hydrocephalus and by isolated or non-
isolated SB, bivariate results showed that infants with hydrocephalus traveled longer one-
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way time and distance to access hospital care than infants without hydrocephalus.  This 
result was expected as hydrocephalus is both an indirect indictor of the more severe form 
of SB known as myelomeningocele and because hydrocephalus itself adds a dimension of 
complexity to the SB presentation.  Similarly, infants with non-isolated SB traveled 
longer times and distances than infants with isolated SB and was an expected result.  
Infants with both hydrocephalus and non-isolated SB experienced the greatest travel 
burden.  The influence of hydrocephalus on isolated SB and non-isolated SB was most 
notable during the birth hospitalization and less so during post-birth hospitalizations.  
 The American Academy of Pediatrics advises that major congenital anomalies in 
infants and children be managed by specialists at pediatric referral centers and 
specifically suggests that infants with myelomeningocele should preferably be cared for 
by a pediatric neurosurgeon, as part of a medical-surgical team [241].  Among the 108 
Florida hospitals used by infants in this study [140], twenty-six had nurseries with a 
designation of Level III care [242], indicating that the nurseries were able to provide 
complex neonatal surgery, pediatric neurosurgery, and neonatal cardiovascular surgery 
services [243].  The findings that children with more complex presentations of SB 
traveled longer travel times and distances to access hospital care are consistent with the 
number of Florida hospitals with Level III nursery care.  Previous literature that suggests 
increasingly complex or severe forms of medical conditions may require more 
specialized and diverse medical care [17, 92, 244] that may not be available in local or 
community hospital settings.   
 There were no significant differences for travel time and distance to access 
hospital care during ages one to four years, based on the presence or absence of 
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hydrocephalus, by isolated or non-isolated SB, or by the presence of both hydrocephalus 
and non-isolated SB.  These findings are consistent with a previous study that found 
medical care use for children with SB is highest in the first year of life [12, 14].  Infants 
with SB typically undergo major surgical repairs during the first few months of life, 
many of which require specialty care not available in all hospitals [241].  Follow-up care 
and hospitalizations after infancy may not require the same level of specialty care as 
during infancy, thus a child ages one to four years may receive adequate care at a 
community hospital.  
 I did not examine the reason for admission in this study.  For example, treatment 
of a urinary tract infection, a common reason for hospitalization among individuals with 
SB [16, 245, 246], could possibly be managed at a community level hospital.  
Alternately, an admission may have been completely unrelated to the child’s SB, for 
example, a hospitalization for pneumonia or an injury caused by an accident.  Local or 
community hospitals may have the resources necessary to adequately care for routine 
conditions, thus reducing the travel burden to access care. 
5.7.3 Discussion of Effects of Other Covariables on Travel Time and Distance 
 Addressing the second research question about other factors associated with travel 
time and distance to access hospital care, two predisposing characteristics were 
consistently associated with travel time and distance during infancy.  Infants born to 
Hispanic or non-Hispanic Black mothers were less likely to travel more than 30 minutes 
to access care compared to infants of non-Hispanic White mothers.  Maternal 
race/ethnicity was also the only characteristic that remained associated with greater travel 
time and distance during ages one to four years.  All 108 Florida hospitals used by 
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children in this study were located in urban or urban cluster areas [140].  Higher 
percentages of Hispanic and non-Hispanic Black mothers in the study population lived in 
urban or urban cluster areas, and may provide a possible explanation for the consistently 
shorter travel distances among infants of mothers of racial/ethnic minority groups.   
 While shorter drive times may indicate better access to care, shorter travel time 
may also indicate a more limited understanding of options available for health care or 
access to fewer resources that facilitate travel and may not lead to better quality of 
services nor better health outcomes.  Previous research has also shown that cultural 
influences, such as medical mistrust, limited proficiency in the English language, and 
hesitancy to adopt unfamiliar medical care can influence use of health care services [247-
249].  The results of this study suggest that mothers in racial/ethnic minority groups may 
seek care for their children with SB at the closest and most familiar health care facility.  
Factors, such as family support, availability of transportation and transportation mode, 
familiarity with a facility, the inability to take time off from work or no childcare for 
siblings, may also contribute to shorter travel observed among mothers in racial/ethnic 
minority groups.    
 A second characteristic consistently associated with travel time and distance 
among infants with SB was a rural maternal residence at birth.  As expected, infants of 
mothers with a rural residential address were less likely to travel less than 30 minutes to 
access hospital care compared with infants of mothers with an urban maternal residential 
address.  As noted previously, all 108 Florida hospitals used by infants in this study were 
located in urban or urban cluster areas [140], thus minimizing travel times for people 
living in urban areas.  Surprisingly, however, rural maternal residence was not associated 
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with longer travel during ages one to four years in either the unadjusted or the adjusted 
logistic regression models.  These findings suggest that rural residents may seek hospital 
care at nearby community hospitals.  It may be that a child’s medical condition was stable 
and thus she or he required less complex care; on the other hand, if the family faced 
travel barriers, a child could have received less than optimal care. 
 Other covariables also influenced travel time and distance.  Infants of mothers 
who were married or born in the United States were more likely to travel more than 30 
minutes to access care for their infants compared with unmarried or foreign-born 
mothers.  Married and foreign-born mothers in this study were more often of a minority 
racial/ethnic group.  Mothers of a minority racial/ethnic group in this study were more 
likely to live in urban areas with shorter access to a hospital facility.  An infant born 
preterm was more likely to travel less than 30 minutes to access hospital care.  This 
finding was expected as a premature delivery may be unplanned and result in a birth 
hospitalization at the closest hospital.  Infants of mothers with less than a high school 
education were also less likely to travel less than 30 minutes to access hospital care.  I 
expected that lower maternal education might be associated with rural residence, but no 
association existed between maternal education and rural residence in this study 
population (data not shown).  However, cell sizes were small (rural, no high school 
diploma: n=21) and had insufficient power to detect significant associations in this group.  
Surprisingly, the type of health care payer showed no association with travel time or 
distance to access hospital care during infancy, although one previous study also reported 
a similar finding [123].  While health payer has been associated with access to health 
care, particularly for CSHCN [108, 126, 127, 166, 250, 251], this finding suggests that 
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payer type may be associated with a different dimension of access to care than the 
geographic access described by the accessibility component [121]. 
 In models that examined each category of predisposing, enabling, and need 
factors separately, no notable differences existed when compared to the full model, which 
included all predisposing, enabling and need factors.  These results suggested that all 
three categories of characteristics described in the Aday and Andersen model [152] 
contributed to describing travel time and distance. 
 In summary, infants who have increasingly complex presentations of SB (SB with 
hydrocephalus or with non-isolated SB or an accompanying preterm birth) may 
experience greater travel time and distance during infancy than infants with SB but no 
additional comorbidities; this was particularly true for birth hospitalizations.  The 
increased travel time and distance for children with hydrocephalus or non-isolated SB 
does not appear to continue after the first year of life, possibly signaling a reduced need 
for specialty hospital care as the child matures, and medical conditions stabilize.  
Maternal race/ethnicity and rural residence were the two demographic characteristics 
most consistently associated with travel time and distance in this study.  Surprisingly, 
health care payer type was not associated with travel time and distance.  
 The interpretation of travel time and distance presents several challenges.  A 
shorter travel experience may be interpreted positively as a reflection of easier access to 
hospital care.  For CSHCN, however, appropriate care may only be available in a limited 
number of pediatric specialty centers that may require more travel for families.  Some 
parents of children who travel shorter times and distances may have access to care, but 
not to appropriate, optimal, or multidisciplinary specialty care.  Other children may live 
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near a hospital with a high level of specialty care and experience a shorter travel time and 
distance to access care, but face other barriers that may influence hospital use.  
Conversely, while long distances to access hospital care may be interpreted as a high 
travel burden, a family with health knowledge and resources, or for other reasons, may 
intentionally select a distant hospital for their child’s care.  Families of children with SB 
may choose hospitals based on a wide variety of factors not directly associated with 
travel time and distance that we were unable to measure in this study.  
5.8 Strengths and Limitations 
5.8.1 Innovation and Strengths in the Research Topic 
 This study examined the differences in geographic access to hospital care in a 
population-based, statewide study of unduplicated Florida children insured by different 
health care payer types.  The study followed children for the first four years of life, which 
provided new opportunities to examine changes in access to care and associated 
predisposing, enabling, and need characteristics over time.  The comparison of access to 
care findings by payer type and in the presence of hydrocephalus was also unique.  With 
the exception of one study, which explored hospital costs for North Carolina children 
with SB and SB with hydrocephalus born 1995-2002 continuously enrolled in Medicaid 
[12], no similar work related to comorbidities and SB existed.  Additionally, little work 
has been done to explore travel time and distance to access health care for children with 
SB [140], so each of these topics represents new or expanded areas of research. 
5.8.2 Innovation and Strengths in Methodology  
 The study population for this research was an important strength in that it 
represented a robust and diverse group of children.  The state of Florida was among the 
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fastest growing and the fourth most populous state in the 2000 U.S. Census [22, 23].  
Florida was fourth in number of annual live births, second in number of live births to 
non-Hispanic Black women, and third in number of live births to Hispanic women, 
nationwide [22-24].  Florida also supports a statewide, population-based birth defects 
registry and a statewide agency for the collection of hospital discharge data that provided 
information for this project.  This statewide, population-based study sample used linked, 
longitudinal data from the FBDR and the Florida AHCA, which provided a robust source 
of information for this project. 
 A second significant strength of the methodology, and perhaps the most 
significant, was the derivation of the variables for evaluating travel time and distance.  
The travel time and distance variables were calculated using network methodology, rather 
than Euclidian “straight line” distances.  Topological road networks provide a more 
accurate measure of travel time and distance because they account for speed limits, one-
way restrictions, and reflect connectivity between roads, including highways, overpasses, 
and access ramps [140, 252, 253].  Straight-line Euclidean distances typically 
underestimate the actual travel time and distance, and can thus introduce error in analyses 
[254]. 
 Additionally, this research incorporated several methods that are not frequently 
used in health services research for birth defects and thus are both strengths and 
innovations of the proposed project.  First, because of the nature of the data, the unit of 
analysis for this project was the individual child, rather than the more typical observation 
level of hospital admission or other aggregate level data, such as the hospital visit.  
Secondly, the dataset provided access to hospital discharge data for children from 
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multiple payer sources, rather than the more commonly researched single payer source.  
This allowed for a more complete picture of access to care across multiple payer types.  
Third, the linked, longitudinal data provided the opportunity to follow each child through 
early childhood to give unique insights into the differences in access to hospital care over 
time.  
 A final strength of this methodology is its ability to be replicated for other birth 
defects by health services researchers and public health researchers examining different 
types of birth defects in collaboration with other birth defect registries and state and 
federal agencies.  These methods underscore the value of collaboration between local, 
state, and federal public health agencies, academic universities, public health and health 
services researchers and the use of geographic information system (GIS) methods. 
 The demographic findings are similar to the characteristics of all Florida-born 
infants during with study period with a few exceptions, which make this study 
generalizable.  In comparison to all infants born in Florida, 1998-2007, the study 
population included a slightly lower proportion of Hispanic mothers (29% statewide 
compared to 25% in the study sample), a notably higher proportion of  preterm births 
(27% compared to 11% in Florida 2007, 12.8% nationwide 2006), and a slightly higher 
proportion of infants with public payer sources (50% compared to 43%) [27, 255].  The 
higher percentage of preterm births was consistent with previous research that has 
reported an association between low birth weight and prematurity among infants with 
birth defects [172, 196].  In comparison specifically to other children with SB, about 26% 
of this study sample had non-isolated SB.  This finding is generally consistent with 
previous research that found between 15% and 25% of infants with SB have non-isolated 
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SB [81, 161, 162].  Findings for death (8.5%) were also consistent with previous research 
on mortality among children with SB [56-59]. 
 5.8.3 Limitations Inherent in the Data Sources 
 This research faced several limitations based on the data used.  Infants identified 
for this study were based on the passive surveillance methodologies for identifying 
infants with birth defects using ICD-9-CM codes.  Some birth defects surveillance 
systems actively identify birth defect diagnoses using modifications of the British 
Pediatric Association (BPA) Classification of Diseases [198, 199].  In contrast, passive 
birth defects surveillance systems, while widely used, do not actively verify the birth 
defect diagnosis by review of medical records, hospital charts, or nursery logs.  Also, 
limited information on prenatal diagnosis is available in passive surveillance systems 
[27].  For Florida, there is no access to data on prenatal diagnosis for birth defects 
through the FBDR.   
 While passive surveillance techniques may lead to under-reporting or miss 
reporting of infants with birth defects or a specific defect type [27-29, 200, 201], the 
FBDR’s overall completeness of ascertainment of birth defects has been estimated at 
87%, with case ascertainment variation noted by specific defect [28, 29].  Because SB is 
relatively easy to detect, a passive surveillance system may be less of a limitation than 
with other birth defects that are more difficult to detect.  In the FBDR data, ascertainment 
of infants with SB without anencephaly was 88.0% [29], a relatively high completeness 
of ascertainment of SB.  In addition, because this analysis used data from the FBDR, it is 
a state-specific study, which may limit generalizability to other states or regions of the 
country. 
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The nature of the study sample also presented a limitation because the sample size 
was not constant over the ten-year study period.  While the Florida AHCA provided ten 
years of hospital discharge data, the full ten years only applied to the children born in the 
first year of the study as per ascertainment methods of infants with birth defects used 
with the FBDR and is common with most birth defect registries in the United States.  
Each subsequent birth cohort had one less year of data, ending with the birth cohort of 
2007, which had only one year of data.  This decreasing sample size for each cohort 
resulted in a decreased statistical power, thus making the outcomes at risk for Type II 
error, the report of a false negative decision.  To reduce this risk, I limited the analyses to 
the first four years of life. 
Additionally, the principal payer source variable that was used in analyses of birth 
payer and payer types across the four years was an expected principal payer source.  It is 
not known if this was the actual payer source.  Furthermore, some infants may have dual 
payer sources (e.g., private and public payer) for a single hospitalization.  Such 
information is not generally reported with hospital discharge data.   
Another limitation was the fact that the data were based on Florida hospital 
administrative data.  Administrative data may be at risk for error or inconsistent coding 
that could incorrectly code maternal residential addresses and hospital facility codes or 
introduce error in diagnostic coding.  This data did not include information on families 
that sought care out-of-state for their child.  Additionally, while approximately 290 
Florida hospitals report data to the Florida AHCA, not all are required to report, including 
one Shriner’s Hospital that provides care at no cost to patients, as well as long and short-
term psychiatric hospitals, inpatient residential treatment and rehabilitation facilities, and 
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military hospitals [202].  The lack of reporting to the Florida AHCA means I was not able 
to capture access to care data on all the children within the Florida SB population under 
study.  However, because data from 108 different Florida hospitals were represented in 
the data set [140] and because most of the non-reporting hospitals do not provide 
newborn care, the amount of data lost was likely limited and thus the findings of this 
research may be generalizable at least to the state of Florida.   
 Lastly, the use of administrative data does not capture all aspects of an 
individual’s inclination to use health services resources, and specifically factors related to 
travel to access care.  Characteristics, such as family resources, employment status, 
access to a personal vehicle, and health beliefs and health literacy, are not available in 
administrative data, but are all characteristics that may influence the use of hospital 
services separate from the influence of travel time and distance.   
5.8.4 Limitations Inherent in Research Design 
 This research faced additional limitations resulting from the study design.  
Because of data limitations, I assumed a single maternal residential address (from infant 
birth records) for all admissions when calculating average one-way travel time and 
distance to hospitals of care.  Families of children with SB, however, could have made 
one or more intrastate moves during the study period or children may move to live with 
someone other than their mothers.  The assumption of the maternal address at the infant’s 
delivery for all later hospital admissions likely introduced error in the calculations; 
however, Florida state law specifically prohibits follow-up contact by the FBDR or 
FDOH with families of children with birth defects, so addresses associated with 
subsequent hospital visits could not be confirmed.  
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 No research has examined residential mobility among children with birth defects 
during infancy or in childhood.  However, several studies provide general insight into 
residential mobility.  A 2003 U.S. Census Bureau Current Population Survey found that 
14% of all U.S. residents moved between 2002 and 2003 [256].  The same U.S. Census 
also reported that among individuals who moved, 59% moved within the same county 
and 19% moved to a different county within the same state [256].  Among all individuals 
who moved between 2002 and 2003, the U.S. Census reported that 19% moved to a 
different state [256].  A study of 1984 data from the population-based Maryland Birth 
Defects Reporting and Information System reported residential mobility among pregnant 
women of 20% and suggested that residential mobility likely resulted in misclassification 
of the exposure measured [257].  Similarly, research using geocoded data from the 1993-
1997 Birth Defects Risk Factor Surveillance Study found that maternal mobility may 
introduce non-differential misclassification into analytic findings [258], as did two 
subsequent studies [259, 260].  Error introduced by residential mobility following an 
infant’s birth is an important limitation that should be acknowledged for this study.  In 
future research, residential addresses could be updated and geocoded at the zip code level 
for hospitalizations subsequent to the birth hospitalization using the Florida AHCA data.  
Future research that included collaborative, multistate work could also be useful in 
addressing the challenges introduced by residential mobility. 
 The use of network methodology and geocoding techniques involved additional 
assumptions that may have introduced error into the findings.  First, I assumed that all 
travel was made by personal vehicles.  No adjustments in time and travel distances were 
made for public transportation methods.  Second, families were assumed to have driven 
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the shortest and fastest travel routes to access hospital care.  This assumption may not be 
valid, as parents may have taken more familiar routes, chosen to avoid certain areas or 
types of roads, or linked trips to the hospital with other family commitments or needs 
(trip-chaining) [261, 262].  Also, the shortest travel times and distances may change 
throughout the day based on traffic congestion patterns, thus affecting the actual travel 
experience.  Additionally, about 3% of the infants were geocoded at the ZIP-code level 
rather than the street address level [140], thus introducing a level of uncertainty about 
their actual travel time and distance.  Any of these assumptions could have resulted in an 
over or understatement of the actual one-way travel time and distance.  Time and travel 
distance were also reported as one-way travel and did not include the reverse trip.  This 
method of report therefore underestimated the full travel burden to access hospital care. 
 Finally, while the study population was comprised of children with SB, the 
reasons for travel to access hospital care was unknown.  While hospitalization may have 
been directly related to a children’s SB diagnosis, hospitalizations could also occur 
because of other illnesses or injuries unrelated to SB.  Any interpretations and 
conclusions must therefore be made with caution.  
5.9 Implications for Public Health Practice and Research  
 This study suggests several points for consideration in the areas of public health 
and access to health care services.  First, this research suggests that the use of birth 
defects surveillance data combined with geocoding methodology contributes vital 
information about patterns, predictors, and barriers to accessing hospital care for children 
with SB.  While geocoding methodology has often been used in birth defects research to 
map geographic distribution of birth defects and to examine exposures to potential 
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teratogens [145-149, 263], this study demonstrates that the use of GIS methodology in 
association with birth defect registry data can provide valuable data related to health 
services use [264].  An understanding of patterns and predictors of the travel burden 
associated with access to hospital care may be important to the coordination of delivery 
of services by health care planners or by governmental providers, such a federal state, and 
local agencies, particularly those serving CSHCN [13, 123, 140].  Further exploration of 
these data may suggest geographic areas in which shortages of adequate health care 
resources exist. 
 Second, results identified several factors associated various travel burdens to 
access hospital care for children with SB.  These findings suggest areas in which to focus 
heath care resources.  Opportunities may exist to better educate parents or caregivers 
about the best options for health care for their child with SB and how to access those 
resources, especially if they include greater travel burdens.  Information on insurance 
acceptance, ways to minimize travel costs, and means of obtaining support services such 
as housing away from home [265] could be helpful, especially if longer travel meant 
access to more appropriate specialty hospital care for a child with SB.  However, the 
factors most often associated with travel time and distance that are reported in this 
research (clinical needs including hydrocephalus, non-isolated SB, and preterm birth; 
maternal race/ethnicity; and rural residence) each have a low degree of mutability.   
This observation reinforces the importance of primary prevention, with a particular focus 
on continued support for folic acid fortification of the U.S. food supply and continued 
education about prenatal intake of folic acid among women of childbearing age [50, 52, 
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116, 266] and other health practices that have been shown to reduce the risk of birth 
defects. 
 This study also suggests opportunities for further public health research or 
research related to access of health care services.  First, future research could further 
explore factors and patterns associated with travel time and distance to access health care, 
including not only hospital care, but also outpatient care, and follow-up care at specialty 
centers.  Factors warranting further examination could include the influence of public 
transportation or ownership of personal vehicles, daily traffic patterns, the effects of 
direct and indirect travel costs, and travel burdens by type of hospital; for example, 
comparing travel to children’s specialty hospitals versus local community hospitals.  
Second, a more complete understanding of both individual and area-based socioeconomic 
measures could provide insights into the influence of socioeconomic status on choice of 
hospital and associated travel.  Third, qualitative research could be important to gaining a 
deeper understanding of factors that influence parents’ decisions related to travel and the 
selection of a hospital for the care their children with SB.  A better understanding of 
qualitative findings, such as feelings, perceptions, barriers and conflicting pressures, 
previous hospital experiences, and other reasons for choosing one hospital or doctor over 
another, could inform our understanding of the role of personal decision-making in the 
selection of a hospital.  Fourth, understanding the reasons for hospitalizations (e.g., the 
admitting diagnoses) could contribute to a more accurate understanding of the reason for 
choosing one hospital over an alternate location. 
 Finally, the findings of this study can help to inform research for other birth 
defects.  Birth defects, such as orofacial clefts, congenital heart disease, and 
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chromosomal anomalies may also have multiple presentations, associated comorbidities, 
and require long-term specialty care.  A better understanding of factors that influence 
access to care, including geographic location and travel time and distance, can suggest 
ways to identify and address barriers to care.  Increased access to health care, whether 
through increased geographic accessibility to hospital care or by facilitating 
improvements in availability, accommodation, affordability, or acceptability of health 
care, may improve health outcomes, reduce health costs, and improve long-term quality 
of life for children with SB or other similar birth defects. 
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Table 5.1: Selected characteristics of Florida-born children with spina bifida and with a geocoded maternal residential 
address at birth, 1998-2007 
Characteristics 
All children with SB 
(n=612) 
Without 
hydrocephalus 
(n=265, 
43.3%) 
With 
hydrocephalus 
(n=347, 56.7%) p-value 
n (%) n (%) n (%) 
Exposures of interest        
Hydrocephalus        
     Yes 347 (56.7)      
     No 265 (43.3)      
Spina bifida 1        
     Isolated  456 (74.5) 198 (74.7) 258 (74.4) 0.918 
     Non- isolated  156 (25.5) 67 (25.3) 89 (25.6)  
Hydrocephalus and SB        
     No 523 (85.5)      
     Yes 89 (14.5)      
Predisposing characteristics        
Maternal age (in years)        
     ≤ 24 224 (36.6) 78 (29.4) 146 (42.1) 0.006 
     25-29 164 (26.8) 79 (29.8) 85 (24.5)  
     >30 224 (36.6) 108 (40.8) 116 (33.4)  
Maternal race/ethnicity        
     Non-Hispanic White 321 (52.4) 136 (51.3) 185 (53.3) 0.005 
     Hispanic 153 (25.0) 73 (27.6) 80 (23.1)  
     Non-Hispanic Black 128 (20.9) 54 (20.4) 74 (21.3)  
     Other 10 (1.6) 2 (0.7) 8 (2.3)  
Maternal nativity        
     Born in U.S. 464 (75.8) 198 (74.7) 266 (76.7) 0.849 
     Foreign-born 146 (23.9) 66 (24.9) 80 (23.0)  
     Missing 2 (0.3) 1 (0.4) 1 (0.3)  
 Maternal marital status        
     Married 366 (59.8) 162 (61.1) 204 (58.9) 0.558 
     Not married 246 (40.2) 103 (38.9) 143 (41.2)  
Maternal parity        
     First child 237 (38.7) 99 (37.5) 138 (39.8) 0.234 
     Second subsequent child 374 (61.1) 165 (62.5) 209 (60.2)  
     Missing 1 (0.2)      
Maternal education        
     High school diploma or more 466 (76.1) 48 (18.3) 90 (26.3) 0.112 
     No high school diploma 138 (22.6) 214 (81.7) 249 (72.8)  
     Missing 8 (1.3)      
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Table 5.1 (continued)        
 All children Without hydrocephalus 
With 
hydrocephalus p-value 
Sex of child        
     Female 315 (51.5) 142 (53.6) 173 (49.9) 0.360 
     Male 297 (48.5) 123 (46.4) 174 (50.1)  
Enabling characteristics        
Prenatal care 2        
     Adequate prenatal care 445 (72.7) 194 (77.9) 251 (76.3) 0.647 
     Inadequate prenatal care 133 (21.7) 55 (22.1) 78 (23.7)  
     Missing 34 (5.6)      
Rurality 3        
     Urban/urban cluster 525 (85.8) 226 (85.3) 299 (86.2) 0.756 
     Rural 87 (14.2) 39 (14.7) 48 (13.8)  
Payer for birth hospitalization 4        
     Public payer 292 (47.7) 128 (48.3) 192 (55.3) 0.113 
     Private payer 253 (41.3) 123 (46.4) 145 (47.8)  
     Self or uninsured 24 (  3.9) 14 (5.3) 10 (2.9)  
     No birth hospitalization 43 (7.0)      
Payer type during infancy 4        
      Public payer only 305 (49.8) 123 (46.4) 182 (52.4) 0.097 
     Private payer only 235 (38.4) 114 (43.0) 121 (34.9)  
     Self or uninsured 8 (1.3) 5 (1.9) 3 (0.9)  
     Multiple payers 64 (10.5) 23 (8.7) 41 (11.8)  
Payer type, ages 1-4 years 4        
     Public payer only 117 (46.6) 29 (47.5) 88 (46.3) 0.157 
     Private payer only 68 (27.1) 21 (34.4) 47 (24.7)  
     Multiple payers 66 (26.3) 11 (18.0) 55 (29.0)  
Need characteristics      
Preterm birth (< 37 weeks gestation)        
     Yes 162 (26.5) 205 (78.0) 242 (69.9) 0.027 
     No 447 (73.0) 58 (22.0) 104 (30.1)  
     Missing 3 (0.5)      
Low birth weight (< 2500 grams)        
     Yes 120 (19.6) 206 (77.7) 285 (82.4) 0.153 
     No 491 (80.2) 59 (22.3) 61 (17.6)  
     Missing 1 (0.2)      
Plurality        
     Singleton birth 591 (96.6) 252 (95.1) 339 (97.7) 0.080 
     Multiple birth 21 (  3.4) 13 (4.9) 8 (2.3)  
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Table 5.1 (continued) 
All children Without hydrocephalus 
With 
hydrocephalus p-value 
Level of nursery care in birth hospital 5 
 Level III 437 (71.4) 152 (57.6) 285 (82.1) <0.0001 
 Level I or II 174 (28.4) 112 (42.4) 62 (17.9) 
 Missing 1 (0.2) 
Death 6 
 No death before age 4  560 (91.5) 239 (90.2) 320 (92.2) 0.310 
 Died during infancy 41 (6.7) 22 (8.3) 19 (5.6) 
 Died in ages 1-4 11 (1.8) 4 (1.5) 8 (2.3) 
Note: Columns may not add to 100% because of missing or unknown values
Note: Presence of hydrocephalus and major birth defects used to identify non-isolated SB were based on coded data and not clinically 
verified.  
1 Isolated spina bifida is defined as SB with no additional major defects, other than the sequence of  defects related to SB. 
2 Adequacy of prenatal care was determined using the Kotelchuck Index.  Based on Kotelchuck scoring, adequate and adequate plus 
are considered “adequate prenatal care”.   
3 Rurality calculated using the 2000 U.S. Census block group data corresponding to the maternal residential address at birth. 
4 Payers are expected health care payers.  Public insurance included Medicare, Medicaid, KidCare, and Veterans Administration 
insurance.  Private included employer-based insurance, including military coverage (CHAMPUS/TriCare).  Self or under-insured 
defined as no insurance or no third party coverage or less than 30%.  Multiple payer type means child had different types of health 
care payer sources over multiple hospitalizations. 
5 Level 3 is highest level of hospital nursery care.  Level 1 is the lowest level of hospital nursery care.
6 Death were those that occurred during the study period, prior to December 31, 2008. 
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Figure 5.1 Map of geomasked maternal residential addresses at delivery for 
Florida-resident infants with spina bifida, 1998-2007 (n=612) 
Figure 5.2 Map of geomasked maternal residential addresses at delivery for  
Florida-resident children with spina bifida, ages one to four years, 1998-2007 
 (n=251) 
Data sources: Agency for Health Care Administration, 1998-2008; Florida Birth Defects Registry, 1998-
2007; U.S. Census Bureau, 2000 (www.census.gov); Florida Department of Transportation, 2007  
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Figure 5.3 Map of Florida hospitals where Florida-resident children with spina bifida 
were hospitalized, 1998-2008 (n=108 hospitals) 
Data sources: Agency for Health Care Administration, 1998-2008; Florida Birth Defects Registry, 1998-
2007; U.S. Census Bureau, 2000 (www.census.gov); Florida Department of Transportation, 2007  
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Figure 5.4 Map of travel patterns to access hospital care for Florida-resident infants with 
spina bifida, 1998-2007 (n=612) 
Figure 5.5 Map of travel patterns to access hospital care for Florida-resident children with 
spina bifida, ages one to four, 1998-2007 (n=251) 
Data sources: Agency for Health Care Administration, 1998-2008; Florida Birth Defects Registry, 1998-
2007; U.S. Census Bureau, 2000 (www.census.gov); Florida Department of Transportation, 2007  
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Figure 5.6: Average one-way travel time to access hospital care for Florida-born children 
with spina bifida, birth to 4 years, 1998-2007 
.
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APPENDIX A:  NBDPN MAJOR BIRTH DEFECTS 
Birth Defects Included in the Case Definition  
of the National Birth Defects Prevention Network (NBDPN) 
Birth Defects ICD-9-CM Codes CDC/BPA Codes 
Central Nervous System 
Anencephalus 740.0 - 740.1 740.00 - 740.10 
Spina bifida without anencephalus 741.0, 741.9 w/o 740.0 -740.10 
741.00 - 741.99 
w/o 740.0 - 740.10 
Hydrocephalus without spina bifida 742.3 w/o 741.0, 741.9 742.30 - 742.39 w/o 741.00 - 741.99 
Encephalocele 742.0 742.00 - 742.09 
Microcephalus 742.1 742.10 
Eye 
Anophthalmia/microphthalmia 743.0, 743.1 743.00 - 743.10 
Congenital cataract 743.30 - 743.34 743.32 - 743.326 
Aniridia 743.45 743.42 
Ear 
Anotia/microtia 744.01, 744.23 744.01, 744.21 
Cardiovascular 
Common truncus 745.0 745.00 - 745.01 
Transposition of great arteries 745.10, .11, .12, .19 745.10 - 745.19 
Tetralogy of Fallot 745.2 745.20 - 745.21, 746.84 
Ventricular septal defect 745.4 745.40 - 745.490 (exclude 745.498) 
Atrial septal defect 745.5 745.50 - 745.59 (exclude 745.50) 
Endocardial cushion defect 745.60, .61, .69 745.60 - 745.69 
Pulmonary valve atresia and stenosis 746.01, 746.02 746.00 - 746.01 
Tricuspid valve atresia and stenosis 746.1 746.10 (exclude 746.105) 
Ebstein’s anomaly 746.2 746.20 
Aortic valve stenosis 746.3 746.30 
Hypoplastic left heart syndrome 746.7 746.70 
Patent ductus arteriosus 
(Include only if weight=>2500 grams 
or note if unable to exclude <2500 
grams infants.) 
747.0 747.00 
Coarctation of aorta 747.10 747.10 - 747.19 
Orofacial 
Cleft palate without cleft lip 749.0 749.00 - 749.09 
Cleft lip with and without cleft palate 749.1, 749.2 749.10 - 749.29 
Choanal atresia 748.0 748.00 
260 
Birth Defects ICD-9-CM Codes CDC/BPA Codes 
Gastrointestinal 
Esophageal atresia/tracheoesophageal 
fistula 750.3 750.30 - 750.35 
Rectal and large intestinal 
atresia/stenosis 751.2 751.20 - 751.24 
Pyloric stenosis 750.5 750.51 
Hirshsprung's disease (congenital 
megacolon) 751.3 751.30 - 751.34 
Biliary atresia 751.61 751.65 
Genitourinary 
Renal agenesis/hypoplasia 753.0 753.00 - 753.01 
Bladder exstrophy 753.5 753.50 
Obstructive genitourinary defect 753.2, 753.6 753.20-29 - 753.60- 69 
Hypospadias and Epispadias 752.61, 752.62 752.600 - 752.627 (excluding 752.621) 
Musculoskeletal 
Reduction deformity, upper limbs 755.20 - 755.29 755.20 - 755.29 
Reduction deformity, lower limbs 755.30 - 755.39 755.30 - 755.39 
Gastroschisis 756.79 756.71 
Omphalocele 756.79 756.70 
Congenital hip dislocation 754.30, .31, .35 754.30 
Diaphragmatic hernia 756.6 756.610 - 756.617 
Chromosomal 
Trisomy 13 758.1 758.10 - 758.19 
Down syndrome (Trisomy 21) 758.0 758.00 - 758.09 
Trisomy 18 758.2 758.20 - 758.290 
Other 
Fetal alcohol syndrome 760.71 760.71 
Amniotic bands No code 658.80 
Source: National Birth Defects Prevention Network Inc. (NBDPN), Guidelines for Conducting Birth Defects 
Surveillance, L. Sever, Editor 2004: Atlanta, GA 
